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Abbreviations
Abbreviations in this thesis comply with the policy of the 
Biochemical Journal, but in addition the following are also 
used:
E.I. Endocytic Index
PTA phosphotungstic acid
T.A.R. tissue-associated radioactivity
TCA trichloroacetic acid
y.s. yolk sac
125I-fdBSA 125formaldehyde-denatured I-labelled 
bovine serum albumin
125I-PVP 125I-labelled polyvinylpyrrolidone
*2"*I-ribonuclease 125I-labelled ribonucléase
125I-RNase 125I-labelled ribonucléase
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Abstract
The rat visceral yolk sac (17.5 days gestation) was incubated in 
vitro to try to elucidate some of the factors important in controlling 
pinocytosis and protein degradation. An investigation of four closely- 
related ribonuclease molecules revealed that a minor structural change 
in a protein (possibly of a type that occurs in vivo) greatly enhanced 
its rate of uptake by the yolk-sac tissue, supporting the suggestion 
that proteolytic "nicking" may be a signal for removal of a protein 
from the circulation. This study also showed there to be no mannose 
receptor on the surface of the yolk sac, and that the presence of a small 
oligosaccharide on the surface of the ribonuclease molecule neither 
hindered its entry into the tissue, nor affected its subsequent rate 
of digestion.
The maximum pinocytic rate was exhibited when yolk sacs were 
incubated in serum-free medium. Addition of serum (up to 50%, v/v) 
led to a progressive fall in both the pinocytic rate and the rate of 
degradation of internalized radiolabelled-protein. Addition of amino 
acids and formaldehyde-denatured BSA to the incubation medium also led 
to a fall in the rate of degradation of endogenous proteins (data 
provided by F.J.B. and S.E.K.). These findings support the suggestion 
that the control of pinocytosis and autophagy may be related by virtue 
of them both being membrane-related processes.
The effects of a variety of agents (insulin, cycloheximide, 
puromycin and bacitracin) on pinocytosis and on proteolysis of exogenous 
and endogenous proteins (the latter data compiled by F.J.B. and S.E.K.) 
were examined, and compared with the effects in other tissues, as 
reported in recent literature. Neither of two hypotheses (one based 
on membrane movement and one on response to intracellular amino acid
\IV
levels), postulated to relate the rate of pinocytosis to the rate of 
degradation of endogencms proteins, is supported by the data.
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CHAPTER 1
GENERAL INTRODUCTION
1General Introduction
Every mammalian cell is bounded by its plasma membrane and, in 
order to survive, the cell needs to be able to ingest materials from 
its extracellular environment. Both low molecular weight and macro- 
molecular materials can be ingested, and the cell has evolved a number 
of different mechanisms to achieve this. Certain low molecular-weight 
molecules (mainly non-polar) are able to diffuse across the lipid 
bilayer which surrounds the cell (e.g. C^, (X^ and H^O) whereas the 
passage of small, polar compounds into the cell is achieved by active 
or passive transport mechanisms that involve membrane proteins (e.g. 
the transport of amino acids in the gut). The translocation of 
macromolecular material into the cell (important, for example, in the 
turnover of extracellular materials and in the defence of the organism) 
is realised by a different mechanism called endocytosis, which is the 
process by which such materials as serum proteins, bacteria and viruses, 
and antigen-antibody complexes are ingested by cells.
Endocytosis is a membrane-related phenomenon. The process often 
begins with a small depression in the plasma membrane which increases 
in size through a hemi-sphere to an almost complete sphere that 
communicates through a narrow neck with the extracellular space. 
Invagination is completed by the plasma membrane "pinching off" at the 
neck returning the cell surface to its former, smooth appearance and, 
at the same time, forming a vesicle located just beneath the surface of 
the plasma membrane. The cytoplasmic surface of the original plasma 
membrane becomes the cytoplasmic surface of this vesicle, and the 
extracellular surface of the plasma membrane becomes its internal 
surface. Any extracellular material in close proximity to the 
invaginating membrane can be captured by the cell and contained within
the vesicle.
2Endocytosis can be divided into two different forms. The 
first of these, phagocytosis, involves the ingestion of particulate 
material, and the size of vesicle formed is 1 pm, or larger, in 
diameter. Phagocytosis was first described by Metchnikoff in 1883, 
who followed the ingestion of particles by leucocytes under the light 
microscope. This process has a variety of important physiological 
roles such as providing a feeding mechanism for amoebae, and in 
enabling macrophages to engulf invading microorganisms as part of the 
organism's defence system. The second form of endocytosis is called 
pinocytosis, and is distinguishable from phagocytosis on two counts: 
firstly, pinocytosis involves the ingestion of extracellular fluid 
(not particles); and secondly, the vesicles formed are smaller than 
those formed in phagocytosis. Pinocytosis was first described by 
Lewis (1931) who observed the formation of small vesicles (0.2 to 1 ym 
in diameter), not containing particulate matter, from the plasma 
membrane of rat macrophages under the light microscope. Following 
the successful introduction of the electron microscope, Palade (1953) 
demonstrated that pinocytosis also occurred at the sub-light microscopic 
level in blood capillaries. To distinguish the electron microscopically- 
detectable pinocytic activity from that viewed in the light microscope, 
pinocytosis has been sub-divided into two forms, namely micropinocytosis 
and macropinocytosis respectively. Micropinocytosis has since been 
demonstrated, to different degrees, in virtually all mammalian cells; the 
vesicles formed are approximately 70 nm in diameter.
Conceptually, the process of pinocytosis is further sub-divided 
into two distinct types, fluid-phase and adsorptive (or surface) 
pinocytosis, but in the majority of cell types both occur concurrently. 
Fluid-phase pinocytosis is, as its name implies, simply the engulfing 
of extracellular fluid within the pinocytic vesicle as it forms.
3Any solutes in the extracellular medium which have no affinity for 
the cell surface may be taken up into the cell by this route, and 
their rate of uptake will depend only upon their concentration in 
the extracellular fluid and upon the rate of vesicle formation by the 
cell (Williams et al., 1975a; Steinman et al., 1978). Adsorptive 
or surface pinocytosis, on the other hand, involves interaction of 
an extracellular solute with the plasma membrane, either by non­
specific adsorption onto the surface of the cell, or by the binding of 
the component to a specific receptor molecule (Williams et al., 1975b; 
Brown et al., 1978). This effectively increases the concentration 
of the component within the forming pinosome, and therefore increases 
its rate of uptake by the cell. Mathematical models of these two 
forms of pinocytosis have been developed by Jaques (1969); these 
permit expression of the rate of uptake of extracellular components 
by these routes. The successful testing of these models has been 
performed by Williams et al. (1975a,b) and Roberts et al. (1977).
Once inside the cell, the pinosome is translocated through the 
cell with the contents becoming more concentrated, and perhaps fusion 
occurring with other incoming vesicles, until it comes into close 
proximity with lysosomes (membrane-bound vesicles containing a large 
range of acid hydrolases). Primary lysosomes are believed to be 
formed in a specialized portion of smooth endoplasmic reticulum, 
which is distinct from, but adjacent to, the concave face of the Golgi 
and is called the GERL (Golgi-associated Endoplasmic Reticulum from 
which Lysosomes arise). The incoming pinosome can fuse with a primary 
lysosome to form a secondary lysosome, and the contents of the pinosome 
become degraded by the hydrolytic enzymes from the lysosome; incoming 
pinosomes may also fuse with secondary lysosomes. Macromolecules within 
the secondary lysosome are degraded to the level of monomers and, since
4the lysosomal membrane is permeable to components with a molecular 
weight of up to approximately 200 daltons, free amino acids produced 
by intralysosomal proteolysis are able to diffuse across the lysosomal 
membrane and escape from the cell. Following many fusion events, a 
secondary lysosome will eventually lose most of its hydrolytic capacity 
and be identified within the cell as a vesicle containing only 
indigestible remains, often appearing whorled under the electron 
microscope; such a vesicle is called a residual body. Continual 
removal of membrane from the cell surface during endocytosis quickly 
raises the problem of membrane replacement (Duncan & Pratten, 1977). 
Evidence is now accumulating that plasma membrane fragments are recycled 
back to the cell surface after transit through the lysosomal compartment 
(Schneider et al., 1978).
Other cell functions also depend on the vacuolar system of 
the cell but are not directly related to pinocytosis. Secretion is one 
such process where secretory vesicles, packed with secretory products 
from the Golgi, are translocated to the surface of the cell. Fusion 
of the secretory vesicle with the plasma membrane occurs by a process 
called exocytosis (the reverse of pinocytosis) resulting in the secretory 
components being expelled from the cell. If the cell is producing 
excess secretory products then lysosomes will fuse with the secretory 
vesicles before their arrival at the cell surface so that the products 
for export are catabolized; this process is called crinophagy.
Pinocytosis following secretion may be envisaged as a mechanism for 
membrane recovery in such secretory cells. [Secretion has been 
extensively reviewed (Silverstein, 1978).] A process related to 
crinophagy is autophagy, and this appears to be present in all cell 
types. Its function is the turnover of intracellular materials, 
whether soluble intracellular proteins or organelles, and involves a
5portion of the cytoplasm (often containing organelles) being surrounded 
by membrane (presumably originating from the endoplasmic reticulum) 
which eventually totally encapsulates the region. Fusion of such an 
autophagic vacuole with the lysosomal system will ensure the digestion 
of its contents. [This process has also been extensively reviewed 
(Rapoport & Schewe, 1978).]
In certain specialized cells, such as the endothelial cells 
lining the capillaries, pinosomes may be translocated right across the 
cell without any interaction with the lysosomal compartment; this is 
an exception to the usual rule of fusion between vesicles and lysosomes.
On reaching the other side of the cell the vesicles fuse with the 
plasma membrane, extruding their contents into the extracellular medium, 
and this overall process is called diacytosis (Pitt, 1975). The 
function of diacytosis is to translocate extracellular components across 
the cell intact, and an example of this is the passage of immunoglobulins 
across cells (Wild, 1975).
The rate of uptake of a macromolecule by fluid-phase pinocytosis 
is dependent upon both the concentration of the extracellular material 
and the rate of vesicle formation by the tissue. The latter is greatly 
influenced by a number of other factors. The rate of pinocytosis is 
very dependent upon temperature, and a lowering of the temperature from 
37°C by only a few degrees can substantially reduce the pinocytic activity 
of cells (Duncan & Lloyd, 1978); pinocytosis is completely inhibited 
at 4°C. The rate of pinocytosis is also known to be influenced by the 
presence of either metabolic inhibitors or microtubular inhibitors 
(Duncan & Lloyd, 1978; Pratten & Lloyd, 1979), implicating both metabolic 
energy and microtubular function as being important in the control of this 
membrane process.
Adsorptive pinocytosis, besides being dependent upon the factors
6discussed above, is also dependent on additional factors. The number 
and type of binding sites or receptors on the surface of the cell at 
any one time is going to directly influence the rate of uptake of a 
particular ligand by the cell. Since it is inconceivable that every 
material has a specific receptor, the term binding site is used for 
an area of the plasma membrane where an affinity between a ligand and the 
cell surface exists and which is relatively non-specific in character, 
whereas the term receptor is reserved for a very specific interaction.
The binding capacity of the plasma membrane for a ligand can in principle 
be determined by measuring the affinity of the ligand for the cell 
surface when pinocytosis is fully inhibited. Clearly the physical 
nature of a substrate is going to be of the utmost importance in 
determining its rate of uptake into cells, and many physical properties 
of the substrate may be important in this context: its general chemical 
structure (e.g. a protein, a glycoprotein, a glycolipid), the charge on 
the substrate (negative, positive cr neutral), the size of the substrate 
(small or large, monomer or polymer), the conformation of a given 
substrate (whether in its native form or in some degree of denaturation). 
These considerations are more fully discussed in Section 3.1. Little 
is understood in general terms of the factors controlling the rate of 
formation of autophagic vacuoles in cells. The depletion of certain 
amino acids in the extracellular medium may be of some importance 
since autophagy has been shown to be stimulated under these conditions 
in a variety of cell types. Another possibly important controlling 
factor is the influence of hormones since glucagon has been shown to 
stimulate and insulin to depress this process in most cell types studied.
Methods used in the study of endocytosis usually involve following 
the fate of some tracer molecule within the cell, by either physical 
or chemical methods. These tracer molecules are usually labelled in
7one of three ways: firstly, if the tracer molecule is an enzyme which
is ^_________  active, then its inherent "label" is its enzyme
activity, secondly, tracer substrates may be labelled with radioactivity 
and thirdly, the tracer molecule may be chemically labelled. All 
of these methods are useful, but they all have their limitations 
which must be borne in mind during interpretation of results. Once 
an enzymB has been successfully pinocytosed by a cell, one
would expect it to be degraded within the lysosomal system. If the 
level of tracer enzyme activity within the tissue falls, then one 
could attribute this to either loss of the tracer enzyme from the 
cell, its non-proteolytic inactivation or its proteolytic degradation.
The problem is, of course, to determine the fate of the enzyme with 
confidence. If the tracer macromolecule is radiolabelled, then the 
problems experienced are different. Interference of the radiolabel 
with the normal functioning of the molecule may occur or, following 
degradation of the tracer, reincorporation of the label into other 
molecules may occur within the cell. The major problems associated 
with chemically-labelled substrates (e.g. macromolecules labelled 
with electron opaque or fluorescent moieties for detection by microscopy) 
are again that the addition of the tracer moiety may modify., the behaviour of 
the molecule; also one can never be sure of the label remaining 
attached to the molecule so that the location of the labelling moiety 
does not necessarily indicate the location of the conjugate.
Both in vivo and iri vitro methods have been used to measure rates 
of pinocytosis in tissues. In vivo experiments usually involve 
injection of the substrate under investigation into the circulation of 
the intact animal, and then following either its rate of clearance 
from the circulation or uptake by the different tissues. The limitations 
of this method are obvious if digestible substrates are used since
8digestion within a tissue will be followed by release of digestion 
products into a common pool. Other practical considerations involve 
interanimal variations, the cost and convenience with regard to time- 
course experiments and the problem of low molecular weight markers 
being removed by the kidneys. A number of different in vitro systems 
have been used. Perfusion studies allow a substrate to come into 
contact with an organ and permit measurement of the amount of substrate 
retained by the tissue. Although this method allows the structural 
integrity of the tissue to be maintained, there are some drawbacks 
to this technique. It is not simple to set up, and again one will produce 
a common pool of digestion products, so again it is impossible to establish 
from which cell types digestion products arise. Another well-used 
in vitro method is that of cell culture, where cells isolated from a 
tissue are cultured in suspension or in monolayers, either as a 
mixed population of cells oar after a preliminary separation step. The 
main advantages of these techniques are that they can be fairly simple, 
and also allow the study of different cells from a given tissue (e.g. 
Kupffer and parenchymal cells from liver). Unfortunately any vectorial 
feature of the cells is often, although not always, lost when the 
structural arrangement of the whole tissue is destroyed, and treatment 
with proteolytic enzymes to free the cells may damage protein components 
of the membrane surface; any residual proteolytic activity may also 
interfere itl subsequent experiments. A valuable compromise between 
these two techniques is the culture of an organ or tissue excised from 
a freshly-killed animal and maintained in vitro until it begins to 
behave atypically; this method has the simplicity of the cell culture 
technique with the physiological advantages of the retention of the 
anatomical structure of the tissue. It is particularly suitable for 
tissues with a large surface area to volume ratio, and one such tissue
9that has been extensively studied using this technique is the rat 
visceral yolk sac.
The rat visceral yolk sac, in the last third of gestation, surrounds 
both the fetus and the amnion and forms the outermost barrier between the 
fetus and the uterus. [Until 16 days of gestation another membrane, 
the parietal yolk sac, surrounds the visceral yolk sac. At 16 days 
this disappears, leaving the visceral yolk sac in contact with the 
uterine fluid (Beck & Lloyd, 1968).] It is the visceral yolk sac 
that is incubated in vitro in this well-documented method (Williams et^  al., 
1975a,b). The tissue is composed of three separate cellular layers:
firstly the visceral endoderm, composed of columnar epithelial cells 
resting on a basement membrane; secondly the mesenchymal layer, composed 
of mesenchymal cells and blood capillaries resting on a thick, serosal 
basement membrane; thirdly a sparse layer of mesothelial cells
*
(Seibel, 1974). It is the tightly packed layer of columnar epithelial 
cells in the first of the three layers that is pinocytically active; 
the apical faces of these epithelial cells are exposed to the uterine 
cavity (post 16 days gestation) and are microvillous in character.
Investigation of the visceral yolk sac is technically fairly easy.
Yolk sacs are incubated with radiolabelled substrates in gassed 
(95% 0^/57, CC^) medium 199, either in the presence or absence of 
calf serum (10%, v/v) for up to 6h. At the end of the incubation 
period, following their removal from the medium, the yolk sacs are 
washed in ice-cold saline and are assayed for both radioactivity and 
protein content; the residual medium is assayed for radioactivity.
The yolk-sac tissue is fairly robust, and quantitative measurements of 
the pinocytic activity of the tissue have proved to be very reproducible.
It therefore presents itself as an excellent system for studying factors 
affecting pinocytosis, and has already been used to investigate quite
10
a diverse range of factors that may control pinocytosis. The effects 
of temperature (Duncan & Lloyd, 1978), oxygen tension (Seymour, 
unpublished data), and removal of serum from the incubation medium 
(Ibbotson & Williams, 1979) have been investigated. The presence of 
metabolic inhibitors, microtubular inhibitors (Duncan & Lloyd, 1978) and 
proteolytic inhibitors (Livesey et al., 1980; Knowles et al., 1981) 
in the incubation medium and their effects on pinocytosis have been 
studied, and the properties of simple protein substrates (Livesey & 
Williams, 1981; Livesey & Williams, 1982), immunoglobulins (Weisbecker, 
1981), denaturation of proteins and galactose moieties (Moore et al., 1977) 
on rates of protein uptake by the tissue have been examined. However, 
the yolk-sac incubation technique has left many questions unanswered.
Very little has been found out about how subtle changes in protein 
conformation can affect protein uptake by the tissue, or about the 
presence of any receptors on the cell surface. Another area which is 
of great importance, but which has received very little attention, is 
the effect of the medium composition on the basal rate of pinocytosis
s
in the yolk sac.
The aim of this project was to use the yolk-sac system to investigate 
two questions. The first question asked was: "Can subtle changes in 
the chemical nature of a simple protein substrate affect its rate of 
pinocytic uptake?"; the second: "Can changes in the composition of 
the incubation medium affect the pinocytic uptake of a substrate?".
The first question was investigated by examining the rate of uptake of 
a family of closely-related ribonuclease molecules, to try to relate 
any differences in rates of pinocytosis to differences in structure, 
and to see if there were any differences in their subsequent degradation
11
by the yolk-sac tissue (Chapter 3). The second question was sub­
divided into three parts. The first was to investigate whether the 
basic composition of the incubation medium (presence of inorganic 
salts, vitamins, proteins and other components) could affect the rate 
of fluid-phase pinocytosis and the rate of adsorptive pinocytosis of 
a protein and its subsequent degradation within the yolk-sac tissue 
(Chapter 4). The second was to investigate the effect of hormonal 
influences upon these parameters (Chapter 5), and the third, to examine 
the effects of antibiotics upon these same parameters (Chapter 5).
It would be interesting to establish whether factors controlling 
rates of pinocytosis also influence rates of degradation of intracellular 
proteins. This study was expanded by collaboration with F.J. Ballard 
and S.E. Knowles, (CSIRO, Division of Human Nutrition, Adelaide,
S.A. 5000, Australia) who examined a number of factors that may 
affect the rate of endogenous protein degradation in the rat visceral 
yolk sac. It was envisaged that a comparison of the effects of these 
factors upon pinocytosis, and upon exogenous and endogenous protein 
degradation in the yolk sac, may provide evidence for some underlying 
control mechanism relating these phenomena.
CHAPTER 2
MATERIALS AND GENERAL METHODS
12
2.1 Materials
(i) Equipment
Centrifuge Mistral 4L. M.S.E., U.K.
Gamma counter 5142 Selektronic Gamma Spectrometer. Packard 
Instruments Ltd., Caversham, Berks., U.K.
Spectrophotometer CE 373 Linear Reading Grating Spectrophotometer. 
Cecil Instruments Ltd., Cambridge, U.K.
Water baths Laboratory Thermal Equipment, A Searle Comp., 
Oldham, U.K.
LP3 tubes Luckhams Ltd., Burgess Hill, Sussex, U.K.
(ii) Incubation Requirements
Medium 199 Powdered medium 199, with Earle's Salts, with
L-glutamine; contained 100,000 units Penicillin- 
Streptomycin. Gibco Europe Ltd., Uxbridge, 
Middlesex, U.K.
Earle's B.S.S.
M.E.M.
Saline (0.9%)
(IX)
(Eagle) (IX) with Earle's Salts, 
without L-Glutamine
Gibco Europe, 
Glasgow, 
Scotland, U.K.
Sodium Chloride Injection B.P. 0.90% w/v for 
Intravenous Administration. Baxter Division, 
Travenol Laboratories Ltd., Thetford, Norfolk, 
U.K.
Calf Serum Calf Serum 1, Inactivated. Wellcome Reagents Ltd.,
Beckenham, England, U.K.
Gas 0- 95%/CO„ 5% British Oxygen Co. Ltd., Medical Gases Division,
1 1 London, U.K.
(iii) Chemicals
Na125I
125I-PVP
Insulin
Supplied as Sodium Iodide > 
in Dilute NaOH Solution, 
pH 7-11, free from Reducing 
Agents (Code No. IMS.30)
12SPVP ( I) in Succinate 
Buffer Solution 
(Code No. IM.33P)
Amersham International 
\  Ltd.,
Amersham, Bucks, 
England, U.K.
"Actrapid" MC Neutral Insulin Injection B.P. (mono 
component Forcine Insulin). Novo Industrai A/S, 
Denmark.
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Bacitracin
BSA
Cycloheximide
2,4-DNP 
Puromycin 
RNase A
RNase B
RNase S
RNase Sprotein
(Code No. B 0125)
Cystallised and Lyophilized 
(Code No. A 4378)
3 [2(3,5-Dimethyl-2-oxycyclohexyl) 
2-hydroxyethyl ] glutarimide 
(Code No. C 6255)
Grade II
(Code No. D 7004)
Puromycin Dihydrochloride 
(Code No. P 7255)
Type Xl-A, from Bovine Pancreas 
Protease Free 
(Code No. R 5375)
Sigma
Chemical Co., 
London, U.K.
Type XII-B, from Bovine Pancreas, 
Protease Free 
(Code No. R 5875)
Type XII-S, from Bovine Pancreas, 
Prepared from RNase XII-A 
(Code No. R 6000)
Type XII-PR, from Bovine Pancreas 
Prepared from RNase XII-A 
(Code No. R 6250
All other chemicals used were of Analytical Grade
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1252.2.1 Preparation of I-labelled ribonucleases
The method used for radioiodination of ribonucleases was adapted
from the method of Bocci (1969). Protein (10 mg) was dissolved in
4.25 ml phosphate buffer (0.05 IM^HPO^-K^PO^, pH 8.0), and put on
ice whilst being continuously stirred. Na I (1.0 mCi, usually in
10 yl solution) was added and the mixture stirred for 2 min. When
2.5 ml chloramine-T solution (2.0 mg in 2.5 ml water) had been added,
the mixture was stirred for 8 min before the reaction was stopped by
the addition of 2.5 ml sodium metabisulphite solution (2.0 mg in 2.5 ml
125water). After a further 2 min agitation, unreacted I-iodide was
diluted out by addition of excess KI (approximately 100 mg). The
radiolabelled solution was transferred to Visking tubing (0.25" diam.)
and dialysed at 4°C against 5 1 NaCl (1%), the dialysis fluid being
changed several times a day until its contained radioactivity gave a
125reading less than 5 times that of background. The I-labelled
protein solution was then removed from the tubing and stored at -20°C.
125The exact concentration of I-labelled protein was measured spectro-
photometrically via the &28Q values*
Immediately after iodination the reaction vessel was washed out
with medium 199 containing 10% (v/v) calf serum, and the total- and
acid-soluble radioactivity levels were measured (see Section 2.4.2) in
order to estimate both the labelling efficiency of the protein (usually
12530 to 40%) and the quantity of unreacted I-iodide discarded.
Before iodination began, the chloramine-T and sodium metabisulphite 
solutions were checked for reactivity. A few drops of the chloramine-T 
solution was added to a test-tube containing a little aqueous KI and 
some chloroform. This resulted in liberation of iodine, turning the 
dilute KI solution yellow and the chloroform pink. Addition of sodium
1252.2 Preparation of i-labelled Proteins
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metabisulphate solution led to the iodine being reduced to KI, and 
both liquids becoming colourless again.
Labelling of ribonucleases with non-radioactive iodide was 
achieved by substituting Na I with an equal weight of Na I, and 
then following the same procedure as above.
1252.2.2 Preparation of formaldehyde-denatured I-labelled BSA
The experimental procedure for the radioiodination of BSA was the 
same as is described in Section 2.2.1, up to the point when non-radio­
active KI (100 mg) was added, with the following exceptions: twice the
125amount of protein (20 mg) was iodinated with 1.0 mCi of Na I;
chloramine-T solution (4.0 ml) was added at a concentration of 1.0 mg/ml
and sodium metabisulphite solution (3.0 ml) was added at a concentration
of 2.0 mg/ml. After addition of excess non-radioactive KI, 16.0 ml
of formaldehyde solution (10%, w/v, in 0.5 M-NaHCO^ buffer, pH 10.0)
was added to the radiolabelled protein solution and kept at 4°C for
24h. The solution was then transferred to Visking tubing (0.25" diara.)
and dialysed at 4°C against changes of 5 1 NaCl (1%), after which it
was handled as in Section 2.2.1. The labelling efficiency of
125 125formaldehyde-denatured I-labelled BSA ( I-fdBSA) was approximately
60%.
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2.3 Rat Visceral Yolk-Sac Incubation Technique
The method used for the incubation of the rat visceral yolk 
sac was essentially as described by Williams e_t al. (1975a,b) . Pairs
of Wistar rats from an inbred colony were mated overnight in grid 
cages. If a sperm plug was detected underneath the grid the following 
morning, pregnancy was timed from midnight of the night of mating.
After 17.5 days the rats were asphyxiated with carbon dioxide, and the 
uterus quickly removed and placed in a Petri dish containing incubation 
medium that had previously been warmed to 37°C. (The percentage calf 
serum present in the dissecting medium was the same as in the incubation 
medium for each separate experiment). The uterine wall was cut open 
longitudinally, and the conceptuses gently freed from the wall. The 
placental caps were removed, the cut edge of the yolk sacs enlarged by 
a single cut, and the fetuses dissected free. The yolk sacs were placed 
in fresh, warm incubation medium, and any remaining amniotic tissue was 
removed.
Each yolk sac was placed in a sterile 50 ml Erlenmeyer flask,
containing 9.0 ml of incubation medium (either medium 199 alone or
medium containing calf serum) that had previously been gassed with a
mixture of 95% oxygen and 5% carbon dioxide, and sealed with a sterile
silicone rubber bung. The flasks were placed in a water bath maintained
at 37°C, with the shaker attachment set to a stroke of 3.4 cm at a
frequency of 100 ± 5 strokes per min. After a preincubation period 
125of 15 - 45 min, I-labelled substrate was added to each flask as a 
solution in 1.0 ml of incubation medium. The flasks were then regassed 
and stoppered.
125If the effect of some compound on the uptake of I-labelled 
substrate was being investigated, the flask initially contained 8.0 ml 
of medium. After gassing and a preincubation of at least 15 min, the
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compound was added as a solution in 1.0 ml of medium. After a further
incubation period of 20 min, the JI-labelled substrate was, likewise,
added in 1.0 ml of medium, and the flasks regassed and stoppered.
Yolk sacs were removed after different periods of incubation, washed
three times for 2 min in approximately 30 ml ice-cold 1% NaCl, and
stored in 5.0 ml volumetric flasks at -20°C until assayed. For non- 
125 125degradable I-labelled substrates ( I-PVP), duplicate 1.0ml samples
of medium were pipetted into disposable 3 ml (LP3) tubes at the time of
sampling, stoppered and stored at 4°C until assayed. For degradable
^"^I-labelled substrates ('^ "’i-labelled proteins), the flasks were
returned to the water bath after removal of the yolk sac and kept there
until the end of the experiment. This ensured that the effects of any
proteolytic activity released into the medium, or of instability of the
substrate, were the same in all flasks. Duplicate 1.0 ml samples were
then pipetted into disposable 3 ml (LP3) tubes, stoppered and stored at
-20°C until assayed. Two control flasks, containing both medium and 
125I-labelled substrate but no yolk sacs, were incorporated into each 
experiment with a degradable substrate. The medium in these flasks 
was sampled at the end of the experiment as above, and stored at -20°C 
until assayed.
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1252.4.1 Assay after incubation with I-PVP
125Samples of incubation media containing I-PVP were assayed for 
radioactivity with a gamma spectrometer, using a constant geometrical 
relation of sample to detector.
NaOH (1.0 M) was added to each yolk sac in a 5.0 ml graduated flask 
and made up to the mark. The yolk sacs were then dissolved over a 
period of l.Oh at 37°C, the solutions being agitated at 0.5h and l.Oh*. 
Duplicate 1.0 ml samples of the yolk-sac solution were pipetted into 
disposable 3 ml (LP3) tubes and assayed for radioactivity. The protein 
content of each yolk-sac solution was determined by the method of Lowry 
at al. (1951) with bovine serum albumin as reference protein. Duplicate 
0.1 ml samples of each yolk-sac solution were made up to 1.0 ml by 
adding 0.4 ml 1 M-NaOH and 0.5 ml distilled water. Similarly, a 
calibration curve was constructed by assaying in triplicate a series 
of five solutions containing 0, 0.05, 0.10, 0.15 and 0.20 mg of BSA.
To each solution was added 5 ml Folin A (100 ml 2% anhydrous sodium 
carbonate: 1 ml 1% copper sulphate: 1 ml 2% potassium sodium tartrate), 
and, after at least 20 min, 0.5 ml Folin B solution (Folin Ciocalteau's 
reagent freshly diluted with an equal volume of distilled water). After 
the Folin B solution was added the contents of each test tube were 
immediately vigorously mixed using a vortex-mixer. After a period of 
at least 45 min (the developed colour is stable up to 24h) the 
absorbance of each solution was read against a water blank at 750 nm.
The number of milligrams of protein present in each sample was determined 
from the calibration curve, and this figure multiplied by fifty to give 
the total yolk-sac protein. Calibration curves were typically virtually 
linear between absorbances of 0.3 and 0.7.
2.4 Assay of Incubation Media and Yolk-Sac Tissue
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1252.4.2 Assay of incubation media containing I-labelled proteins
Duplicate (1.0 ml) samples of incubation media were first assayed 
for their total content of radioactivity. Then, if the media contained 
no calf serum, 0.1 ml calf serum was added to each tube to act as a 
carrier protein in the precipitation of acid-insoluble radioactive
material. (Media already containing calf serum required no such
125 125addition). If the "I-labelled protein under examination was I-fdBSA,
then precipitation of acid-insoluble material was achieved by addition
of 0.5 ml 20% trichloroacetic acid (TCA) leaving TCA-soluble radioactivity 
• 125in solution. If JI-RNases were being investigated, the precipitation 
was achieved by addition of 0.5 ml phosphotungstic acid solution 
(125 ml 1M-HC1, 10g sodium tungstate, 25.2g Na2HP0^, 9g NaCl, lg 
phenol, made up to 1.0 litre) followed by 0.5 ml 20% TCA. After 
precipitation of protein in this manner, the tubes were centrifuged for 
20 min at 1500g, the supernatant decanted and assayed for radioactivity; 
the pellets were discarded.
The radioactivity associated with the yolk-sac tissue was assayed
125by the same procedure as used when I-PVP was the substrate (see 
Section 2.4.1).
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2.5 Determination of Correction Factors fòr the Acid-Soluble Radioactivity
Acid-soluble radioactivity was always assayed in a sample volume 
greater than 1.0 ml because of the addition of solutions of acidic 
reagents during the precipitation of acid-insoluble material (see Section 
2.4.2). The observed radioactive counts had therefore to be corrected 
for two factors: first the loss of acid-soluble radioactivity occluded 
within the protein pellet after centrifugation; second, for the change in 
counting efficiency resulting from the increase in sample volume. 
Correction factors were established to permit calculation of the counts 
that would have been observed had all the acid-soluble radioactivity been 
contained within a 1.0 ml sample volume.
125Williams ejt al_. (1975,b) showed that after uptake of I-fdBSA
125by the rat yolk sac, the major (95%) degradation product was x-iodo-<
tyrosine; this compound was therefore used as the acid-soluble species in
determinations of the correction factors.
125I-labelled tyrosine was diluted in medium containing different 
amounts of calf serum to produce an acceptable number of counts. Six 
groups of ten tubes contained the following amounts of calf serum:-
Group A •• 0% calf serum
Group B • 10% calf serum
Group C •• 20% calf serum
Group D •• 50% calf serum
Group E • 0% calf serum
Group F •• 10% calf serum
Each 3 ml (LP3) tube contained 1.0 ml of the appropriate medium.
The tubes were counted for 30s on a gamma spectrometer. Calf 
8erum (0.1 ml) was added to those tubes in groups A and E. Then protein
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was precipitated by adding either 0.5 ml TCA (for tubes in groups 
A, B, C and D) or by adding 0.5 ml PTA followed by 0.5 ml TCA (for 
tubes in groups E and F). All tubes were then centrifuged for 20 min
at 1500 g, (as in Section 2.4.2), and the supernatant decanted and 
counted for 30s.
The correction factors were determined from the following equation:-
Correction Factor Total counts (cpm, corrected for background) Observed acid-soluble counts (cpm, corrected
for background)
The resulting correction factors are shown in Table 2.5a.
Table 2.5a Correction Factors Determined for Acid-Soluble Radioactivity 
Assays
Correction factors were determined as described in Section 2.5. Values 
reported are the means (± S.D.) of ten determinations.
Group
Initial 
Percentage 
Calf Serum
Method of 
Protein 
Precipitation
Correction Factor 
Mean ± S.D.
A 0 TCA 1.37 ± 0.07
B 10 TCA 1.29 ± 0.04
C 20 TCA 1.33 ± 0.06
D 50 TCA 1.47 ± 0.07
E 0 PTA + TCA 1.86 ± 0.04
F 10 PTA + TCA 1.80 ± 0.04
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The only non-degradable substrate used in this study was I-PVP.
125The uptake (and subsequent accumulation) of I-PVP was expressed in 
a form in which the reproducibility of the results between experiments 
could be easily assessed, see Williams et al. (1975a), namely as the 
volume of culture medium whose contained substrate was captured by unit 
quantity of yolk-sac tissue (in microlitres per milligram yolk-sac 
protein). Uptake, determined after different periods of incubation, 
was expressed by the following equation:-
2.6 Quantitation of the Uptake of a Non-degradable Substrate
125
where U 
Y
M
P
uptake (yl per mg yolk-sac protein)
total radioactivity in whole yolk sac (cpm, 
corrected for background)
radioactivity per yl of incubation medium (cpm, 
corrected for background)
protein content of yolk sac (mg)
125Since the rate of fall of the I-PVP concentration in the 
incubation medium was equivalent to only approximately 0.1% per h 
(Williams elt cd., 1975a), the concentration was effectively constant 
for the duration of the incubation, and the value of M above was therefore 
taken as the measured value of the radioactivity in the incubation 
medium at the end of an incubation period. Uptake values were routinely 
calculated by the simple program shown in Appendix I.
The rate of substrate uptake was the gradient of the plot of uptake 
against the period of incubation. This rate was termed the Endocytic 
Index (El), and has the units microlitresymilligram yolk-sac protein 
Per hour. After each plot had been visually inspected to confirm 
linearity, the gradient (El), the intercept and the correlation 
coefficient for the best straight-line fit were calculated using a
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standard statistical package on a computer. A correlation coefficient 
°f well over 0.95 was usually obtained. However, linearity was always 
confirmed by visual inspection since the correlation coefficient is only 
a crude index of linearity; slight curvatures would not be detected by 
a fall in the correlation coefficient alone.
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125When using degradable substrates ( I-labelled proteins), the
bulk of the radiolabel taken up is not retained within yolk-sac tissue,
but is released back into the medium as acid-soluble degradation products
(see Williams et aL, 1975b). These substrates are also taken up at a
125much higher rate than I-PVP, resulting in a significant depletion of 
the amount of acid-insoluble radioactivity present in the medium during 
the incubation period. Both of these factors had to be taken into
2.7 Quantitation of the Uptake of a Degradable Substrate
consideration when calculating the uptake of such substrates. Thus the
125expression suitable for describing the uptake of I-PVP (see Section
2.6) has to be modified to:-
Y + 10(S-F) 
M'.P
where U 
Y
S
uptake (yl per mg yolk-sac protein)
total radioactivity retained in whole yolk sac 
(cpm, corrected for background)
acid-soluble radioactivity per ml of medium at 
end of incubation period (cpm, corrected for 
background)
F = acid-soluble radioactivity per ml of medium 
present at beginning of incubation, and that 
released by spontaneous degradation not 
associated with yolk sac during incubation 
(cpm, corrected for background)
P - protein content of yolk sac (mg)
M' = mean acid-insoluble radioactivity per yl
medium over the particular incubation period 
(cpm, corrected for background)
The value of M' was calculated from M, the observed value of the 
acid-insoluble radioactivity per microlitre of medium, by adding one 
half of the acid-soluble radioactivity per microlitre of incubation 
medium generated by the yolk sac during the incubation period. The 
following expression was used:-
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M' -  M + — ------~ o
2 x 10°
where M = Acid-insoluble radioactivity per yl of medium at 
end of incubation period (cpm, corrected for 
background)
The values of S and F were calculated using the correction factors 
evaluated to correct for loss of acid-soluble radioactivity occluded 
within the pellet after centrifugation following acid precipitation, and 
for the change in counting efficiency resulting from the volume increase 
(see Section 2.5). The value of S was calculated from:-
S = A.E
where S - acid-soluble radioactivity per ml of medium at end of
incubation period (cpm, corrected for background)
A ■ acid-soluble radioactivity in whole medium sample at
end of incubation period (cpm, corrected for background)
E - correction factor 
The value of F was calculated from:-
F - B.E
where F - acid-soluble radioactivity per ml of medium present at
beginning of incubation, and that released by spontaneous 
degradation not associated with yolk sac during incubation 
(cpm, corrected for background)
B ■ acid-soluble radioactivity in whole medium sample from 
control flask (cpm, corrected for background)
E - correction factor
Data were routinely processed by using the simple computer program 
shown in Appendix II. The rate of uptake of the substrate was determined 
as in Section 2.6, the resulting El having the units microlitres/milligram 
yolk-sac protein per hour. A correlation coefficient of over 0.95 was 
usually obtained.
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o 1252.8 Effect of pH on the Degradation of I-labelled Ribonucleases
by Yolk-Sac Homogenate
125The effect of pH on the degradation of I-labelled ribonucleases 
125( I-ribonucleases) by an homogenate of 17.5-day yolk sacs was examined 
over the pH range 3.0 to 9.0, at intervals of 0.5 pH unit. Sodium 
acetate buffer (0.1M, adjusted to the correct pH with glacial acetic 
acid) was used over the pH range 3.0 to 6.0. Tris [2-amino-2-(hydroxy- 
methyl) propane-1,3-diol] (0.1 M, adjusted to the correct pH with HC1) 
was used over the pH range 6.5 to 9.0.
Rat yolk sacs were dissected as in Section 2.3, and washed in ice- 
cold saline (1%). The yolk sacs were blotted and homogenised in 
distilled water (1.0 ml/yolk sac) using a Potter-Elvehjem type Teflon-on- 
glass homogeniser (0.19 mm clearance). Four up-and-down strokes at a 
speed of 2,500 rpm were made within a 30s period. The homogenate was 
diluted with 2 volumes of distilled water, centrifuged at 150g for 
10 min, the supernatant decanted and the pellet discarded. The supernatant 
(yolk-sac homogenate) was kept on ice until required, but used within 2h 
of preparation.
Incubations were performed in 3 ml (LP3) tubes initially containing 
130 yl appropriate buffer and 20 yl substrate (0.5 mg/ml) and preincubated 
at 37°C, and the incubation started by addition of 50 yl yolk-sac homogen­
ate (37°C) to each tube, followed by thorough mixing. Controls were 
performed by addition of 50 yl distilled water in place of substrate.
Each incubation was allowed to proceed for 1.0 h before being terminated 
by addition of 0.5 ml ice-cold aqueous calf serum (10%), followed 
immediately by 0.5 ml PTA and 0.5 ml TCA.
The tubes were stoppered, the contents mixed and assayed for 
radioactivity. The tubes were then centrifuged at 1500 g for 20 min 
and the acid-soluble supernatant decanted and assayed for radioactivity;
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the pellets were discarded. The percentage acid-soluble radioactivity 
present at each pH value was calculated, the observed acid-soluble 
radioactivity counts being corrected for the loss of acid-soluble 
radioactivity occluded within the pellet after centrifugation and for the 
change in counting efficiency resulting from the increase in sample 
volume. A suitable correction value was therefore evaluated by applying 
the method in Section 2.5 to the experimental conditions in this section; 
the correction value determined was 1.04.
The protein content of the yolk-sac homogenate was determined as 
described in Section 2.4.1.
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2.9 Stability of i-labelled RibonuCleaseS iti "Conditioned Incubation 
Media"
Some "conditioned incubation media" were prepared by incubating
normal media with or without yolk sacs; others were prepared by similarly
• * 125incubating media to which 2,4-DNP had been added. A I-labelled
ribonuclease preparation was incubated in each of these media, and the
amount of acid-soluble radioactivity produced during the incubation was
measured.
Yolk sacs were dissected as in Section 2.3, and incubated individually
in 50 ml Erlenmeyer flasks in a shaking water bath at 37°C for 3.Oh
in gassed serum-free or serum-containing (10%) medium, either in the
absence or in the presence of 2,4-DNP. An identical set of flasks was'
incubated in the absence of any yolk sacs. At the end of the incubation
period the yolk sacs (if present) were removed, washed for 3 x 2  min
in changes of ice-cold saline (1%), and then placed in 5.0 ml volumetric
flasks for protein estimations as in Section 2.4.1. The incubation
medium from each flask was decanted into capped centrifuge tubes,
centrifuged at 1500 g for 15 min, and 8.0 ml of the supernatant removed
and placed in a fresh incubation flask. To each flask was added 1.0 ml
fresh medium (either in the absence or presence of calf serum, 10% v/v,
125as appropriate) and 1.0 ml of the same medium containing I-ribonuclease
1 25(to give a final i-ribonuclease concentration of 1.0 yg/ml). These 
flasks were gassed and incubated for 3.Oh, samples (2 x 1.0 ml) of the 
incubation medium being removed at 0, 1.0, 2.0 and 3.Oh and assayed as 
in Sections 2.4.1 and 2.4.2.
125
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2.10 Effect of Various Agents on the Release of a Non-Degradable 
Substrate from Yolk Sacs
Yolk sacs were dissected as in Section 2.3, and incubated in pairs
in 50 ml Erlenmeyer flasks in shaking water baths at 37°C. Each flask
contained 10.0 ml gassed medium 199 in which was dissolved the substrate 
125( I-PVP, 2 yg/ml) and the agent of interest. After an incubation 
period of 2.5 to 3.Oh the yolk sacs were removed, and 2 x 1.0 ml of 
this medium was sampled. The yolk sacs were washed for 3 x 2  min in 
warm (37°C) medium 199 containing both non-radioactive PVP (2 pg/ml) 
and agent, and then reincubated in the same pairs in fresh Erlenmeyer 
flasks containing 10.0 ml gassed medium 199 in which was dissolved 
non-radioactive PVP (2 yg/ml) and the agent. The yolk sacs were 
reincubated for a further 2.5 to 3.Oh, 2 x 1.0 ml samples being taken 
at intervals of 0.25h for the first hour, and then at 0.5 or l.Oh 
intervals. After each sampling, 2 x 1.0 ml of medium containing 
non-radioactive PVP and agent were added back to the flask and regassed, 
to keep the volume in the flask constant. At the end of the incubation 
the yolk sacs were washed 3 x 2  min in ice-cold saline (1%) and assayed 
for protein as in Section 2.4.1. The samples were assayed for radio­
activity as in Section 2.4.1.
In those experiments in which the effect of different media on the 
yolk-sac tissue was being investigated, medium 199 was simply replaced 
by the appropriate medium in all stages of the experiment, including the 
dissection.
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2*1! Quantitation of Release of a Nori-Degradable Substrate
The total activity released into the incubation medium over the 
reincubation period was calculated by the following formula:-
i=(n-l)
Tn ' 10Ci(i>n) + 2 ^i-o
where T = radioactivity released up to the time of the nthn sampling (cpm)
C.1
* radioactivity per ml of incubation medium of the 
ith sample (cpm, corrected for background)
The sum of the total quantity of radioactivity released into the 
incubation medium over the reincubation period, and the quantity of 
radioactivity remaining associated with the tissue at the end of the 
reincubation period, is equal to the total amount of radioactivity 
associated with the yolk-sac tissue at the beginning of the reincubation 
period. Using these values it is possible to calculate the amount of 
radioactivity released during any part of the reincubation period as a 
percentage of the quantity of radioactivity associated with the yolk sac 
at the beginning of the reincubation. Likewise, knowing the amount 
of radioactivity equivalent to a given mass of labelled substrate, it 
is possible to calculate the amount of radioactivity released in ng 
per mg yolk-sac tissue. Data were routinely processed using the 
simple computer program shown in Appendix III.
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2.12 Recovery of I-PVP Uptake by Yolk Sacs after Exposure to 
Various Agents
Yolk sacs were dissected and incubated, as described in Section 2.3, 
• 125in the presence of JI-PVP (2 yg/ml) and various agents. Yolk sacs 
were removed and washed for 3 x 2  min in ice-cold saline (1%), and 
2 x 1.0 ml volumes of incubation medium were sampled at 0.5h intervals 
UP to 2.5h. At 2.5h, all remaining unsampled yolk sacs were washed 
for 3 x 2  min in medium 199 (37°C), put into clean 50 ml Erlenmeyer 
flasks containing 10.0 ml medium with I-PVP (2 yg/ml) only, gassed 
and then reincubated. These yolk sacs were sampled as above at 
0.5h intervals for a further 2.5h. Yolk-sac tissue and samples of 
incubation medium were assayed as described in Section 2.4.1.
CHAPTER 3
PINOCYTOSIS AND DEGRADATION OF DIFFERENT 
RIBONUCLEASES IN THE RAT VISCERAL YOLK SAC
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3.1 Introduction
Many factors affect the rate at which a substrate is pinocytosed by 
living cells. One group of factors, which may be sub-divided into more 
specific features is the physical characteristics of the ingested 
substance.
The size of a substance being pinocytosed by cells is probably 
important. Thus, Duncan ej^  _al. (1981) examined the effect of molecular
-i n  e  i o e
size of i-labelled poly(vinylpyrrolidone) ( I-PVP) on its rate of 
pinocytosis by rat visceral yolk sacs and rat peritoneal macrophages 
¿2. vitro. This compound has previously been shown to be a marker of 
fluid-phase pinocytosis in both of these systems(Williams et al., 1975a; 
Pratten et al., 1977). Varying the substrate concentration did not affect 
the rate of uptake of ~i-PVP for a particular polymer size, but rat 
yolk sacs and macrophages each showed different preferences for different­
sized fractions. (The molecular weights of the polymer fractions used
4 6were between 5 x 10 and 7 x 10 daltons). Macrophages preferentially 
captured the very high molecular weight fractions, whereas yolk sacs 
captured virtually none of these fractions, perhaps due to the limiting 
factor being the size of the pinosome. Yolk sacs captured the lowest 
®°lecular weight preparations most rapidly. Similarly, Nilsson _et al. 
(1981) found that small chylomicrons produced in vivo were taken up 
®ore rapidly by rat hepatocyte monolayers in vitro than were large 
chylomicrons.
Another method of approaching the problem of the effect of size of a 
substrate on its rate of pinocytosis is by chemically creating aggregates 
from monomer proteins. Thus, Kooistra e£ al. (1979a) cross-linked 
ribonuclease with dimethyl suberimidate to form dimers and higher 
Polymers in such a way that the charge of the protein was not altered. 
Monomer, dimer and higher polymer fractions were injected into
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nephrectomized rats, and it was found that the polymer fraction was taken 
UP by the liver faster than the dimer, which in turn was endocytosed 
more rapidly than the monomer; aggregated ribonuclease, prepared by 
freeze-drying the protein from 50% acetic acid, gave similar in vivo 
clearance results. They also formed dimers and polymers of hen egg- 
white lysozyme by cross-linking with dimethyl suberimidate (Kooistra 
££. al., 1980), and again found that the rate of clearance into the liver 
°f the rat in vivo followed the same pattern as described above. In
contrast to this finding, Livesey & Williams (1981) found that formaldehyde- 
and bicarbonate-induced aggregates of lysozyme were taken up more slowly 
hy rat yolk sacs incubated in vitro than untreated monomer; formaldehyde- 
induced dimer had an uptake rate similar to that of the monomer. Another 
group that has examined bovine pancreatic ribonuclease A dimers is that of 
Bartholeyns & Baudhuin (1976). They found that hepatoma cells endocytosed 
the dimer much more avidly than the monomer form; the dimer also inhibited 
Proliferation of the tumour cells. This work was extended to examine 
four different types of tumour cell and three normal cell lines (Bartholeyns 
& Zenebergh, 1979). These authors found that three of the four tumour 
cell types interiorized the dimer very rapidly and blocked proliferation; 
the normal cell lines did not take up the dimer to the same extent, and 
cell proliferation was unaffected. Ribonuclease A dimers were injected 
rptramuscularly into rats in the vicinity of solid tumours,
after which cellular proliferation was blocked. Also, development of tumours 
was inhibited if the dimer was injected prior to administration of 
hepatoma cells. Other evidence suggests that the dimer can inhibit fusion 
between phagosomes and lysosomes, and/or inhibit discharge of a protein 
(peroxidase) adsorbed to the phagosomal membrane after fusion (Bartholeyns 
(1979).
Another physical characteristic of molecules that may affect their 
r®te of uptake by cells is their charge. Again there are two clear
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avenues for the investigation of this property, examination of the effect 
°f the inherent charge on a number of different substrates, and chemical 
m°dification of a single substrate so that its charge varies. Thus, 
Kooistra ejt al. (1979b) changed the positively-charged amino groups of 
the cross-linked ribonuclease molecules mentioned above to neutral or 
negatively-charged groups by acetylation or succin^ylation respectively, 
and changed the positively-charged amino groups on lysozyme to neutral 
or negatively-charged groups by the same procedures (Kooistra et al.,
1980). in both cases the rate of uptake of the positively-charged entity 
into the liver and spleen was greater than the rates for either the 
neutral or the negatively-charged derivative.
The work of the group of J.F. Dice and A.L. Goldberg has established 
a correlation between the rates of degradation of proteins in vivo 
and their isoelectric points. One such example of their work (Dice 
¿1., 1979) is a report on soluble proteins from rat lung, heart and 
testes, and from human fibroblasts and mouse-embryo cells grown in culture, 
■^ hey found that the negatively-charged proteins tended to be degraded more 
raPidly than the neutral or basic ones; this finding is consistent with 
data they had previously reported relating to rat liver, skeletal muscle, 
kidney and brain, and mouse liver and skeletal muscle.
Proteins may be modified by different treatments to alter their 
information in a less specific manner than was achieved by Kooistra and 
i-workers in the work described above. For example, Moore et al.
(1977) treated *^I-labelled BSA with acetic acid in the pH range 2.5 
to 3.5, with formaldehyde at pH 10.0 and with urea at pH 5.5. The rates 
°f uptake of these treated forms of BSA by rat yolk sacs in vitro were 
much higher than that of the untreated form, and similar results were 
obtained for in vivo clearance of the substrates by rat tissues. In 
contrast, Livesey & Williams (1981) found that treatment of insulin, 
lysozyme and ribonuclease A with either acetic acid or urea had no
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effect upon the rates of uptake of these proteins by rat yolk sacs in 
^itro compared to the rates of uptake of the corresponding untreated 
forms, and that treatment with formaldehyde led to a reduced rate of 
uPtake. Livesey & Williams discuss these results and come to the conclusion 
that (unlike BSA) insulin, lysozyme and ribonuclease A suffer no permanent 
c°nformational change on exposure to either acetic acid or urea. Since 
lyosozyme and ribonuclease A are basic proteins, they may bind to 
negatively-charged groups on the yolk-sac membrane. The surface of the 
insulin molecule is hydrophobic in character, and may bind to hydrophobic 
Patches on the yolk-sac plasma membrane. As the rate of uptake 
°f BSA is lower than that of any of the smaller, simple proteins described 
above, and the albumin molecule is negatively-charged at physiological 
PH, Livesey & Williams suggest that this effect may be due to the 
inability of BSA to interact successfully with either negatively-charged 
°r hydrophobic binding sites on the yolk-sac surface. They suggest 
that denaturation with, say, formaldehyde may cause hydrophobic groups 
uormally buried within the albumin molecule to be brought to the surface, 
and therefore enhance uptake by binding to hydrophobic binding sites on 
the surface of the yolk sac.
The properties of charge and hydrophobicity of a protein molecule 
Have been further studied by using the isoenzymes of lactate dehydrogenase. 
These proteins consist of four tetrahedrally-arranged subunits of equal 
8ize, and the two types of subunit have been called M and H. The 
attraction of working with these molecules is that subunit differences in 
surface charge and hydrophobicity can be studied without a change in 
Molecular size. Sinke et al. (1979) studied two porcine lactate 
dehydrogenase isoenzymes, namely M4 and H4. They found that the 
isoenzyme M4 was cleared from the blood stream rn vivo (into the liver 
and spleen) much more rapidly than was the H4 protein, and that it showed 
a half-life of about 30 min; the in vivo half-life of H4 was approximately
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8h. Sinke et al. postulated that the differences in the amino acid 
residues on the surfaces of the isoenzymes were responsible for these 
differences, since at neutral pH the isoenzyme M4 carries a positive charge 
and H4 a negative one. This evidence is in agreement with data, discussed 
above, from which Kooistra et al. (1979b, 1980) found a more rapid in vivo 
clearance of positively-charged substrates.
Kooistra & Williams (1981) studied the in vitro uptake of lactate 
dehydrogenase by rat yolk sacs, using the same isoenzymes as Sinke et al. 
(1979). They found that the rates of uptake of the two proteins were 
very similar, the uptake of M4 being only slightly faster than that of 
H4. Competition studies led them to the conclusion that the binding of 
the H4 isoenzyme may be restricted to hydrophobic interactions with the 
yolk-sac surface, whereas the binding of the M4 isoenzyme probably involves
both hydrophobic interactions and interactions between the positive charges
\
0tl the surface of the isoenzyme and the yolk-sac plasma membrane.
Clearly, size and charge have a substantial effect upon the uptake 
°f different molecules, both in clearance from the blood stream in vivo 
and in uptake experiments performed iri vitro. Another outstanding
feature from the data surveyed above is the diverse responses of the(
different tissues studied regarding their ability to endocytose molecules 
with certain physical characteristics, suggesting that differences between 
the surface characteristics of cells are as important as the differences 
between individual substrate molecules in determining the rates of endocytosis.
Another dominant feature of many proteins is the presence of 
carbohydrate moieties attached to the polypeptide chain. These glyco­
proteins have a wide range of diverse physical, chemical and biological 
Properties dependent upon the type and amount of sugars present, and upon 
their distribution along the polypeptide chain. Marshall (1979) has 
tcviewed some features of glycosylated proteins. The attachment of the 
carbohydrate moiety to the protein is almost always achieved by the
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•involvement of sugar tranferases, with the donor molecule being either a 
nucleotide monosaccharide or a dolichyl phosphate-linked oligosaccharide.
One major class of glycoproteins contains a carbohydrate moiety linked at 
asparagine residues. These include glycoproteins found in serum and on the 
plasma membranes of cells. The number of glycosylated asparagine residues 
m  any glycoprotein is usually small since the correct asparagine sequon 
(sequence of amino acids near to the asparagine residue) must be present.
Two types of oligosaccharide have been found, the high-mannose type 
and the complex type; the biosynthetic pathways of these glycoproteins have 
teen reviewed by Staneloni & Leloir (1979). Both types have a common 
Pentasaccharide structure, but differ in the externally-located sugar
residues:-
R-Man I
>s' Man-GlcNAc-GlcNAc-Asn 
R-ManX  I
In ûie high-mannose type, the side chains have a variable number of mannose %
residues with different types of ramification, in addition to some 
acetylglucosamine residues; the complex type of side chain has galactose, 
N-acetylglucosamine and sialic acid, and occasionally three R-chains.
Another major class of glycoproteins contains O-glycosidicâlly-linked 
carbohydrate moieties at the serine and threonine residues, and the protein 
backbone usually contains large amounts of proline. The number of 
carbohydrate moieties attached to a polypeptide chain may vary greatly; 
human apolipoprotein C-III contains only one carbohydrate moiety whereas 
io glycophorin A, 11 of the 15 carbohydrate chains occur within the first 
5^ amino acid residues from the N-terminus. This type of glycoprotein 
forms the mucous layer which protects epithelial layers from mechanical 
and osmotic shock.
Rauvala & Finne (1979) have reviewed the composition of the 
carbohydrate portions of both glycoproteins and glycolipids. They
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point out that although the carbohydrate residues near to the protein or 
lipid part of the molecule can differ, there is a striking similarity 
between the terminal carbohydrate sequences. They suggest that this 
may indicate that terminal carbohydrate sequences may be synthesized 
by common glycosyl transferases for both types of molecule.
The effect of the extent of glycosylation of a protein upon its 
rate of clearance from the bloodstream in vivo, and upon its rate of 
uptake by various cell types in vitro, has been the subject of a large 
amount of recent literature. The experimental work consists mainly of 
removal of a terminal sugar residue; this often leads to an increased rate 
of clearance or uptake of the protein due to exposure of a particular 
carbohydrate residue. The importance of this exposed carbohydrate residue 
can be demonstrated by competition studies between the modified glycoprotein 
and various sugars. The general conclusions from such studies have been 
reviewed by Lloyd & Griffiths (1979). Different tissues recognise 
different terminal carbohydrate residues: hepatocytes recognise galactose 
residues; fibroblasts recognise phosphohexoses; N-acetylglucosamine and 
mannose are recognised by both Kupffer cells and macrophages. More recent 
literature (Burnside & Schneider, 1980 and Fischer et al,, 1980) have 
provided evidence for the presence of phosphomannosyl receptors on rat-liver 
lysosomal membranes which appear to be similar to the phosphohexose 
receptors determined for fibroblast plasma membranes.
Ribonucleases are a group of enzymes involved in the degradation 
of ribonucleic acid by splitting phosphodiester bonds, and in catalysing 
the hydrolysis of 2*,3'-cyclophosphates of pyrimidine nucleotides to the 
corresponding 3'-nucleotides. Many different ribonucleases have been 
isolated from different tissues. The amino acid sequences and conformational
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structures of many of these ribonucleases have been deduced, and it is 
now possible to synthesize ribonucléase A in the laboratory (Fujii &
Yajima, 1981).
Baynes & Wold (1976) determined the half-lives of four bovine pancreatic 
ribonucléase isoenzymes when injected into the circulation of the rat. They 
used ribonucleases A, B, C and D which all have the same polypeptide chain 
backbone containing 124 amino acid residues, but all have different degrees 
of glycosylation at their asparagine-34 residues. Ribonucléase A contained 
no carbohydrate moiety; B had a simple oligosaccharide (GICNAC2 Man^_^);
C had a complex oligosaccharide (GlcNAc^ Man^^ G a ^  Fuc NeuAc^) ; and D 
had a different complex oligosaccharide (GlcNAc^ Man^ G a ^  Fuc NeuAc^).
The jin vivo clearance half-lives were 528-577 min, 15 min, 681-862 min and 
839-941 min respectively, detected by measuring the ribonucléase activity 
present in the blood (the animals were nephrectomized to prevent rapid 
removal of these small proteins by the kidneys). When ribonucléase B 
was treated with a-mannosidase to remove 3 of the 4 mannosyl residues, 
this resulted in an elevation of the circulating half-life to 616-733 min. 
Baynes & Wold concluded that the presence df a complex oligosaccharide 
moiety had no apparent effect on the rate of clearance of these proteins 
from the circulation in the rat, but that the presence of the mannose 
residues in the simple oligosaccharide moiety resulted in rapid clearance; 
the recognition of mannose residues has since been attributed to Kupffer 
cells and macrophages (see above).
The presence of both glycosylated and non-glycosylated forms of a 
protein within an individual of a species may arise by three different ways: 
duplication of the gene specifying the protein chain; gene mutation; 
incomplete conversion within a cell of an apoprotein into the corresponding 
glycoprotein. The last-mentioned of these pathways is assumed to account 
for the different ribonucléase isoenzymes described above (Marshall, 1979).
Richards & Vithayathil (1959) modified bovine pancreatic ribonucléase 
A with subtilisin, resulting in a cleavage between amino acid residues
AO
20 and 21. The eicosapeptide remained non-covalently associated with the 
rest of the protein, and this substance was called ribonuclease S. The 
enzymatic activity of ribonuclease S was negligibly changed from that 
°f A, although various physical and chemical techniques indicated changes 
in the three-dimensional structure. Trichloroacetic-acid fractionation 
led to separation of the eicosapeptide from the main polypeptide chain, 
end these two separate substances were called S peptide and S protein, 
respectively.
The ribonuclease isoenzymes, native and modified, thus provide an 
excellent group of proteins in which to study the effect of the physical 
characteristics of a substrate upon its rate of uptake by cells. A 
comparison between ribonucleases A and B permits an examination of the 
effect of terminal mannose groups. Ribonucleases A and S allow a 
comparison between a native and a partially altered polypeptide chain, 
and also permit examination of the suggestion of Dice & Goldberg (1976) 
that proteolytic "nicking" outside of cells may be a signal for enhanced 
clearance of proteins from the circulation. Removal of the peptide 
fragment from ribonuclease S to form Sproteih will also provide an 
interesting variation on the influence of the composition of the poly­
peptide chain on uptake and degradation. Therefore the rates of uptake and 
subsequent degradation of these four ribonucleases (A, B, S and S protein) 
were studied in the rat yolk sac. (Unfortunately the C and D forms were 
not commercially available, hence could not be obtained for study.)
As an integral part of the comparative study of the rates of uptake
of the different ribonuclease preparations mentioned above, it was
necessary to investigate whether pinocytosis is a prerequisite of yolk-
125sac-mediated digestion of the I-labelled forms of these proteins.
If a significant fraction of the observed proteolysis occurs outside of 
the lysosomal system, there would be an over-estimate of the rate of 
pinocytic capture of these proteins. In the simplest case, extralysosomal
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proteolysis could occur by proteinases released from the tissue into the
incubation medium. In order to investigate this possibility, the
activity of a cell-free yolk-sac homogenate towards the different 
125I-labelled nbonucleases was investigated over a wide pH range, to
establish whether any activity could be exhibited in media of the same
pH as the incubation medium. An alternative source of error in such
uptake experiments would arise if the brush border of the yolk-sac
epithelial cells carries proteinases that degrade a significant fraction
of the I-labelled protein to TCA-solubles; such activity would again
lead to an over-estimate of the amount of proteolysis occurring within
the lysosomal system subsequent to pinocytic capture. Inhibitors of
yolk-sac pinocytosis (2,4-dinitrophenol and NH^Cl) were therefore used
125to establish whether proteolysis of I-labelled ribonuclease preparations
125was inhibited to the same degree as the uptake of I-labelled PVP.
Failure to abolish proteolysis when pinocytic capture has been stopped 
would, in the absence of any proteolysis by enzymes released into the 
medium, indicate that there is significant surface-bound proteinase 
activity present.
125When investigating the rates of uptake of the different I-labelled 
ribonuclease preparations, it was interesting to compare the relative 
effects of the presence, in the incubation medium, of calf serum (10% , 
v/v). Different degrees of competition between individual ribonuclease 
preparations and serum proteins may well help to indicate differences in 
the way(s) in which the different ribonucleases bind to sites on the 
surface of yolk-sac cells.
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3.2 Materials and Methods
All the equipment and materials used in the experiments in this
chapter were as described in Section 2.1. The medium used was 199,
and calf serum (if present) was added at a concentration of 10% (v/v). 
125I-ribonucleases were radiolabelled as described in Section 2.2.1.
Almost all uptake experiments were performed as described in
125Section 2.3, and all assays as in Section 2.4. I-PVP was always
125used at a concentration of 2 pg/ml, and I-ribonucleases at a
concentration of 1 yg/ml. The various agents were added 20 min prior
to the addition of I-labelled substrate, and the concentrations
employed were as described in the text and in the legends to figures
and tables. The only exception was when yolk sacs were preincubated
in the presence of non-radioactive RNase S (see Table 3.3.2f). In
this experiment some yolk sacs were preincubated with non-radioactively
127iodinated RNase S ( I-RNase S) and control yolk sacs were not.
Preincubation was performed in 50 ml Erlenmeyer flasks by placing ten
127yolk sacs in 20 ml gassed medium 199 containing I-iodinated RNase S
(10 yg/ml) and incubating them together in a shaking water bath at 37°C
for 20 min. These yolk sacs were then removed from the flasks, washed
for 3 x 2  min in gassed medium 199 (37°C), then each was put into a
125fresh 50 ml Erlenmeyer flask containing medium 199. Then I-RNase S
125was added alone, or I-RNase ShLus2,4-DNP were added together to make
a final concentration of 1 yg/ml and 50 yg/ral, respectively, in a total
volume of 10.0 ml medium 199. These flasks were gassed and then
incubated for up to 3h, samples being removed at 0.5h intervals as
described in Section 2.3, and incubation media and yolk-sac tissue were
assayed as in Section 2.4. Control yolk sacs were preincubated as above
127in the absence of I-iodinated RNase S (i.e. in medium 199 alone),
125washed, and incubated with I-labelled RNase S either in the absence
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or presence of 2,4-DNP, under the same incubation conditions as described 
above.
The experimental procedure to determine the effect of pH on the 
125degradation of I-labelled ribonucleases by yolk-sac homogenate was
125as described in Section 2.8, I-ribonucleases being present at a
concentration of 10 yg/200 yl incubation medium. The effect of
"conditioned incubation media" on the stability of I-ribonucleases
was determined as described in Section 2.9, the concentration of 
125I-labelled substrate being 1 yg/ml.
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3.3.1 Thé Ratés of Uptake Of Different I-RibomiCleases by Yolk Sacs 
Incubated in thé Presence arid Absence of Sérum
125The uptake of the fluid-phase marker, I-PVP, by yolk sacs in 
the presence and absence of calf serum is shown in Figure 3.3.1a. (In 
this series of experiments the concentration of calf serum, if present, 
was 10%, v/v). Uptake in the presence of serum was linear up to 6h, 
and the mean rate of uptake (or E.I.) was 1.92 yl/mg y.s. protein per h 
(see Table 3.3.1a) In the absence of serum the uptake of I-PVP was 
higher, the mean E.I. being 3.39 yl/mg y.s. protein per h (see Table 3.3.1a), 
and the uptake plot was linear up to 3h (see Figure 3.3.1a). This 
indicates a higher rate of pinosome formation in the absence of serum, 
as was reported by Ibbotson & Williams (1979). Since the rates of uptake
IOCof all the I-ribonuclease preparations were very high (particularly
in the absence of serum, see below), leading to substantial depletion of
their concentration in the incubation medium, incubations were routinely
125terminated at 3h: matched I-PVP controls were also terminated at this / 7
time. (This point is more fully discussed later in this section.)
The time courses of uptake, in the presence of calf serum, of a
number of different I-ribonucleases, A, B, S and Spr were examined.
The results are shown graphically in Figure 3.3.1b and in numerical
detail in Table 3.3.1b. The plots of uptake against incubation time
125were linear for all the ribonucleases. The E.I's for I-RNases S
and Spr were very similar, 351 and 345 yl/mg y.s, protein per h
respectively, and these values were higher than those of the other two
125ribonucleases; the E.I. of I-RNase A was 187 yl/mg y.s. protein per 
125h, and that of I-RNase B was 139 yl/mg y.s. protein per h. The rate 
125of uptake of I-RNase A agrees well with the value of 147 yl/mg y.s. 
protein per h reported by Livesey & Williams (1981) for this protein in 
the presence of 10% serum.
125
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Removal of serum from the medium resulted in an increase in the
rates of uptake of all the ribonucleases, as shown in Figure 3.3.1c
125and Table 3.3.1c. Again the E.I's of both I-ENasea A and B were
similar (515 and 538 pl/mg y.s. protein per h, respectively), but were
lower than those of I-RNases S and Spr (708 and 641 pl/mg y.s.
protein per h, respectively). Livesey (1978) reported an E.I. of
125638 yl/mg y.s. protein per h for I-RNase A in serum-free medium.
Before further analysis of these data was initiated, the simplest
125hypothesis to account for the above results, namely that I-ribonucleases
stimulate the rate of fluid-phase pinocytosis, was examined. Yolk sacs
125were incubated with I-PVP in serum-free medium in the presence of
127ribonucleases iodinated with non-radioactive iodide, I-ribonucleases./
The results of these experiments are given in Figure 3.3.Id and Table
1273.3.Id. None of the four I-iodinated ribonucleases altered the
125linearity or the rate of uptake of I-PVP when present in the medium,
indicating that iodinated ribonucleases do not affect fluid-phase
pinocytosis in rat . yolk sacs at the concentration used (1 yg/ml).
Livesey & Williams (1981) found a similar result for the effect of 
127 125I-iodinated RNase A on I-PVP uptake in the presence of serum.
125The uptake of I-ribonucleases by yolk sacs in the presence of
serum, is accompanied by release of acid-soluble radioactivity into the
incubation medium as shown in Figure 3.3.1e, indicating that degradation
of these substrates occurs in the presence of the yolk-sac tissue. The
release of acid-soluble radioactivity with incubation time was linear,
and the rate of this release was virtually the same as the rate of
125uptake (E.I.) for each of the four I-ribonucleases (compare mean 
E.I. values with rates of soluble release in Table 3.3.1b). The 
quantity of radioactivity associated with the yolk-sac tissue reached 
a constant level during the first hour of incubation, (see Figure
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3.3.If, part (ii)), and the mean value of this tissue-associated
125radioactivity (T.A.R.) was very similar for all the four I-ribonucleases 
(see Table 3.3.1b), ranging from 99 to 119 yl/mg y.s. protein.
If all exogenous I-labelled proteins were ingested at the same 
rate and into the same class of vesicle in the yolk-sac tissue, then 
any difference in the quantity of radioactivity associated with the 
tissue would be expected to reflect the speed at which the different 
Proteins are degraded within the lysosomal system. Thus less readily 
degraded proteins would be expected to reach a higher steady-state 
concentration within lysosomes than those proteins that are more readily 
degraded, and hence the former would be expected to show a higher T.A.R. 
value than the latter. In practice, the T.A.R. values of many proteins 
have been observed to reach constant values within l-2h of incubation 
indicating that steady-state levels are reached during the usual incubation 
period. However, the rates of uptake of individual proteins differ 
considerably, so that meaningful comparison of tissue levels is only 
possible if tissue levels are first normalized for differences in uptake 
rate. If, in the simplest case, tissue levels are constant beyond the 
first hour or so of incubation and the rate of uptake is also constant, the 
normalized tissue level is given as;
T.A.R. (yl/mg yolk-sac protein)
Endocytic Index (yl/mg yolk-sac protein per h)
This ratio has the units of time (h) and was termed by Livesey (1978) the 
'Disposal Time' since he suggested that the magnitude of this ratio 
reflects the time taken for the protein to be fully degraded within the 
lysosomal system to fragments small enough to be released across the 
lysosomal membrane into the incubation medium. However, this interpretation 
assumes that both the quantity of undegraded protein within pinosomes 
that is in transit to the lysosomal system and the quantity of acid-soluble
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material present in the tissue are negligible compared with the amount 
°f protein undergoing degradation within lysosomes. An instantaneous 
value of the disposal time at any point during the incubation period 
may be calculated by normalizing the tissue-associated radioactivity 
for the amount of a substrate taken up during the period of incubation:
T.A.R. (yl/mg y.s. protein) x period of incubation (h)
Uptake over the incubation period (yl/mg y.s. protein)
125The mean Disposal Times for the I-ribonucleases in the presence
of serum were calculated as [mean T.A.R. (yl/mg y.s. protein)/mean
E.I. (yl/mg y.s. protein per h)3, and these values are shown in
125Table 3.3.1b. The values for I-RNases S and Spr were both
125approximately 0.3h, and for I-RNases A and B were approximately
0.6h. The values of the Disposal Time following various periods of
125incubation were also calculated for the four I-ribonucleases 
using the alternative equation (see Figure 3.3.1g). As expected,
these Disposal Times did not change during the period of incubation;
125 . 125those of I-RNases A and B were higher than those of I-RNases
S and Spr.
The duration of the experiments in the absence of serum was 3h only.
125This was because the rates of uptake of the I-ribonucleases were so 
high that continuation of the incubations beyond 3h led to serious 
problems of substrate depletion, resulting in very scattered data with 
apparent falls in total uptake and tissue-associated radioactivity values 
(data not presented here.) This can easily be appreciated from a
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simple calculation involving I-RNase A. In the absence of serum
the E.I. of this protein was 515 pl/mg y.s. protein per h. This is the
volume of incubation medium whose contained substrate is cleared by
each mg of yolk-sac protein during lh. For a yolk sac containing 5 mg
°f protein, this represents the depletion of substrate from a volume of
incubation medium of approximately 2,500 yl in lh. If the incubations
were allowed to proceed much over 3h, then well over half of the substrate
would have been removed from the incubation medium during this time,
leading to reductions in substrate concentrations and hence yielding
data that would no longer be reliable.
125During uptake of I-ribonucleases by yolk sacs incubated in
serum-free medium, the amount of acid-soluble radioactivity released back
into the incubation medium rose linearly with time (see Figure 3.3.lh).
As in the experiments in the presence of serum, the rate of release of
acid-soluble radioactivity was very similar to the rate of uptake for
each of the substrates, and this is shown in Table 3.3.1c. The quantity
of radioactivity associated with the tissue remained constant during the
incubation period (see Figure 3.3.If), and the mean T.A.R. values, as seen
in Table 3.3.1c, were similar, ranging from 164 to 204 yl/mg y.s. protein.
125The disposal times of the different I-ribonucleases in the absence
of serum are shown graphically in Figure 3.3.lg, part (i ), and were
constant during the period of incubation with very little difference
between them. This is reinforced by the mean disposal times reported
125in Table 3.3.1c, which shows the values for I-RNases A and B (0.32
125and 0.33h, respectively) to be almost the same as those for I-RNases
S and Spr (0.29 and 0.26h, respectively). The disposal time for 
125I-RNase A is in agreement with the value of 0.36 h, as found by
Livesey (1978). These findings contrast with those in the presence of
125serum, which show the disposal times for I-RNases A and B to be 
125higher than for I-RNases S and Spr.
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The release of acid-soluble radioactivity into serum-free medium
during the first hour of incubation was carefully monitored, samples of
medium being removed for analysis every 5 min during the first part of
the incubation. Figure 3.3.li shows these results. Each 
125I-ribonuclease had a lag-period of approximately 10 min before acid-
soluble radioactivity release was detectable. Livesey (1978) also
125found a lag-period of 10 min for JI-RNase A in the absence of serum.
125This finding is in agreement with all four I-ribonucleases having
the same mean period of association with the tissue before release
of acid-soluble fragments (the same disposal times) in serum-free medium.
In Table 3.3.1e the results for all the different substrates
ingested in the presence of serum are expressed as percentages of the
corresponding data in serum-free media. The close similarities between 
125I-RNases A and B, and between S and Spr are apparent from this
125table. From the effect on the rate of uptake of I-PVP, the effect
of serum on the rate of fluid-phase pinocytosis is to reduce it to
57% of the corresponding rate in serum-free medium. The effect on 
125I-RNases S and Spr is similar, being 50% and 54% respectively,
but the relative effect of addition of serum on the rates of uptake of 
125I-RNases A and B is much greater, relative rates of uptake being 36%
and 26%, respectively. These results are consistent with serum
125affecting the rates of uptake of I-RNases S and Spr simply by
decreasing the rate of fluid-phase pinocytosis, whereas the larger
125decreases in the rates of uptake of I-RNases A and B suggest 
competition for plasma membrane binding sites between serum proteins 
and these two species of ribonuclease.
Figure 3.3.1a Uptake of I-PVP by Yolk Sacs Incubated in the125
Absence and Presence of Calf Serum (10%, v/v)
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. 125The method used was as described in Section 3.2. I-PVP was
present at a concentration of 2 yg/ml. Each uptake plot shows mean 
values (± S.E.M.) from 4 to 6 separate experiments. These results 
are summarized in Table 3.3.1a.
Table 3.3.1a Summary of Data for ^^I-PVP Uptake by Yolk Sacs Incubated 
in the Absence and Presence of Calf Serum (10%, v/v)
These data are from the experiments shown in Figure 3.3.1a. Rate of 
uptake is expressed as the Endocytic Index (E.I.)» and is given with its 
correlation coefficient (Corr.Co.).
Serum E.I. (Corr.Co.)
Cone. (yl/mg y.s.
(%) (protein per h)
3.51 (0.972)
3.31 (0.984)
n 3.41 (0.946)u
3.24 (0.992)
3.79 (0.984)
3.06 (0.977)
2.51 (0.990)
2.17 (0.995)
10 1.48 (0.962)
1.52 (0.977)
Mean E.I.
± S.E.M. 
(pl/mg y.s. 
protein per h)
3.39 ± 0.10
1.92 ± 0.25
• 125Figure 3.3.1b Uptake of Different I-Ribonucleases by Yolk Sacs
Incubated in the Presence of Calf Serum (10%, v/v)
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125The method used was as described in Section 3.2. All I- 
ribonucleases were present at a concentration of 1 pg/ml. Each 
uptake plot shows mean values (± S.E.M.) from 3 separate experiments 
These results are summarized in Table 3.3.1b.
by Yolk Sacs Incubated in the Presence of Calf Serum 
(10%, v/v)
125Table 3.3.1b Summary of Uptake Data for I-RNases A, B, S and Spr
The data reported below indicate the main features of the uptake and 
degradation of different ribonuclease preparations when incubated m  
medium containing 10% (v/v) calf serum. Rate of uptake is expressed as 
the Endocytic Index (E.I.), and is given with its correlation coefficient 
(Corf.Co.). Mean disposal time is calculated as (mean T.A.R./mean E.I.) 
and it represents the mean time that 125i-ribonucleases are associated 
with the tissue before acid-soluble fragments are released. The rate of 
release of these acid solubles (Rate of Sol. Rel.) are also expressed.
The data in all but the last column of this table are reported more 
fully elsewhere (Figures 3.3.1b, e and f).
RNase
E.I.(Corr.Co.) 
(yl/mg y.s. 
protein/h)
Mean E.I.
(± S.E.M.) 
(yl/mg y.s. 
protein/h)
Rate of 
Sol. Rel. 
(yl/mg y.s. 
protein/h)
Mean
T.A.R.
(yl/mg y.s. 
protein)
Mean
Disposal
Time
(h)
191 (0.988)
A 189 (0.958) 187 ± 7 175 105 0.56
169 (0.988)
123 (0.954)
B 153 (0.991) 139 ± 9 132 99 0.71
141 (0.988)
433 (0.974)
S 309 (0.977) 351 ± 41 344 119 0.34
311 (0.971)
364 (0.982)
Spr 345 (0.964) 345 ± 11 347 112 0.32
326 (0.910)
• i 2 5Figure 3.3.1c Uptake of Different I-Rlbonucleases by Yolk Sacs 
Incubated in Serum-Free Medium
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125The method used was as described in Section 3.2. All I- 
ribonucleases were present at a concentration of 1 yg/ml. Each uptake 
plot shows mean values (± S.E.M.) from 2 to 5 separate experiments. 
These results are summarized in Table 3.3.1c.
bv Yolk Sacs Incubated in Serum-Free Medium
These data are from the experiments shown in Figures 3.3.1c, f and h.
The abbreviations used are as in Table 3.3.1b.
125Table 3.3.1c Summary of Data for Uptake of Different----I-Rib°nucleases
RNase
E.l.(Corr.Co.) 
(yl/mg y.s. 
protein/h)
Mean E.l.
(± S.E.M.) 
(yl/mg y.s.
protein/h)
Rate of 
Sol. Rel. 
(yl/mg y.s. 
protein/h)
Mean
T.A.R.
(yl/mg y.s. 
protein)
Mean
Disposal
Time
(h)
518 (0.971)
A
535 (0.959) 
525 (0.983) 
553 (0.982) 
446 (0.996)
515 ± 18 526 164 0.32
499 (0.972)
B
404 (0.980) 
603 (0.971) 
620 (0.969) 
564 (0.991)
538 ± 39 484 179 0.33
S
720 (0.983) 
600 (0.959) 
772 (0.992) 
740 (0.961)
708 ± 33 713 204 0.29
Spr
712 (0.985) 
570 (0.975) 641
669 166 0.26
Figure 3.3.Id Effect of the Presence of Different____I-Ribonucleases
125on Uptake of I-PVP by Yolk Sacs Incubated m  Serum- 
Free Medium
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127The method used was as described in Section 3.2. All I-ribonucleases 
were present at a concentration of 1 yg/ml, and were added 20 min before 
addition of l^I-PVP (2 yg/ml). Each uptake plot shows mean values from 
2 to 6 separate experiments. Individual S.E.M. values of the means are 
not indicated but all means have a S.E.M. of less than 1.0. These results 
are summarized in Table 3.3.Id.
Table 3.3.Id Summary of the Effect of the Presence of Different
127 . 125I-Ribonucleases on Uptake of I-PVP by Yolk Sacs
Incubated in Serum-Free Medium
These data are from the experiments shown in Figure 3.3.Id. Each 
E.I. value (rate of uptake) is given with its correlation coefficient 
(Corr.Co.
E.I. (Corr.Co.)
RNase (yl/mg y.s.
(protein per h)
No Addition 3.01 (0.990)
(Control) 3.28 (0.937)
4.22 (0.983)
3.11 (0.974)
2.87 (0.985)
3.79 (0.996)
2.75 (0.973)
A 3.10 (0.977)
3.34 (0.976)
2.73 (0.959)
B 2.83 (0.959)
3.62 (0.976)
3.26 (0.989)
S 3.16 (0.965)
2.92 (0.983)
Spr 2.67 (0.981)
3.48 (0.959)
3.38 ± 0.21 100.0 ± 6.2
3.06 ± 0.17 90.5 ± 5.0
3.06 ± 0.28 90.5 ± 8.3
3.21 95.0
3.02 ± 0.24 89.3 ± 7.1
125Medium by Yolk Sacs during Uptake of Different- I- 
Ribonucleases in the Presence of Calf Serum (10%, v/v)
Figure 3.3.1e Release of Acid-Soluble Radioactivity into Incubation
• — • RNase B —■ RNase Spr
The acid-soluble radioactivity released into the incubation 
medium is expressed as mean values. These results are from the 
experiments shown in Figure 3.3.1b, and are summarized in Table 
3.3.1b.
Figure 3.3.If Quantity of Radioactivity that becomes Associated with
125Yolk-Sac Tissue during Uptake of Different I-Ribonucleases 
when Incubated in the Absence and Presence of Calf Serum 
(10%, v/v)
(i) In absence of serum
Incubation Time (h)
(ii) In 10% serum
Incubation Time (h)
Key: O— O  RNase A □— □ RNase S
t- •  RNase B ■--- ■ RNase Spr
The quantity of radioactivity that becomes associated with yolk-sac 
tissue (tissue-associated radioactivity, T.A.R.) is expressed as mean 
values. Individual S.E.M. values of the means are not indicated, 
but all means have a S.E.M. of between 5 and 15. These results are 
from the experiments shown in Figures 3.3.1b and c, and are summarized 
in Tables 3.3.1b and c.
I-Ribonucleases after their
Uptake by Yolk Sacs Incubated in the Absence and Presence 
of Calf Serum (10%, v/v)
Figure 3.3.1g Disposal Time of Different
(i) In absence of serum
<u
0•H
cd
COo
Cu
CO•H
Incubation Time (h)
Cii) In presence of serum
<u
0
rtwoP-
CO
Incubation Time (h)
Key: O — O  RNase A o □ RNase S
» —  9 RNase B ■ ■ RNase Spr
Disposal time is calculated as (T.A.R. x period of incubation (h)/ 
uptake), and it represents the mean time iribonuGleasses are associated 
with the tissue before acid-soluble fragments are released. These 
results are from the experiments shown in Figures 3.3.1b and c.
Figure 3.3.1h Release of Acid-Soluble Radioactivity into Incubation Medium
125by Yolk Sacs during Uptake of Different I-Ribonucleases 
in Serum-Free Medium
Incubation Time (h)
Key: O— O  RNase A 
•— • RNase B
The acid-soluble radioactivity released into the incubation medium 
is expressed as mean values. These results are from the experiments 
shown in Figure 3.3.1c, and are summarized in Table 3.3.1c. A detailed 
study of the acid-soluble radioactivity released into the incubation 
medium during the first hour of incubation in serum-free medium is 
shown in Figure 3.3.1i.
□-- □ RNase S
■-- ■ RNase Spr
Medium by Yolk Sacs during the First Hour of Uptake of 
125Different I-Ribonucleases in Serum-Free Medium
Figure 3.3.1i Release of Acid-Soluble Radioactivity into Incubation
Key: O— O RNase A □— □ RNase S
RNase B RNase Spr
The acid-soluble radioactivity released into the incubation medium 
is expressed as mean values (± S.E.M.) from 3 separate experiments. The 
acid-soluble radioactivity released into the incubation medium during 3h 
of incubation in serum-free medium is shown in Figure 3.3.1h.
Table 3.3.1e Summary of the Relative F.ffects of Calf Serum (10%) on
12*5 125Uptake of I-FVP and I-Ribonucleases by Yolk Sacs 
Compared to their Uptake in Serum-Free Medium.
The data presented here are taken from Tables 3.3.1a, b and c, and the
abbreviations and units used are as in Table 3.3. ! es a ^
are expressed relatively by reporting the quantity m  the presence of 
serum as a percentage of the equivalent quantity rom expe 
absence of serum.
Quantity
Measured PVP
Mean E.I. 57
Rate of 
Sol. Rel. -
Mean T.A.R. -
Mean Disposal 
Time -
RNase A RNase
36 26
33 27
64 55
175 215
RNase S RNase Spr
50 54
48 52
58 67
117 123
48
3.3.2 The Effects of NH.Cl and 2,4-DNP on the Uptake of Different  4_______
125I-Ribonucleases by Yolk Sacs.
The results in this section are illustrated graphically in figures,
and presented in greater detail in corresponding tables. Since the
variety of experimental conditions was large, the relative effects of
the different agents used are summarized in tables at the end of the
section (results being expressed as percentages of the results in the
absence of any agent). The relative effects of the agents in the
Presence of serum are reported in Table 3.3.2g, and the relative effects
in serum-free medium are reported in Table 3.3.2h.
Ammonium ions (in the form of 20mM NH^Cl) were added to yolk sacs,
and their effect on fluid-phase pinocytosis in serum-free medium is shown
125in Figure 3.3.2a. The uptake of the fluid-phase marker, I-PVP, 
virtually ceased in the presence of the ammonium ions, the E.I. being 
0,20 yl/mg y.s. protein per h (see Table 3.3.2a) which is similar to the 
value reported by Livesey et a]^ . (1980) for experiments with 20mM
nh4ci.
125The effect of NH^Cl on uptake of I-rxbonucleases from serum-free
medium is shown in Figure 3.3.2b. Likewise, their uptake was virtually
completely inhibited by 20mM NH^Cl; the E.I. values are reported in
Table 3.3.2a. The rate of release of acid-soluble radioactivity was
125similarly completely inhibited for each I-ribonuclease, as would be
expected from the uptake data. The relative effects of NH^Cl (20mM) on
uptake of I-PVP and I-ribonucleases in serum-free medium are
summarized in Table 3.3.2h. The relative mean E.I's and rates of release
of acid-soluble radioactivity are all 6%, or less, than control values
125(Livesey elt al. (1980) found uptake of I-PVP was 16% and uptake of
125formaldehyde-denatured I-labelled BSA was 10% of control values).
The quantity of radioactivity associated with the yolk-sac tissue
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(T.A.R. value) remained constant throughout the incubation period, although
the mean values of this quantity for I-RNases S and Spr were higher
than those of ^2"^I-RNases A and B. The T.A.R. value for I-RNases
A and B in the presence of 20mM NH4Cl is reduced to 10% of the control
125value, whereas the relative mean T.A.R. values for I-RNases S and
Spr are about 50% of the control values. This may be indicative of a
125higher non-specific binding of these last two i-ribonucleases to yolk
125sacs over and above that of I-RNases A and B.
Mean disposal times were not calculated from these data, since in 
the absence of any progressive uptake of radioactivity, the concept of 
the disposal time (the mean time for which radioactivity is associated 
with the yolk-sac tissue before its release as acid-soluble radioactivity)
has no real meaning.
The rate of fluid-phase pinocytosis, as determined by the rate
of uptake of 12^I-PVP, was measured in the presence of 2,4-DNP. The
effect of 2,4-DNP at a concentration of 50 pg/ml in the presence of 10%
calf serum is shown in Figure 3.3.2c, and the calculated E.I. values are
reported in Table 3.3.2b. These data support the observation by
Duncan & Lloyd (1978) that, under these conditions, the pinocytic uptake
125of 12^I-PVP was completely abolished. The uptake of I-PVP in the 
presence of 2,4-DNP in serum-free medium was virtually completely 
inhibited at 50 pg/ml DNP, but inhibition was much less marked at a DNP 
concentration of 10 yg/ml (see Figure 3.3.2c and Table 3.3.2b). Similar 
findings were reported by Weisbecker (198l).
125The effect of 2,4-DNP (50 pg/ml) on the uptake of I-nbonucleases 
it the presence of serum is shown in Figure 3.3.2d. The uptake plots 
show that the rates of pinocytosis were greatly reduced under these 
conditions; these rates are reported in Table 3.3.2c. Again, as with 
inhibition of uptake by NH^Cl, the rate of release of acid-soluble
50
radioactivity was very close to the observed E.I. The quantity of
radioactivity associated with the yolk-sac remained constant during
the incubation period, and was very low for I-RNases A and B, but
higher for 125I-RNases S and Spr. The calculated mean disposal times
were higher than in the absence of 2,4-DNP, ranging from 0.92 to 1.86 h.
125The effect of 2,4-DNP (50 yl/ml) on the uptake of I-labelled
substrates from medium containing serum are summarized in Table 3.3.2g.
The mean E.I. of 125I-PVP was 4% of the control value. The relative
uptake rate of 125I-RNase A was very similar (3%), whereas the relative
rates of uptake of the other 125I-ribonucleases were slightly higher,
ranging from 9% for 125I-RNase B to 18% of the control value for
l25I-RNase S; these relative uptake rates reflect the relative rates of
release of acid-soluble radioactivity. The relative mean disposal times
were higher than control values, varying between 1.3- and 5.5-times the
125control values. [Calculation of a mean disposal time for I-RNase A
is questionable since uptake of this protein was completely abolished m  
the presence of 50 yg/ml 2,4-DNP (see above for discussion on this 
Point), but it has been included for completeness.] These findings 
suggest that although 2,4-DNP (50 yg/ml) in the presence of serum can 
virtually fully inhibit fluid-phase pinocytosis, it is not as effective
as NH.C1 at inhibiting the apparent uptake and degradation of some 4
of the 125I-ribonucleases in serum-free medium.
• j? j • no**-•?m ifv associated with the tissue,The relative quantity of radioactivi y
, . , _ , . nfp,pnce of 50 ug/ml 2,4-DNP inwhen yolk-sacs are incubated in the pres V
125medium containing serum, is 10% of the control values £or I-RNases A 
and B, which is similar to the effect for incubation in the presence of
NH4C1 in serum-free medium. Again the relative T.A.R. values are higher 
for l25I-RNases S and Spr, being 100% and 50% of control values 
respectively; this gives further support to the suggestion that some
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of the binding of 125I-RNases S and Spr to rat yolk sacs may be non-specific
125compared with the binding of I-RNases A and B.
The rates of uptake of 12^I-ribonucleases from serum-free medium
were also examined in the presence of 2,4-DNP. Two different concentrations
of 2,4-DNP (10 and 50 yg/ml) were used, as in the experiments with
125I-PVP. The results for 125I-RNases A and S are shown graphically in
125Figure 3.3.2e. The same trends were found with I-RNases B and Spr, but 
the results for these were not included in this figure m  order to help 
maintain clarity. Figure 3.3.2e shows that 2,4-DNP at a concentration 
of 50 yg/ml greatly inhibited uptake of 125I-RNases A and S, and that 
at the lower concentration of 10 yg/ml the inhibition of uptake was not 
so great. These results are summarized in Tables 3.3.2cland e together 
with the equivalent results from experiments with I-RNases B and Spr. 
Again, rates of release of acid-soluble radioactivity were very similar 
to mean E.I. values, and the mean T.A.R. values, which remained constant 
during the incubation period, were lower for I-RNases A and B than 
for 125I-RNases S and Spr. The lowering of uptake rates was accompanied
by increases in mean disposal times.
The relative effects of 2,4-DNP in serum-free medium on uptake of 
^■’i-PVP and 12^I-ribonucleases are summarized in Table 3.3.2h.
Fluid-phase pinocytosis virtually ceased in the presence of 50 yg/ml
2.4- DNP, the uptake rate falling to 5% of the control value. When
the concentration of 2,4-DNP was decreased to 10 yg/ml, the relative E.I.
125rose to 26%. Again, the effect of 2,4-DNP on I-RNase A was the same 
as on 125I-PVP; the effect on 125I-RNase B was also very similar. At a
2.4- DNP concentration of 50 yg/ml the relative rates of uptake of 
125I-RNases A and B were 5% and 10% respectively; at 10 yg/ml the 
corresponding values were 27% and 30%, respectively. At the highest
2.4- DNP concentration used in serum-free medium (50 yg/ml) the relative 
effects on the mean E.I. values of ^2^I-RNases S and Spr were only
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23% and 31% of the control values respectively, and at 10 pg/ml 2,4-DNP
the uptake rate and the rate of release of acid-soluble radioactivity
rose to 70% of the control value. The relative mean disposal times
again showed no clear pattern, although at the higher 2,4-DNP concentration
(50 yg/ml) the value for each ^2~*I-ribonuclease was greater than at
lO yg/ml 2,4-DNP. These values were in the same range as when the
incubation medium contained 10% calf serum. (Again, calculation of a
mean disposal time for ^2^I-RNase A is questionable.)
The quantity of radioactivity associated with yolk-sac tissue in the
Presence of 2,4-DNP in serum-free medium was again high. Mean T.A.R.
values for 125I-RNases A and B in the presence of 50 pg/ml were between
30% and 40% of control values, but at 10 pg/ml they were equal to the
control values. The values for 125I-RNases S and Spr were consistently
greater than their control values. These high T.A.R. values may be
125indicative of strong non-specific binding of these 1-ribonucleases to 
the yolk-sac membrane.
Since the quantity of radioactivity associated with the yolk-sac
tissue for 125I-RNases S and Spr in the presence of 2,4-DNP was always
very high, a single experiment was performed in which the yolk sacs were
127Preincubated in serum-free medium with non-radioactive, I-iodinated
RNase S. This was followed by washing the tissue and reincubating it with
l25I-RNase S, both in the absence and presence of 2,4-DNP (50 yg/ml).
The purpose of this experiment was to see if the saturation of any non-
127specific binding sites for 125I-RNase S by the non-radioactive I- 
iodinated RNase S could be achieved before addition of the radioactive 
stialogue. This would be expected to reduce the mean T.A.R. values for 
^I-RNase S. This was not found (see Table 3.3.2f), and again the 
mean T.A.R. value was greater in the presence of 2,4-DNP. It is possible 
that non-radioactive 127I-iodinated RNase S binds only very loosely to
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the membrane, and that the washing procedure may remove a large proportion
of it. But if this was the case the same would happen during the washing
procedure at the end of conventional incubations. One may therefore
conclude that the T.A.R. values measured following conventional incubations
represent relatively strong binding (able to withstand the washing procedures),
125
and that this binding is reversible (since an excess of I-RNase S 
is able to displace any bound non-radioactive I-iodinated RNase S).
The rate of release of acid-soluble radioactivity into the incubation 
medium from 125I-RNases A and B in the presence of-2,4-DOT m  serum-free 
medium paralleled the rate of uptake, and this inhibitor had the same 
relative effect on these substrates as on 125I-PVP. One can conclude 
that these findings are due to the change in rate of pinocytosis m  the 
rat yolk sac. However, more solubles are produced when yolk sacs are 
incubated with 125I-RNases S and Spr than can be accounted for by the 
above reasoning. It is possible that the incubation medium has the 
capacity to liberate acid-solubles from 125I-RNases S and Spr in the 
Presence of 2,4-DNP, or some proteolytic activity may be present on the 
surface of the yolk sac and results in 125I-RNases S and Spr being 
cleaved to form acid-soluble fragments in the presence of 2,4-DNP at
Physiological pH.
Figure 3.3.2a Effect of NHaCI on the Uptake of I-PVP by Yolk Sacs 
Incubated in Serum-Free Medium
125
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The method used was as described in Section 3.2. NH.Cl (20mM) 
was added 20 min before addition of i^5i-pvp (2 yg/ml). Each uptake 
Plot shows mean values (± S.E.M.) from 3 separate experiments. The 
results in the presence of NH^Cl are summarized in Table 3.3.2a, and 
ell these results are further summarized in Table 3.3.2h.
125and of Different I-Ribonucleases by Yolk Sacs Incubated 
in Serum-Free Medium.
Table 3.3.2a Summary of the Effect of NHaCX on the Uptake of J~‘~v,I~PVP
These data are from the experiments 
abbreviations used are as in Table 
summarized in Table 3.3.2h.
shown in Figures 3.3.2a and b. 
3.3.1b. These data are further.
The
Substrate
E.I. (corr.co.) 
(pl/mg y.s. 
protein per h)
0.37 (0.795)
PVP 0.13 (0.514) 
0.10 (0.633)
RNase A 2.10 (0.3.77) 
2.62 (0.537) 
2.57 (0.681)
RNase B 12.64 (0.837) 
10.30 (0.617)
RNase S 24.00 (0.955) 
15.66 (0.847)
RNase Spr 26.94 (0.821) 
7.14 (0.803) 
13.36 (0.834)
Mean E.I.
± S.E.M. 
(pl/mg y.s. 
protein per h)
Rate of 
Sol. Rel.
(pi/mg y.s. 
protein per h)
Mean
T.A.R.
(pl/mg y.s. 
protein)
0.20 ± 0.09
2 ± 2
11
17
20
20 16 122
16 ± 6 11 81
I-RibonucleasesFigure 3.3.2b Effect of NHaCI on Uptake of Different
125
by Yolk Sacs Incubated in Serum-Free Medium
125All I-ribonucleasesThe method used was as described in Section 3.2.
Were present at a concentration of 1 pg/ml, and were added 20 min after 
addition of NH4CI (20mM). Each uptake plot shows mean values (± S.E.M.) 
from 2 to 3 separate experiments. The results in the presence of NH4CI 
are summarized in Table 3.3.2a, and all these results are further summarized 
in Table 3.3.2h.
Figure 3.3.2c Effect of 2,4-DNP on Uptake of I-PVP by Yolk 
Sacs Incubated in Absence dr Presence of Calf 
Serum (10%, v/v)
125
Incubation Time (h)
Key: O— O  No Addition
O  DNP (10 yg/ml) 
•— • DNP (50 yg/ml)
□— □ No Addition
■— ■ DNP (50 yg/ml)
Serum-Free Medium
Serum (10%, v/v)
The method used was as described in Section 3.2. 2,4-DNP (10 or 50
Vg/ral) was added 20 min before addition of i^Sp-pyp (2 yg/ml). Each 
uptake plot shows mean values (± S.E.M.) from 4 to 6 separate experiments. 
The results in the presence of 2,4-DNP are summarized in Table 3.3.2b, and 
all these results are further summarized in Tables 3.3.2g and h.
Table 3.3.2b Summary of the Effect of 2,4-DNP on the Uptake of 
12-*I-pyp by Yolk Sacs Incubated in the Absence .or 
Presence of Calf Serum (10%, v/v)
These data are from the experiments shown in Figure 3.3.2c, and are 
further summarized in Tables 3.3.2g and h. The abbreviations 
used are as in Table 3.3.1a.
Mean E.I.Serum DNP E.I.(Corr.Co.) ± S.E.M.Cone. Cone. (yl/mg y.s. (yl/mg y.s.(%> (yg/ml) protein per h) protein per
0.60 (0.686)
1.17 (0.853)
0 10 0.85 (0.896) 0.88 ± 0.22
0.36 (0.656)
1.84 (0.926)
0.48 (0.447)
0.15 (0.284)
0.04 (0.129)
0 50 0.13 (0.400) 0.17 ± 0.04
0.27 (0.343)
0.26 (0.657)
0.09 (0.630)
10 50 0.05 (0.198) 0.08 ± 0.010.12 (0.713)
0.07 (0.614)
Figure 3.3.2d Effect of 2,4-DNP on Uptake of Different I-Ribonucleases 
by Yolk Sacs Incubated in Presence of Calf Serum (10%, y/y)
125
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125The method used was as described in Section 3.2. All I-ribonucleases 
were present at a concentration of lyg/ml, and were added 20 min after 
addition of 2,4-DNP (50yg/ml). Each uptake plot shows mean values (± S.E.M.) 
from 2 to 3 separate experiments. The results in the presence of 
2,4-DNP are summarized in Table 3.3.2c, and all these results are further 
summarized in Table 3.3.2g.
Table 3.3.2c Summary of the Effect of 2,4-DNP on the Uptake of
Different 125I-Ribonucleases by Yolk Sacs Incubated
in the Presence of Calf Serum (10%, v/v)
These data are from the experiments shown in Figure 3.3.2d. The 
abbreviations are as in Table 3.3.1b. Since the inhibition of uptake 
in the presence of DNP (50 yg/ml) is large, the errors in the mean E.I. 
and mean quantities of tissue-associated radioactivity (T.A.R. values) 
are larger than those of the controls. Therefore the calculated mean 
disposal times will also be subject to some error. These data are 
further summarized in Table 3.3.2g.
RNase
E.I.(Corr.Co.) 
(yl/mg y.s. 
protein/h)
Mean E.I.
± S.E.M. 
(yl/mg y.s. 
protein/h)
Rate of 
Sol.Rel. 
(yl/mg y.s. 
protein/h)
Mean
T.A.R.
(yl/mg y.s. 
protein)
Mean
Disposal
Time
(h)
A 2 (0.215) 
11 (0.481)
6 7 9 1.50
15 (0.781)
B 12 (0.575) 12 + 2 17 11 0.92
8 (0.540)
S
84 (0.692)
63 (0.868) 64 ±12 60 119 1.86
44 (0.555)
30 (0.713) 
Spr 44 (0.915)
64 (0.956)
46 ± 10 43 56 1.22
Figure 3.3.2e Effect of 2,4-DNP on Uptake of Different 125I-Ribonucleases
by Yolk Sacs Incubated in Serum-Free Medium
Key: O--O
3  — 3
□— □ 
□— a
No Addition 
DNP (10 yg/ml) 
DNP (50 yg/ml) 
No Addition 
DNP (10 yg/ml) 
DNP (50 yg/ml)
RNase A
RNase S
125The method used was as described in Section 3.2. All four I-ribo- 
nucleases were used at a concentration of 1 yg/ml, and were added 20 min 
after addition of 2,4-DNP (10 or 50 yg/ml). Only the results for 
^•^^I-RNases A and S are shown here; the results for 125i_Rjjaseg 3 and gpr 
were similar to those of A and S respectively. Each uptake plot shows mean 
values (* S.E.M.) from 2 to 3 separate experiments. The above results in 
the presence of 2,4-DNP are summarized in Table 3.3.2d together with the 
results for 125j-RNases b and Spr. These results are further summarized 
in Table 3.3.2h.
Table 3.3.2d Summary of the Effect of 2,4-DNP on the Uptake of Different 
125I-Ribonucleases by Yolk Sacs Incubated in Serum-Free 
Medium
These data are from the experiments shown in Figure 3.3.2e, and are for a 
DNP concentration of 10 yg/ml. The abbreviations are as in Table 3.3.1b. 
These data are further summarized in Table 3.3.2h.
RNase
E.I. (Corr.Co.) 
(yl/mg y.s. 
protein/h)
Mean E.I. 
(± S.E.M.) 
(yl/mg y.s. 
protein/h)
Rate of 
Sol. Rel. 
(yl/mg y.s. 
protein/h)
Mean
T.A.R.
(yl/mg y.s. 
protein)
Mean
Disposal
Time
(h)
130 (0.799)
A 142 (0.676 141 ± 6 166 166 1.18
152 (0.662) *
140 (0.722)
B 206 (0.887) 
143 (0.836
164 ± 21 186 147 0.90
S
392 (0.796) 
556 (0.963) 474 435 312 0.66
407 (0.875)
Spr 571 (0.972) 
452 (0.918)
477 ± 49 471 268 0.56
Table 3.3.2e Summary of the Effect of 2,4-DNP on Uptake of Different 
125I-Ribonucleases by Yolk Sacs Incubated in Serum-Free
Med ium
These data are from the experiments shown in Figure 3.3.2e, and are for a 
DNP concentration of 50 yg/ml. The abbreviations are as in Table 3.3.1b. 
Since the inhibition of uptake in the presence of DNP (50 yg/ml) is 
large, the errors on the mean E.I. and mean T.A.R. values are larger than 
those of the controls. Therefore the calculated mean disposal times
will also be subject to some error, 
in Table 3.3.2h.
E.I,.(Corr.Co.) Mean E.I.
RNase (yl/mg y.s. (± S.E.M.)
protein/h) (yl/mg y.s.
protein/h)
4 (0.134)
A 46 (0.811) 24 (± 12)
22 (0.238)
88 (0.973)
B 71 (0.775) 56 (± 24)
9 (0.265)
205 (0.771)
S 59 (0.563) 160 (± 50)
215 (0.754)
189 (0.901)
Spr 264 (0.812) 198 (± 36)
140 (0.731)
These data are further summarized
Rate of Mean Mean
Sol. Rel. T.A.R. Disposal
(yl/mg y.s. (yl/mg y.s. Time
protein/h) protein) (h)
33 53 2.21
61 67 1.20
156 248 1.55
207 226 1.14
Table 3.3.2f Effect of Preincubation with I-RNase S on the Uptake of127
125,I-RNase S by Yolk Sacs Incubated in Serum-Free Medium 
in Absence or Presence of 2,4-DNP
The details of this experiment are reported in Section 3.2. Yolk sacs 
were preincubated with 127i-Rjjase S (lOyg/ml), and washed in medium 199 
(37°C) to remove any loosely-associated 127i-RNase S. Then the substrate, 
^•^^I-RNase S (1 yg/ml), was added at the same time as 2,4-DNP (50 yg/ml);
lly 2,4-DNP was 
performed once
iadded 20 min 
only.
before the substrate. This experiment
Preinc. with Inc. with E.I. (Co.Coeff.) Mean T.A.R.
127i_RNase S 2,4-DNP (yl/mg y.s. (yl/mg y.s.
(lOpg/ral) (50yg/ml) protein/h) protein)
0 0 894 (0.921) 152
+ 0 828 (0.945) 171
0 + 576 (0.926) 337
+ + 629 (0.936) 404
Table 3.3.2g Overall Summary of the Effect of 2,4-DNP on Uptake of
■I n r  1 O  C
I-PVP and of Different I-Ribonucleases by Yolk 
Sacs when Incubated in the Presence of Calf Serum (10%,v/y)
These summary data are from the experiments shown in Figures 3.3.2c and d, 
and data from Tables 3.3.2b and c. The abbreviations and units are as m  
Table 3.3.lb..i The relative effect of the agent, expressed as a percentage 
of the control value (no addition of agent), is in parentheses beside each 
experimental result:
Agent PVP RNase A RNase B RNase S RNase Spr
(i) Mean E.I. (yl/mg yolk-sac protein per h)
No addition 1.92 (100) 187 (100) 139 (100) 351 (100) 345 (100)
DNP (50yg/ml) 0.08 (4) 6 (3) 12 (9) 64 (18) 46 (13)
(ii) Rate of Sol. Rel. (yl/mg yolk-sac protein per h)
No Addition 175 (100) 132 (100) 344 (100) 347 (100)
DNP (50yg/ml) 7 (4) 17 (13) 60 (17) 43 (12)
(iii) Mean T.A.R. (yl/mg yolk-sac protein)
No Addition 105 (100) 99 (100) 119 (100) 112 (100)
DNP (50yg/ml) 9 (9) 11 (ID 119 (100) 56 (50)
(iv) Mean Disposal Time (h)
No Addition 0.56 (100) 0.71 (100) 0.34 (100) 0.32 (100)
DNP (50yg/ml) 1.50 (270) 0.92 (130) 1.86 (550) 1.22 (380)
Table 3.3.2h Overall Sümiflàry of thé Effects of NH&C1 and 2,4-DNP on the 
Uptake of ^i - p y p  and of Different ^I-Ribonucl eases by 
Yolk Sacs when Incubated in Serum-Free Medium.
These summary data are from the experiments shown in Figures 3.3.2a,b,c 
and e, and data from Tables 3.3.2a,b,d and e. The abbreviations and units 
are as in Table 3.3.1b. The relative effect of each agent, expressed as
a percentage of the 
Parentheses beside
control value (no addition of a, 
each experimental result.
gent), is given in
Agent PVP RNase A RNase B RNase S RNase Spr
(i) Mean E.I. (yl/mg yolk-sac protein per h)
No Addition 3.39 (100) 515 (100) 538 (100) 708 (100) 641 (100)
NH4C1 (20mM) 0.20 (6) 2 (<1) 11 (2) 20 (3) 16 (2)
DNP (lOyg/ml) 0.83 (26) 141 (27) 164 (30) 474 (67) 477 (74)
DNP (50yg/ml) 0.17 (5) 24 (5) 56 (10) 160 (23) 198 (31)
(ii) Rate of Sol. Rel. (yl/mg yolk-sac protein per h)
No Addition — 526 (100) 484 (100) 713 (100) 669 (100)
NH4C1 (20mM) - 2 (<1) 6 (1) 16 (2) 11 (2)
DNP (10yg/ml) - 166 (32) 186 (38) 435 (61) 471 (70)
DNP (50yg/ml) - 33 (6) 61 (13) 156 (22) 207 (31)
(iii) Mean T.A.R. (yl/mg yolk-sac protein)
No Addition - 164 (100) 179 (100) 204 (100) 166 (100)
NH4C1 (20mM) - 17 (10) 20 (ID 122 (60) 81 (49)
DNP (10yg/ml) - 166 (101) 147 (82) 312 (153) 268 (161)
DNP (50yg/ml) - 53 (32) 67 (37) 248 (122) 226 (136)
(iv) Mean Disposal Time (h)
No Addition — 0.32 (100) 0.33 (100) 0.29 (100) 0.26 (100)
DNP (10yg/ml) - 1.18 (370) 0 .90 (270) 0.66 (230) 0.56 (220)
DNP (50yg/ml) - 2.21 (690) 1.20 (360) 1.55 (530) 1.14 (440)
54
3.3.3 The Influence of pH and the Presence of Yolk-Sac Tissue on the
. 125Stability of Different I-Ribonucleases
The effect of yolk-sac homogenate on the stability of different
125I-labelled RNases over a range of pH values was examined. The
stability of the substrates was determined by incubating them with yolk-
sac homogenate and buffer, and determining the rate of production of acid-
125soluble radioactivity over a lh incubation period; I-ribonucleases 
were present at a concentration of 10 yg/200 yl, and each 50 yl aliquot 
of yolk-sac homogenate contained approx. 40 yg protein. The results of 
this investigation are shown in Figure 3.3.3a. Yolk-sac homogenate had 
the capacity to degrade all the I-ribonucleases iii vitro, the 
greatest rate of degradation being in the pH range from 4 to 5. In this
1 O CpH range I-RNase S had the highest rate of degradation with an
125increase in acid-soluble radioactivity of 20%/h; I-RNases B and Spr
125produced about 10% acid-soluble radioactivity per h, and I-RNase A
had the lowest rate, producing around 4% per h. At physiological pH
(pH 7.4, the value at which I-ribonucleases were routinely incubated
with yolk sacs in medium 199), there was no production of acid-soluble
125radioactivity from I-RNase A under the conditions used, but there
125was some acid-soluble radioactivity produced from I-RNases B, S and Spr.
Although this finding is compatible with the proposal that there may be
some proteolytic activity associated with the yolk sac at neutral pH
capable of degrading "l-ribonucleases, it provides no information
as to where this proteolytic activity may be found, whether on the yolk-
sac surface or at some intracellular site.
The stability of I-ribonucleases to incubation media, or to media
that had previously been exposed to yolk-sac tissue, was examined by
measuring the production of acid-soluble radioactivity released from 
125I-ribonucleases during their incubation with "conditioned incubation
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medium". "Yolk-sac conditioned medium" was prepared by incubating
yolk sacs in either serum-free or serum-containing medium, and in either
the presence or absence of 2,4-DNP. "Simple conditioned medium"
was prepared as above but without any yolk sacs being present.
The results of these experiments are shown in Figure 3.3.3b in
the presence of calf serum, and in Figure 3.3.3c in the absence of
calf serum. The quantity of acid-soluble radioactivity released from 
125any of the I-ribonucleases studied did not alter with time. Neither
the presence of calf serum nor the presence of 2,4-DNP appeared to make
any difference to the percentage of acid-soluble radioactivity associated
with each i-ribonuclease. These data suggest that there is no
enzymic activity associated with either the incubation medium or released
from rat yolk sacs, that has the proteolytic capacity to degrade 
125I-ribonucleases at neutral pH.
figure 3.3.3a Effect of pH on the Rate of Degradation of Different 
125I-Ribonucleases when Incubated with Yolk-Sac 
Homogenate
Key: O — O  RNase A □— □ RNase S
•— • RNase B ■— ■ RNase Spr
125The method used was as described in Section 3.2.  ^ I-ribonucleases 
were present at a concentration of 10 vg/200pl xn an incubation mixture 
containing buffer and yolk-sac homogenate; control incubation mixtures 
contained buffer and distilled water. The duration of the incubation was 
l.Oh. The results are expressed as mean values of the increase in acid- 
soluble radioactivity [acid-soluble radioactivity of incubation mixture (%) 
acid-soluble radioactivity of control incubation mixture (%)] from 2 separate 
experiments, each being performed in quadruplicate.
Figure 3.3.3b Effect of 2,4-DNP on the Degradation of Different
125I-Ribonucleases when Incubated in Serum-Containing
"Conditioned Incubation Medium"
10
RNase A
0
No Addition
L L
6-i
L L
Incubation Time (h) 
Key: O — O  "Simple Conditioned Medium"
"Yolk-sac conditioned medium"
The method used was as described in Section 3.2. "Conditioned 
incubation media" were prepared by incubating serum-containing medium with 
or without yolk sacs, either in the absence or presence of 2,4-DNP. 
125i-ribonucieases (1 yg/ml) were then incubated in the presence of these 
media, and the acid-soluble radioactivity produced was calculated. "Simple 
and "Yolk-sac conditioned media" were in the absence (controls) and presence 
of yolk sacs respectively. The results are expressed as mean values 
(± S.E.M.) from 2 separate experiments, each being performed in duplicate.
Figure 3.3.3c Effect of 2,4-DNP on the Degradation of Different
125I-Ribonucleases when Incubated with Serum-Free
"Conditioned Incubation Medium"
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Key: "Simple conditioned medium" 
"Yolk-sac conditioned medium"
The method used was as described in Section 3.2, and briefly outlined 
as in Figure 3.3.3b with the exception that serum was absent from the 
incubation media. The results are expressed as mean values (± S.E.M.) 
from 2 separate experiments, each being performed in duplicate.
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3.4 Discussion
This study of the rates of uptake of a number of different ribonucleases
hy rat yolk sacs has produced one clearly dominant finding, namely the
general similarity between ^"*I-RNases A and B, and the similarity between
^^I-RNases S and Spr, regardless of the incubation conditions. The
125similarity of all the results obtained for I-RNases A and B leads to 
the conclusion that there appears to be no preferential uptake by the 
rat yolk sac of a protein molecule proffering a terminal mannose residue, 
indicating that there is no mannose receptor on the rat yolk-sac surface.
[This contrasts with the results obtained by Baynes & Wold (1976) who, as 
described in Section 3.1, found that the in vivo clearance of ribonucléase 
B was very much more rapid than that of ribonucléase A, due to the mannose 
residues on the surface of the B isoenzyme being recognised by the liver 
non-parenchymal cells and thence being removed from the circulation.]
These same results in the yolk sac system also show that the introduction 
of the oligosaccharide moiety on the polypeptide backbone of ribonucléase 
A to form ribonucléase B does not appear to mask any determinant, based on 
amino acid residues, that is responsible for the rapid uptake of the 
simple ''protein core".
125The observation that the rates of capture of I-ribonucleases A and
B rise sharply in the absence of serum as compared with the rates of
uptake in the presence of 10% calf serum (see Tables 3.3.2g & h), may in
part be explained by the finding of Fuller & Maras (1979) that calf serum
contains 70 yg of pancreatic ribonucléase A  Per as measured by the
degradation of yeast RNA. This would mean that, for experiments performed
125in the presence of 10% (v/v) calf serum, each molecule of I-labelled 
ribonucléase would have been in competition with approx. 7 molecules of 
unlabelled ribonuclease0 Recently, Livesey & Williams (1982) have shown 
that large amounts(100 yg/ml) of native ribonucléase A decreased the rate
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of uptake of tracer amounts of I-RNase A by approx. 90% when added 
to serum-free medium in which yolk sacs are incubated, a finding that gives 
substance to the above suggestion.
Baynes & Wold (1976) reported that the ribonuclease B that they obtained 
from Sigma was only 20% pure, the remaining 80% being contamination with 
ribonuclease A. More recently Kooistra e£ al. (unpublished data) have 
determined that the ribonuclease B preparations from Sigma have improved 
to 50% purity. The ribonuclease B preparation used in this study was also 
obtained from this source, but any such contamination with ribonuclease A 
(of the order of 50%) would have been unlikely.to have prevented the 
detection of a mannose receptor on the rat yolk-sac surface in these 
experiments. Time allowing, the purity of the ribonuclease B preparation
used here was to have been established.
125The rates of degradation of I-RNases A and B by the yolk-sac tissue, 
as indicated by the similarity in the disposal times, were the same. The 
influence of a carbohydrate moiety upon the rate of degradation of proteins 
is not readily predicted from the literature. For example, Kalish et al. 
(1979) found that among cytosol proteins from.a variety of mammalian 
tissues, glycoproteins tend to be degraded more rapidly than non-glycoproteins. 
Conversely, Wang & Hirs (1977) found that enzymic removal of carbohydrate 
from porcine pancreatic ribonuclease resulted in an increase in sensitivity 
towards attack by subtilisin, indicating that heterosaccharides can 
exert a protective function against degradation. Brown et al. (1979) 
have studied the uptake and subsequent inactivation of native and deglyco­
sylated yeast invertase in rat yolk sacs, by measuring the enzyme activity 
within the tissue with time. They found that the initial rate of uptake 
of the deglycosylated form was several-fold greater than that of the 
native molecule. They also found that, for the deglycosylated form, 
the accumulation of enzyme activity with time levelled off much more 
rapidly than that of the glycosylated form (indicating that, for the
125
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deglycosylated form, a steady-state level within the tissue was more 
rapidly established). After preloading the yolk-sac tissue with the two 
different forms of invertase, the quantity of native invertase enzymic- 
activity associated with the tissue was constant up to 6h, whereas the 
activity of the deglycosylated form declined. These data indicate that 
the carbohydrate moiety protects the invertase molecule from intracellular 
protein inactivation; however, a similar conclusion could not be reached 
from the data presented in this chapter. The extent of glycosylation of 
the invertase molecule is very great in comparison to that of ribonucléase 
B, and this may be a key factor in the ability of the carbohydrate 
moiety to protect the molecule from attack in the case of invertase, but
not in the case of ribonucléase B.
125The rates of uptake of I-RNases S and Spr by rat yolk sacs were 
always extremely similar. Comparison of the structures of these two 
ribonucleases is informative. (Ribonucléase S is formed by cleavage, with 
subtilisin, of the 124 amino acid chain of ribonucléase A between residues 
20 and 21. However, the cleavage fragments remain held together by 
non-covalent forces in ribonucléase S; ribonucléase S protein is formed 
by removal of the eicosapeptide from ribonucléase S by acid precipitation.) 
This structural difference enables one to conclude that the removal of 
a small, non-covalently bound peptide does not appear to affect the 
ability of the yolk sac to pinocytose this protein. It would have been
interesting to have examined the uptake and degradation of the isolated 
small peptide by rat yolk sacs. Unfortunately this peptide could not be 
labelled by the chloromine T method which was used to label the other 
ribonucleases, due to the absence of a tyrosine residue. As it was not 
desirable to label it via a different method the peptide was omitted from 
this study,
125The rate of uptake of I-RNase S was always much greater than that 
125°f I-RNase A. The only difference between the structures of these two
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molecules is that, in ribonuclease S, cleavage of a peptide bond has 
introduced into the protein a change in the conformation of the molecule. 
However, this change leaves the active site of the enzyme virtually 
unaltered. This rapid uptake of the partially denatured ribonuclease 
when compared to the native form is compatible with the suggestion of 
Dice & Goldberg (1976), that the rate-limiting step in the catabolism of 
serum proteins may be proteolytic "nicking", within the circulation, 
followed by selective pinocytosis of the partially-degraded protein.
The shortest measurable time between the addition of a radio—labelled 
protein to a yolk sac during incubation and the detection of acid—soluble 
radioactivity in the incubation medium (the lag-period) was the same 
for all four ribonucleases in serum—free medium. The calculated value 
of the mean disposal time (the mean time during which radioactivity is 
associated with yolk-sac tissue before its release as acid—soluble fragments) 
was also very similar for each of the four different ribonucleases. This 
suggests that, although the rates of uptake of the different ribonucleases 
by yolk sacs varied, once inside the tissue they are degraded with equal 
ease.
125The influence of calf serum upon I-RNases S and Spr was the same
as on ^^I-PVP, the fluid-phase marker (see Table 3.3,le). The effect
of serum on ^"*1— RNases A and B was always much greater, which suggests
that these two ribonucleases are in greater competition with serum proteins
for binding sites on the yolk-sac surface than the other two (vide supra).
Since the ribonucleases S and Spr were produced by a proteolytic cleavage
that induces a conformational change, it is possible that, during the
conversion of ribonuclease A to S, some formerly buried domains within the
polypeptide chain of ribonuclease A were uncovered and that these residues
125are responsible for the increased affinity of I-RNases S and Spr for 
the yolk-sac surface. The finding of Moore et al« (1977) that bovine 
serum albumin is cleared more rapidly, both from the bloodstream in vivo
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and from the incubation medium by yolk sacs in vitro, when the molecule 
has been exposed to urea, supports this suggestion that conformational 
changes within a simple protein can modify clearance rates.
The disposal times for 125I-RNases A and B in the presence of 10% 
calf serum are higher than those of I-RNases S and Spr (see Table 
3.3.2g), which contrasts with the situation in serum-free medium (see 
Table 3.3.2h). This evidence suggests that for some reason, there is
a lengthening of the time that the radioactivity remains associated with 
the tissue compared with ^2^I-RNases S and Spr. For example, this may 
be indicative of a longer intralysosomal half-life of these proteins when 
serum is present. It would have been interesting to have measured the 
lag-phases of these four ribonucleases in the presence of serum.
Ammonium chloride has been shown to inhibit intralysosomal proteolysis
in rat yolk sacs; at the same time it inhibits pinocytosis (Livesey at a1.,
1980). In order to ensure that the 125I-labelled ribonucleases were
being digested only after pinocytic:> uptake into rat yolk sacs, a high
concentration (20 mM) of ammonium chloride, sufficient to fully inhibit
uptake of 125I-labelled PVP, was added to the incubation medium to see
whether production of acid—soluble radioactive fragments was completely
abolished. Indeed, the uptake of all four ribonucleases was abolished
by 20 mM ammonium chloride, as was the release of acid-soluble radioactivity
into the incubation medium (see Table 3.3.2h). [The quantity of
radioactivity associated with the tissue in the presence of 20 mM ammonium chlor
ide was taken to represent the binding affinity of each ribonucléase for
125the yolk-sac surface; this was greater for I-RNases S and Spr than for 
the other two. ] The above findings were compatible with the assumption 
that all the 125I-ribonucleases are pinocytosed by the tissue, and that 
acid—soluble radioactivity is generated mainly by intralysosomal 
proteolysis.
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It was desirable to reinforce this conclusion by the use of a
different inhibitor of pinocytosis, 2,4-DNP (Duncan & Lloyd, 1978). This
agent (50 yg/ml) causes a similar inhibition of the rate of uptake of 
125I-PVP as ammonium chloride (20 triM); the rate of uptake and rate of
125release of acid-soluble radioactivity from I-RNases A and B were also
125similarly inhibited, but the inhibitions of these rates for I-RNases S
and Spr were less marked. (The quantity of radioactivity associated
with the yolk-sac tissue for I-RNases S and Spr was greater than that
when the yolk sacs were incubated in the absence of any inhibitor.)
However, when pinocytosis is noticeably inhibited, the apparent uptake
which is calculated becomes greatly influenced by the quantity of
radioactivity associated with the tissue. This latter value will be very
strongly influenced by random experimental factors such as incomplete
washing. (Compare Section 4.3.1, where one can follow experimentally an
initial rapid release of I-PVP from the surface of yolk sacs after
putting them into substrate-free medium. Such release is presumably a
result of the washing process being inefficient in removing surface-
associated radioactivity). A lower concentration of 2,4-DNP (10 yg/ml)
was therefore used to only partially inhibit pinocytosis. The effect of
the inhibitor, at this concentration, on the rate of uptake and rate of
125release of acid-soluble radioactivity derived from I-RNases A and
B again paralleled the response of the tissue to the fluid-phase marker,
12 5I-PVP (see Table 3.3.2h). The amounts of tissue-associated radioactivity
for these two proteins were similar to the T.A.R. values in the absence
of the inhibitors. The rate of uptake and the rate of release of acid-
soluble radioactivity for 125I-RNases S and Spr were again higher than for
the other two proteins. Therefore the relative effect of the inhibitor 
125upon I-RNases S and Spr was less than the relative effect on the uptake 
125of I-PVP.
This large apparent uptake and release of acid-soluble radioactivity
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125from I-RNases S and Spr by rat yolk sacs incubated in the presence of
2,4-DNP (10 yg/ml) was greater than would be expected from the pinocytic
capacity of the yolk sac under these conditions. The experiments in
Section 3.3.3 excluded the possibility of degradation in media alone, or
by enzymes released from the yolk sac. The ability of a yolk-sac
125homogenate to degrade some of the i-ribonucleases at physiological pH
is consistent with, but not direct evidence for, the existence of some
proteolytic activity on the surface of the yolk sac. Time permitting,
the composition of the acid-soluble radioactivity would have been
examined by column chromatography. It may be that some degradative
125enzyme activity, having the capacity to split I-RNases S and Spr 
125(but not I-RNases A or B) into two or more large acid-soluble fractions,
may be present on the yolk-sac surface. This, if true, would help to
account for the high rate of production of acid-soluble radioactivity 
125from I-RNases S and Spr under conditions in which pinocytosis in
the rat yolk sac is almost fully inhibited by 2,4-DNP.
CHAPTER 4
THE EFFECT OF INCUBATION MEDIUM COMPOSITION ON 
PINOCYTOSIS AND PROTEIN DEGRADATION IN THE
RAT VISCERAL YOLK SAC
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4.1 Introduction
The steady-state level of protein within a cell is a result of the 
balance between protein synthesis and degradation, the rates of which 
must be influenced by factors and processes both inside and outside the 
cell. Protein degradation is unlikely to be an entirely indiscriminate 
catabolic function since it can be very specific. For example, proteins 
such as proinsulin require the cleavage of specific peptide bonds to 
liberate the hormonally-active insulin molecule, and the selective 
removal of abnormal proteins, perhaps containing one or more incorrect 
amino acid residues, is probably essential to the efficient running of 
the cell (Knowles et al., 1975). Some of the functions of protein 
degradation are necessarily less specific, such as the digestion of 
exogenous proteins captured by endocytosis, and the digestion of 
endogenous proteins to provide amino acids as a fuel source in times of 
starvation.
It is clearly important to try to understand those factors that 
influence and control protein degradation, and to locate where proteolysis 
takes place within a cell. Any proposed theory of intracellular protein 
breakdown must be able to encompass the degradation of both exogenous and 
endogenous proteins, and specify their site(s) of degradation. The 
influence of extracellular factors, such as the general composition of 
the extracellular fluid including its hormone, vitamin, ion and protein 
content, must be accounted for. The influence of the extracellular medium 
on intracellular protein degradation, and also upon the rate of endocytosis 
of the cell, is likely to be important since the amino acid pool size 
within the cell may need expanding or contracting as metabolic conditions 
change. Much work has been done in the field of protein digestion, 
and amongst the suggestions that have been forwarded by different laboratories 
is a "dual-pathway" hypothesis of protein degradation within cells
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(Ballard, 1975; Dean, 1978b). The "dual-pathway" hypothesis of intracellular 
protein degradation proposes that both a lysosomal and a non-lysosomal 
pathway are important in protein digestion. The lysosomal route is 
thought to be used by all exogenous proteins following their endocytic 
capture, and is also involved in the degradation of some endogenous 
proteins, for example by lysosomal reduction. (In lysosomal reduction 
it is envisaged that partially-denatured proteins can adsorb onto the 
cytoplasmic surface of lysosomes. Involution of the lysosomal membrane 
enables subsequent digestion of both the vesicle and its contents within 
the lysosome (Dean, 1978b).] Similarly, autophagy, which may proceed 
either at a basal rate or at an accelerated rate, provides a way by 
which endogenous proteins may be passed into the lysosomal system. The 
non-lysosomal route is proposed for the degradation of abnormal and 
short half-life proteins (Knowles e£ al_., 1975).
Internalized exogenous proteins, taken into the cell by endocytosis, 
are degraded within the tissue, and this has generally been assumed to 
occur following fusion of the endocytic vesicles with lysosomes.
Circumstantial evidence for this is not difficult to find. For example, 
evidence of exogenous material being degraded intracellularly within lysosomes 
is provided by Myagkaya et. al. (1979) who performed an ultrastruetural 
study on the breakdown of erythrocytes within lysosomes of trophoblastic 
epithelial cells from sheep placenta. They demonstrated acid phosphatase 
activity in the space between the erythrocyte membrane and the lysosomal 
membrane, but not inside the ingested erythrocytes. The erythrocyte 
plasmamembrane remained observable until the final stage of the break­
down process, and presumably formed a barrier preventing the penetration 
of lysosomal enzymes into the ingested erythrocytes during the earlier 
stages of degradation. But, conclusive evidence for the degradation of 
soluble proteins within the lysosomal system alone is much more difficult
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to obtain. However, Livesey & Williams (1979) have provided substantial
125evidence that an exogenous protein, formaldehyde-denatured I-labelled 
bovine serum albumin, is digested exclusively intralysosomally by rat 
yolk sacs in vitro. They found that more than 80% of the radiolabelled 
digestion products appearing in the incubation medium consisted of 
125I-labelled L-tyrosine, and that larger digestion products were only 
found in association with the yolk-sac tissue; association of trichloroacetic 
acid-insoluble radioactivity with the tissue always preceded detection of 
acid-solubles in the incubation medium. This degradation is believed 
to take place intralysosomally since the tissue—associated acid-insoluble 
radioactivity showed a lysosomal distribution on subcellular fractionation 
of tissue exposed to this marker protein, cell—free homogenates of yolk 
sacs degraded albumin only at acid pH values, and the rate at which acid- 
soluble radioactivity was formed was equal to the rate of uptake of 
acid-insoluble radioactivity by the tissue.
The rate of digestion of endogenous proteins has been the subject 
of a great deal of research. Kay (1978) has reviewed the main 
experimental approaches which have been used, and has discussed their 
merits and disadvantages. Many symposia have been held in this field 
fSchimke, R.T. & Katunuma, N. (1975); Rapoport, S. & Schewe, T. (1978);
Evered, D. & Whelan, J. (1980)]. Many of the contributions in these works 
support and expand the suggestions made below, and are an excellent 
source of reference.
Evidence for lysosomes being involved in the breakdown of endogenous 
protein is also extensive. If one examines the rate of protein 
degradation of cultured cells _in vitro under varying conditions of medium 
composition, one finds that the rate of proteolysis changes. Sommercorn (
& Swick (1981) showed that primary monolayer cultures of adult rat hepatocytes 
when incubated in a balanced salts medium degraded their endogenous protein
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at a high rate, but, when incubated in a more complete medium, a lower
rate of protein digestion was observed. Similarly, Frelin (1980)
found that addition of serum strongly inhibited the rate of release of 
3t HJleucine from the prelabelled, long-lived myocardial proteins of 
newborn rat heart cells in culture. The inhibiting serum factor was 
found to be heat stable. The possibility of this factor being albumin 
or fatty acids was ruled out.
Amenta & Brocher (1980b), culturing rat embryo fibroblasts in 
vitro, observed that the rates of protein degradation of cells in serum- 
free medium were greater that those for cells cultured in medium 
containing 10% serum. Addition of NH^Cl (20mm) to the media resulted 
in inhibition of protein degradation and was accompanied by an accumulation 
of autophagic vacuoles (as observed by electron microscopy), particularly 
in the cells incubated in serum-free medium. When the cells were removed 
from media containing NH^Cl and placed into fresh media, the accumulated 
material within the autophagic vacuoles was digested. From this they 
concluded that NH^Cl inhibits rapidly and specifically the lysosomal 
proteolytic compartment and that this accounts for approximately 25% 
of protein turnover; proteolysis within this compartment can be stimulated 
to account for 50% of the protein degradation within the cell. They 
also stated that the major pathway for the degradation of fast-turnover 
proteins appeared to be separate from the lysosomal system.
The effect of "step-down" conditions (removal of serum from the 
incubation medium) on the rate of protein degradation in cultured cells 
was further investigated by Dean (1979). He concluded that the presence 
of 10% (v/v) serum in the incubation medium of cultured mouse macrophages 
established a basal rate of proteolysis in the cultures; this was assumed 
since insulin (1 pM-1 yM) and glucagon (lOyM) had negligible effects on 
rates of protein degradation under these conditions (the effects of these 
hormones on protein degradation will be discussed more fully in Chapter 5).
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Using the selective carboxyl proteinase inhibitor pepstatin, an inhibition 
of basal proteolysis of up to 40% was observed. If pepstatin can be 
assumed to enter the cells by pinocytosis, the inhibitor will probably 
remain within the lysosomal compartment following fusion between the 
incoming pinosomes and lysosomes. Cytochalasin B and the local 
anaesthetics lidocaine and procaine all had inhibitory effects on basal 
degradation, and since these agents all affect microfilaments, this 
inhibition of proteolysis may have resulted from a decrease in the rate of 
autophagy, thus implicating autophagy in basal proteolysis. Alternatively, 
lidocaine and procaine are weakly basic tertiary amines which may 
accumulate in lysosomes and thus inhibit proteolysis by altering the 
intralysosomal pH. Ward e_t al. (1979) found similar evidence in
perfused rat liver and heart for the involvement of the lysosomal system 
in basal and deprivation-induced proteolysis.
Dean (1980), in an article in which he outlines some of the 
characteristics and inhibitory factors of endogenous protein degradation, 
presents further evidence for the involvement of lysosomes in basal 
proteolysis, by using an inhibitor of thiol proteinases, Z-Phe-Ala-CHN2 
(carbobenzoxycarbonyl-L—phenylalanyl-L—alanine—D—diazomethane). The 
inhibitor, like pepstatin, enters mouse peritoneal macrophages in culture 
quite slowly, probably by pinocytosis, and under basal conditions 
reaches a maximum of 30-40% inhibition of protein degradation.
The rate of endogenous protein degradation within cultured cells can 
readily be altered by using "step-up" or "step-down" conditions. This 
effect may be mediated by changes in levels of amino acids; this is 
possibly a physiologically relevant mechanism. Many examples of the 
absence of amino acids from incubation or perfusion media inducing 
increased rates in proteolysis are to be found in the literature. For 
example, three studies involving perfused liver [Neely et al. (1977),
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amino acid deprivation leads to increased rates of autophagy within the
cells, and therefore enhanced rates of protein degradation. The
reverse conditions elicit the reverse response. Kovâcs et al, (1981)
inhibited lysosomal protein degradation (propylamine-sensitive
degradation) by 70-75% in cultured isolated hepatocytes following addition
of excess amino acids, and found that after incubation of the cells with
the amino acid mixture for lh, the formation of autophagic vacuoles was
virtually completely inhibited. The amount of protein degradation that
was attributed to lysosomes (75%) is much higher than in the examples
quoted earlier in this section (25-40%). However, these earlier '
values were from cells of different tissues, and the high value quoted
above is in agreement with those of Seglen & Gordon (1980). These
«
authors examined a large range of different amine derivatives and found 
that all the lysosomotropic amines inhibited protein degradation to 
approximately 75% in isolated rat hepatocytes. It is perhaps useful at 
this point to make a general comment on experiments using combinations of 
inhibitors to try to estimate the percentage of the total proteolysis that 
involves lysosomes. Any residual activity after lysosomal inhibition 
may or may not provide a fair estimate of the contribution of a non- 
lysosomal degradative route (as outlined by Dean, 1980), since if one 
route is inhibited, another may undergo a compensatory acceleration.
More evidence for amino acids affecting lysosomal degradation was 
provided by Seglen ejt al. (1980) who, after looking at the inhibitory 
effect of seven different amino acids, determined that, in isolated rat 
hepatocytes, amino acids act exclusively on the lysosomal pathway of 
protein degradation. Sommercorn & Swick (1981) investigated the 
inhibition of endogenous protein degradation in isolated rat hepatocytes 
by amino acids in more detail, by trying to determine which amino acids
Schworer étal. (1979) and Schworer & Mortimer (1979)] have shown that
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had most influencé upon the rate of digestion. They found that in 
monolayer cultures of adult rat hepatocytes, the inhibition required at 
least two of the amino acids methionine, phenylalanine, tryptophan and, 
to a lesser extent, proline; phenylalanine and tryptophan were the most 
effective inhibitors. They suggested that the regulation of protein 
degradation by essential amino acids may be physiologically important m  
maintaining adequate intracellular amino acid pools when the exogenous 
supply of amino acids is diminished. It would be interesting to see 
if one can detect any lysosomal pools of amino acids. Harms ejt al.
(1981) measured the amount of free (non-protein) amino acids in whole 
rat liver and in unmodified lysosomes prepared from rat liver by the 
technique of free-flow electrophoresis. They reported significant 
intralysosomal pools of threonine, serine, valine, cystine, isoleucine, 
leucine, methionine^ tyrosine, phenylalaninine, lysine and arginine in 
rat liver lysosomes maintained at 0 C.
The literature reviewed so far has been involved in bulk proteolysis 
by the lysosomal system within cells. Before considering the evidence 
fô'r a non-lysosomal route, it is important to ask the question whether 
the lysosomal route itself proffers any scope for selective degradation 
of proteins. Marzella et al. (1980) studied autophagic degradation in
rat liver after vinblastine treatment. They found that vinblastine- 
induced autophagy enhanced degradation of both old and newly synthesized 
proteins, and that this was therefore a random process. But Hernandez-Yago 
et al. (1980) have provided some evidence that autophagy may be involved 
in selective protein degradation. Ferritin was trapped in negatively 
charged unilamellar liposomes and incubated with Hela cells for two hours 
when fusion of the liposome and plasma membrane occurred. They followed 
the fate of the ferritin within the Hela cells by electron microscopy 
and presented evidence that the free ferritin in the cytoplasm became
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concentrated within lysosomes with time. The cytoplasmic ferritin 
formed clusters (not membrane bound) which were often observed in 
osmiophilic areas of the cytosol. They postulate that there could be 
a mechanism by which certain cytoplasmic areas are separated (by local 
lipid deposition isolating them from the rest of the cytoplasm) and 
act as a primary site for individual molecule selection. These electron 
opaque bodies may be incorporated into the vacuolar system by autophagy, 
and subsequently be degraded.
Another very indirect piece of evidence for selection in autophagy has 
been proposed by Dean (1978a). It has been observed that selective 
binding of cytosol and serum proteins can occur on hydrophobic supports 
and on membranes, and that the short half-life proteins tend to bind more 
avidly than proteins with longer half-lives. Since selective binding at 
the plasma membrane of the cell can lead to selective internalization 
and subsequent degradation of exogenous proteins, it is not unrealistic 
to propose that selective binding of proteins to cytoplasmic membranes 
performing autophagy may provide a mechanism of selective entry of 
proteins into the lysosomal degradative system. However, this still 
remains to be established.
The literature presented thus far indicates only indirectly the 
presence of a non-lysosomal proteolytic pathway within the cell by 
virtue of the fact that attempts to inhibit lysosomal degradation do 
not lead to complete inhibition of proteolysis. To date, there has 
been little direct evidence to characterise this alternative pathway of 
degradation. Kay (1980) has reviewed this topic in some detail, and 
has outlined several candidates as possible routes of extralysosomal 
degradation. Proteins that come into contact with the lysosomal system 
will experience a very acidic environment, and if this results in partial 
denaturation, attack by lysosomal proteinases may be readily initiated.
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Extralysosomal degradation will not have this "initial advantage", and
so it has been postulated that denaturating enzymes may exist to make
proteins more susceptible to proteolytic activity, [Some evidence for
intracellular membrane-bound enzymes with the capacity to inactivate
cytoplasmic proteins is already available (Ballard & Hopgood (1976).]
Proteins already in a partially-altered state would presumably be
degraded faster than native proteins. Thus, Knowles ej: aJL. (1975)
found that Reuber H35 hepatoma cells incorporate the arginine-analogue
canavanine into cell protein when arginine is omitted from the incubation
medium. They labelled arginine-containing proteins with [^Clleucine,
3and canavanine-containing proteins with [ H]leucine, and found that the 
canavanine-containing proteins were degraded at a rate several-fold 
greater than the normal proteins. Comparable results were found when 
6-fluorotryptophan was used as an analogue for trytophan. From these 
results they concluded that the data supported the hypothesis that 
aberrant proteins are degraded more rapidly than native proteins, Data 
has also been found to show that metabolic energy is required for some 
non-lysosomal proteolysis [Seglen e£ al. (1979), Libby & Goldberg (1981)].
The effect of "step-up" and "step-down" conditions on endogenous 
protein degradation have been discussed (see above); "step-up" conditions 
lead to decreased protein degradation, and vice versa. It would be of 
great interest to see if there is a relationship between the rate of 
pinocytosis of a tissue and its rate of endogenous protein degradation 
under different media changes. Perhaps both are subject to some central
homeostatic control mechanism. The rat yolk sac affords an excellent
system for such a study since pinocytic and proteolytic rates are well 
quantitated as, to a lesser extent, are the rates of endogenous protein
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turnover.
125The rate of uptake of the fluid-phase marker I-labelled polyvinyl- 
125pyrrolidone ( I-PVP) has been well established (Williams et al., 1975a). 
It was used by Ibbotson & Williams (1979) to investigate the effect of 
10% (v/v) calf serum on the rate of fluid-phase pinocytosis in rat yolk 
sacs incubated Jri vitro. They found that the absence of serum resulted 
in an increase in the rate of fluid-phase pinocytosis of approximately 
45%; experiments with [^^Aujgold and [U-^C]sucrose gave similar results. 
Likewise, absence of serum led to an increase in uptake of formaldehyde- 
denatured ^ “*I-labelled BSA (^^I-fdBSA) up to 75%. Degradation of this 
protein has been well characterized in the rat yolk-sac system, and has 
been shown to be an intralysosomal event (Livesey & Williams, 1979). These 
studies provide a foundation for this proposed investigation.
Several collaborative studies have taken place between this laboratory 
and that of F.J. Ballard and S.E. Knowles of the CSIRO Division of 
Human Nutrition, Adelaide, South Australia. For example, the effects of 
weak bases on toe degradation of endogenous and exogenous proteins by 
rat yolk sacs have been examined (Livesey jet al., 1980) . The data 
on exogenous protein ( I-fdBSA) uptake and degradation were compiled 
in this laboratory, and the data on endogenous protein degradation were 
provided by F.J.B. and S.E.K. The conclusion drawn from this earlier 
study was that, since I-fdBSA has been shown to be degraded intralyso- 
somally within yolk sacs (see above), the results were compatible with the 
proteolysis of endogenous proteins being at two sites (lysosomal and non- 
lysosomal).
The purpose of the work reported in this chapter was to investigate
more fully the effect of "step-up" and "step-down" conditions on the
125rate of fluid-phase pinocytosis ( I-PVP) and on the rate of adsorptive
125pinocytosis of a protein ( I-fdBSA) and its subsequent intralysosomal
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degradation in rat yolk sacs. This study was performed in collaboration 
with F.J.B. and S.E.K., who provided data on the effect of "step-up" 
and "step-down" conditions on endogenous protein degradation in rat 
yolk sacs (these data will be presented and discussed in Section 4.4), 
to permit a comparison of the effect of different media changes on the 
rates of exogenous and endogenous protein degradation, and their 
relationship to the pinocytic rate in rat yolk-sac tissue.
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4.2 Materials and Methods
All the equipment and materials used in the experiments reported
in this chapter were as described in Section 2.1. Formaldehyde-denatured
*^I-labelled BSA ('^I-fdBSA) was prepared as described in Section
2.2.2. All the uptake experiments were performed as described in
125Section 2.3, and all assays as in Section 2.4.; I-PVP was always
125used at a concentration of 2 yg/ml, and I-fdBSA at a concentration 
of 1 yg/ml.
In Section 4.3.1, the serum-free media used were as described
in the text and in the legends to figures and tables. The effects
125of the media on the release of I-PVP from yolk sacs were measured 
as described in Section 2.10.
In Section 4.3.2, medium 199 was used throughout. Calf serum
(if present) was used at the concentrations described in the text and
in the legends to figures and tables.
The method of F.J. Ballard and S.E. Knowles for measuring the
rate of endogenous protein degradation in the rat yolk sac (see Table
4.4a) was as described in detail by Livesey et al. (1980). Briefly,
yolk sacs were incubated for 3h in the appropriate medium (see Table
34.4a) containing 2yCi of [ H]leucine/ml and 10 yM-L-leucine, rinsed 
in radioisotope-free medium and incubated for a further 90 min in
"degradation" medium [medium containing 2mM-L-leucine and 20mM-Tes;
/
2-{ [2-hydroxy-1,1 -bis(hydroxymethy 1)ethy 1 ] amino} ethan^sul/phoiiic. acid, 
pH7.5] to degrade unstable proteins. The sacs were subsequently 
transferred to fresh "degradation" medium which, in some experiments, 
contained an agent (e.g. amino acids, bovine serum albumin), and were 
incubated, usually for 4h. Rates of degradation were expressed as the 
percentage of the H-labelled protein that was degraded over this period. 
The concentrations of the various agents used were as described in
Table 4.4a.
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4.3.1 Effect of Different Media on Uptake of I-PVP
125The rates of uptake of I-PVP were determined for rat yolk sacs 
incubated in three different serum-free media, namely medium 199,
Minimum Essential Medium and Earle's Salts; physiological saline was also 
used. The compositions of these three media are outlined in Table 4.3.1a. 
The inorganic salt content is essentially the same in each case, as is 
the amount of glucose and phenol red present; Earle's Salts consists 
only of these compounds. In addition to these inorganic components, 
Minimal Essential Medium (M.E.M.) contains 13 amino acids and 8 vitamins. 
Medium 199 contains the entire composition of M.E.M.plus a further 
8 amino acids and 9 vitamins, the antibiotics penicillin and streptomycin, 
and 14 "other components", including compounds such as adenosinetri- 
phosphate (disodium salt), cholesterol and glutathione.
125The effect of these three media on the rate of uptake of I-PVP
by yolk sacs is shown in Figure 4.3.1a. All the plots are linear up
to 6h. Yolk sacs in the presence of 0.9% saline do not pinocytose
any 125I-PVP. The mean Endocytic Index (E.I.) of 125I-PVP in the
presence of medium 199 (control value) was 3.50 yl/mg yolk-sac protein per
h (see Table 4.3.1b), and in Earle's Salts was 2.89 ul/mg yolk-sac protein
per h. The mean E.I. of I-PVP in Earle's Salts as a percentage of
the control (in medium 199) was 83% ± 19%, indicating that the rates of
uptake of I-PVP in these two media are very similar. The rate of uptake 
125Of I-PVP in M.E.M. was 2.64 pl/mg yolk-sac protein per h, or 75% ± 11% 
of the control value. This was slightly less than the rate of uptake in 
Earle's Salts. It therefore appears that the rates of fluid-phase 
pinocytosis of yolk sacs incubated in the three different media were very 
similar, although slightly lower in Earle's Salts and M.E.M. than in 
Medium 199.
125The release of I-PVP with time from yolk sacs that had previously 
been incubated in the presence of this radiolabelled substrate, washed
125
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in substrate-free medium and then reincubated in substrate-free medium, 
is shown in Figure 4.3.1b, and was determined by reincubation in each of 
the three different media. In each case it can be seen that there was 
an initial rapid release of radioactivity from the yolk sacs. Presumably 
this is caused by incomplete removal of surface-associated radioactivity
when the yolk sacs had been washed after their initial incubation with
125 125I-PVP, before being reincubated in the absence of I-PVP (the
period being monitored). The quantity of radioactivity released with
time was greatest in M.E.M. and least in medium 199, and the rates of
release (after the initial rapid release) are shown in Table 4.3.1c.
The rate of release of radioactivity from yolk sacs incubated in medium
199 was well under 1% per hour, and in Earle’s Salts was approximately
1% per hour. These figures agree well with the value obtained by
Williams et al. (1975,a), and indicate that the tissue is undamaged.
125Release of I-PVP from yolk-sacs incubated in M.E.M. was only slightly 
faster than the control value, again indicating no appreciable loss 
of intregrity of the tissue.
Table 4.3.1a Composition of Medium 199, Minimal Esseritial Medium 
and Earle's Salts
The concentration of inorganic salts, glucose and phenol red are 
expressed as mg/i, and antibiotics as units/l. Numbers in parentheses 
represent the total number of different substances present. The amino 
acids and vitamins present in minimal essential medium are also present 
in medium 199, although not necessarily at the same concentrations.
Composition Earle'sSalts
Minimal
Essential Medium199Medium
Inorganic Salts:
CaCl2 200 200 200
Fe(N03)3.9H20 0 0 o.;
KC1 400 400 400
MgSO^(anhyd.) 0 0 97.(
MgS04.7H20 200 200 0
NaCl 6,800 6,800 6,800
NaHC03 2,200 2,200 2,200
NaH2P04.H20 140 140 140
Other Components:
Glucose 1,000 1,000 1,000
Phenol Red 10 10 20
Others (0) (0) (14)
Amino Acids: (0) (13) (21)
Vitamins (0) (8) (17)
Antibiotics:
Penicillin-Streptomycin 0 0 20,000
Figure 4.3.1a Uptake of I-PVP by Yolk Sacs Incubated in Serum- 
Free Medium 199, Minimal Essential Medium, Earle’s 
Salts and Saline
125
•--- • Earle’s Salts
□--- □ Minimal Essential Medium
■--- ■ Saline (0.90%)
125The method used was as described in Section 4.2. I-PVP was
present at a concentration of 2 yg/ml. Each uptake plot shows mean 
values (± S.E.M.) from 2 to 4 separate experiments. These results 
are summarized in Table 4.3.1b.
Table 4.3.1b Summary of Data fòt ^I-PVP Uptake by Yólk Sacs 
Incubated in Diffëtërit Sétüm-Fféë Média
125
These data are from the experiments shown in Figure 3.3.1a. Each 
rate of uptake is expressed as an Endocytic Index (E.I.), and is 
given with its correlation coefficient (Corr.Co.).
Medium
E.I.(Corr.Co.)
(yl/mg y.s. 
protein per h)
Mean E.I 
± S.E.M. 
(yl/mg y.s.) 
protein per h)
Mean E.I. 
as % of 
Control (%)
3.57 (0.986)
199 3.91 (0.970)
(Control) 3.03 (0.972)
Minimal 3.22 (0.951)
Essential
Medium
1.61 (0.935)
3.19 (0.917)
2.55 (0.964)
3.46 (0.945)
Earle's 2.08 (0.946)
Salts " 2.62 (0.946)
3.38 (0.980)
Saline 0.07 (0.376)
(0.9%) 0.02 (0.106)
3.50 ± 0.26 100.0 ± 7.4
2.64 ± 0.38 75.4 ± 10.9
2.89 ± 0.66 82.6 ± 18.9
0.05 1.4
Figure 4.3.1b Release of 125I-PVP from Yolk Sacs Incubated in
Serum-Free Medium 199, Minimal Essential Medium 
and Earle's Salts
Time (h)
Key: O--O  Medium 199
•---• Earle's Salts
□---□ Minimal Essential Medium
The method used was as described in Section 4.2. Each release 
plot represents the quantity of radioactivity released with time 
from yolk sacs that had previously been incubated in the presence of 
125j-pypt Each experimental point is a mean value (± S.E.M.) from 
5 separate experiments.
I-PVP fromTable 4.3.1c Summary of the Data for Release of 125
Yolk Sacs Incubated in the Presence of Different
Serum-Free Media
These data are from the experiments shown in Figure 4.3.1b. Each 
rate of release of radioactivity was calculated from the gradient of 
these plots between time points 0.75 and 3.Oh.
Medium
Mean Total 
Uptake at 
Start of 
Reincubation 
Period (ng/mg 
y.s. protein)
Radioactivity 
Released (%/mg 
y.s. protein 
per h)
199
(Control) 30.76 0.43
Minimal
Essential
Medium
32.66 1.46
Earle's
Salts 31.17 0.99
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4*3.2 Effect of Serum on Uptake of I-PVP and ^^I-fdBSA
Yolk sacs were incubated in medium 199 containing different amounts
of serum, from 0% to 50% (v/v). The effect of the serum concentration
125upon the rate of fluid-phase pinocytosis was monitored using I-PVP
as substrate, and the results are shown graphically in Figure 4.3.2a.
All the plots were linear up to 5h, and increasing the serum concentration
decreased the rate of uptake. Table 4.3.2a shows the mean values of
the Endocytic Index (E.I.) of I-PVP for the different serum concentrations
used. The addition of a small amount of serum (5%, v/v) resulted in a
large fall in E.I. (to 70% of the control E.I. in the absence of serum).
The addition of a further 5%, (to give a serum concentration of 10%, v/v)
led to a relatively smaller fall to 64%. The 0% and 10% serum figures
125for the uptake of I-PVP are in agreement with those determined by 
Ibbotson & Williams (1979). In the presence of 20% serum the E.I. 
fell to 50% of the control value, and at a concentration of 50% serum the 
E.I. was down to 29%.
Since the Endocytic Index of a substrate has units pl/mg yolk-sac
protein per h, a potential factor contributing to the calculated fall in 
125E.I. of I-PVP, when incubated with increasing amounts of serum, could 
be the intracellular accumulation of large amounts of serum proteins 
before their degradation; this would increase the tissue-protein term in 
the denominator in the expression for calculation of uptake and hence cause 
the Eil..to fall. The possibility of this occurring was examined by 
plotting the mean protein content of yolk sacs against the time that the 
yolk sacs had been incubated. The protein content of yolk sacs from 
within a single mother can vary considerably (as much as ± 20%), and so 
it was desirable to utilize as many data as possible to average out 
such random variations. Many control experiments had been performed in 
the presence .or absence of 10% (v/v) serum, and all the data from
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November 1978 to November 1980 were pooled, and the results are shown 
in Figure 4.3.2b, part (1); From this graph it is clear that the 
presence of 10% serum in the medium in which yolk sacs were incubated 
made no difference to their mean protein content which did not vary with 
the duration of the incubation.
Experiments in which the serum concentration was higher than 10% 
were also examined, but, since fewer such experiments were performed compared 
with those with 0%and 10% serum, only 0% and 10% serum data produced during 
the period of the high serum concentration experiments (November 1980 
to January 1981) were compared with these high serum data for variations 
in the yolk sac protein content; these data are shown in Figure 4.3.2b, 
part (2). Although the data from the more substantial series of 
incubations in the presence of 0% and 10% serum indicate that, in these 
data collected over a period of 2 years, there is no difference in the 
mean protein content of the yolk sacs [Figure 4.3.2b (1)], for the more 
limited series of such incubations the results are less clear cut. There 
is even an apparent difference in the 0% and 10% serum results for this 
limited series of incubations that served as matched controls to the 
incubations in higher levels of serum [Figure 4.3.2b (2)]. At first 
glance it may appear that the mean yolk-sac protein content was slightly 
greater for yolk-sacs incubated in the presence of higher serum 
concentrations (>10%), but this most probably represents scatter caused 
by so few measurements. Even if this were a true effect, it would not 
be sufficient to cause any marked difference to the mean calculated 
values of the E.I.
1 rtP 1 o  c
Formaldehyde-denatured i i-bovine serum albumin (A 1-fdBSA) has 
been extensively studied in the rat yolk-sac system (Moore et al.,
1977), both in the presence and absence of 10% calf serum (Ibbotson & Williams, 
1979), and has been shown to be degraded exclusively intracellularly,
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within lysosomes (Livesey & Williams, 1979) after being captured by
adsorptive endocytosis. The effect of calf serum concentration (up to
50%, v/v) on the rate of uptake of this protein by rat yolk sacs incubated
in medium 199 was investigated. The results are shown in Figure 4.3.2c,
the uptake being linear up to 5h of culture, with increasing serum
concentrations resulting in decreasing rates of uptake. The mean E.I, of 
125I-fdBSA in serum-free medium was 355 pl/mg yolk-sac protein per h,
and in the presence of 10% calf serum the E.I. fell to 92 pl/mg yolk-sac
protein per h, which was only 26% of the control value (in serum-free
medium). Increasing the calf serum concentration to 50% led to
125virtually complete inhibition of uptake of I-fdBSA, the mean E.I. being
only 5% of the control values. However, the correlation coefficients
of these plots are greater than 0.95, indicating that the calculated
uptake, despite being so low, increases linearly with time. The contrast
in the relative effect of serum on the rate of fluid-phase pinocytosis
125(as measured by uptake of I-PVP) and on the adsorptive uptake of 
125I-fdBSA, is shown in Figure 4.3.2d. Serum has a much greater relative
125 •effect on the uptake of I-fdBSA, reflecting competition between this
substrate and serum proteins for binding sites on the yolk-sac membrane.
The effect of serum on the release of acid-soluble radioactivity
into the incubation medium from yolk sacs incubated in the presence of 
125I-fdBSA is shown in Figure 4.3.2e. This release was virtually linear
beyond the first hour of incubation for serum concentrations up to
20% (v/v), and the rate of the release, shown in Table 4.3.2b, was the
same as the rate of uptake (mean E.I.) for each serum concentration up to
20%. In the presence of 50% serum, however, there was no detectable
release of acid-soluble radioactivity until about 3h.
The quantity of radioactivity that became associated with the yolk-
125sac tissue during incubation with I-fdBSA (T.A.R.) is shown in Figure 
4.3.2f. In the absence or presence of 10% (v/v) calf serum, the T.A.R.
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values remained approximately constant beyond the first 2h of incubation, 
reflecting a steady-state relation between the rate of uptake of radio- 
labelled substrate and the rate of release of acid-soluble radioactive 
fragments following intralysosomal degradation. The absolute T.A.R. 
values in the absence of serum were greater than in the presence of 
serum, due to the higher rate of uptake in serum-free medium.
At high serum concentrations (20% and 50%) the T.A.R. values
at lh were lower than described above because of the lower rate of uptake 
125Of I-fdBSA under these conditions. During the incubation the T.A.R.
values did not remain constant as above, but instead rose progressively.
This cannot be due to changes in pinocytic rates within the tissue since
uptake of both I-PVP and I-fdBSA were linear with time at these
serum concentrations. It is unlikely that the time taken for the
release of radioactive fragments from the lysosomes to appear in the
incubation medium had increased since these radioactive fragments,
125I-tyrosine, move by diffusion. The most likely explanation for 
this finding is that there has been qq " “ inhibition of the
capacity of the lysosomal enzymes to degrade the large amounts of serum 
proteins presenting themselves to the lysosomes.
This explanation was further supported by examination of the calculated 
disposal times of 125I-fdBSA (the mean time that 125I-fdBSA is associated 
with the tissue before acid-soluble fragments are released,see Figure 
4.3.2g). In the absence or presence of 10% (v/v) serum, the disposal 
time remained constant during the period of the incubation, the disposal 
time in serum-free medium being the smaller. At higher serum concentrations 
the disposal time increased during the incubation period. The effect 
is only slight at a serum concentration of 20% (v/v), but is marked when 
the concentration is increased to 50%.
125The effect of calf serum on the uptake and degradation of I-fdBSA
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by yolk sacs during the first hour of incubation is shown in Figures 
4.3.2h and i. The first of these two figures shows that uptake began 
immediately under all the conditions studied. The release of acid- 
soluble radioactivity (see Figure 4.3.2i) was detectable at 6 minutes 
in serum-free medium, and at 15 min in the presence of 10% (v/v) serum.
At a concentration of 20% serum the release of acid-soluble radioactivity 
was not detectable until after 0.5h, and in the presence of 50% serum 
there was no acid-soluble radioactivity released during the first hour 
of incubation (as was expected from Figure 4.3.2e).
Figure 4.3.2a Effect of Càlf Sefum Concentration on the Uptake of
125I-PVP by Yolk Sacs
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125The method used was as described in Section 4.2. I-PVP was
i present at a concentration of 2 yg/ml. Each uptake plot shows mean 
values (+ S.E.M.) from 3 to 4 separate experiments. These results 
are summarized in Table 4.3.2a.
Table 4.3.2a Summary of the Effect of Calf Sérum Concentration on
............ i 0 c.................the Uptake of *4JI-PVP by Yolk Sacs
These data are from the experiments shown in Figure 4.3.2a.^ The^rate of 
uptake is expressed as the Endocytic Index (E.I.)» and is given with its 
correlation coefficient (Corr. Co.).
Serum 
Cone. (%)
E.I.(Corr. Co.) 
(pl/mg y.s. 
protein per h)
Mean E.I.
± S.E.M. 
(jjl/mg y.s. 
protein per h)
Mean E.I. 
as % of 
Control (%)
3.10 (0.944)
0
(Control) 2.89 (0.984) 
3.35 (0.991)
3.11 ± 0.13 100 ±4.2
2.31 (0.988)
5 2.06 (0.983) 
2.31 (0.977)
2.23 ± 0.08 71.7 ± 2.6
2.09 (0.973)
10 1.93 (0.985) 
1.92 (0.990)
1.98 ± 0.06 63.7 ± 1.9
1.81 (0.975)
15 1.68 (0.995) 
1.38 (0.988) 
1.89 (0.949)
1.69 ± 0.11 54.3 ± 3.5
1.81 (0.983)
20 1.59 (0.994) 
1.24 (0.956) 
1.54 (0.989)
1.55 ± 0.12 49.8 ± 3.9
0.84 (0.980)
50 0.95 (0.959) 
0.87 (0.976)
0.89 ± 0.03 28.6 ± 1.0
Figure 4.3.2b Effect of Calf Serum Concentration on the Protein Content
of Yólk Saca düriñg Incubation with 125I-PVP
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125The method used was as described in Section 4.2. I-PVP was
present at a concentration of 2 yg/ml. The protein content of the yolk 
sacs is expressed as mg equivalent of BSA (mean ± S.E.M.) from between 
6 and 24 individual determinations in the presence of serum, and between 
12 and 83 individual determinations in serum-free medium in part (1).
In part (2), the mean protein content of the yolk sacs represents 
between 4 and 10 individual determinations.
Figure 4.3.2c Effect of Calf Serum Concentration on the Uptake of 
125I-fdBSA by Yolk Sacs
Incubation Time (h)
Keys O -“O 0% Serum D——C3 20% Serum
•— • 10% Serum ■— ■ 50% Serum
125The method used was as described in Section 4.2. I—fdBSA
was present at a concentration of 1 pg/ml. Each uptake plot shows 
mean values (± S.E.M.) from 3 to 5 separate experiments. These
results are summarized in Table 4.3.2b. A detailed study of the
uptake during the first hour of incubation is shown m  Figure 4.3.2h.
125...................Uptake of •‘•^1-fdBSA by Yolk Sacs
Table 4.3.2b Summary of thé Effëct ôf Càlf Sërüm Concentration on the
These data are from the experiments shown in Figures 4.3.2c and e. Rate 
of uptake is expressed as the Endocytic Index (E.I.), and is given with 
its correlation coefficient (Corr. Co.). The rate of release of acid- 
soluble radioactivity from the tissue is denoted by "Rate of Sol. Rel.",
Serum 
Cone.(%)
E.I.(Corr.Co.) 
(Pi/mg y.s. 
protein per h)
Mean E.I.
4 S.E.M. 
(Pl/mg y.s. 
protein per h)
Relative E.I. 
as % of 
Control 
(%)
Rate of 
Sol. Rel. 
(pl/mg y.s 
protein per
0
(Control)
377.47 (0.916) 
430.58 (0.991) 
290.27 (0.982)
385.66 (0.980)
289.67 (0.908)
354.73 ± 27.94 100.0 ± 7.9 329.44
113.17 (0.940)
10
92.40 (6.988) 
69.72 (0.975) 
90.98 (0.983)
91.57 ± 8.87 25.8 ± 2.5 84.04
41.63 (0.986)
20
38.10 (0.985) 
37.68 (0.989) 
60.22 (0.989)
45.53 ± 5.27 12.8 ± 1.5 41.30
50
17.24 (0.987) 
16.87 (0.992) 
17.00 (0.957)
17.04 ± 0.11 4.8 ±<0.1 9.82
125 125Endocytic Indices of I-PVP and I-fdBSA by 
Yolk Sacs
Figure 4.3.2d Effect of Calf Serum Concentrations on the Relative
Key: O — O  125I-PVP 
- 125•  I-fdBSA
Each point represents the mean E.I. of the substrate at a particular 
serum concentration expressed as a percentage of the mean control 
E.I. in the absence of serum. These results are from the data 
summarized in Tables 4.3.2a and b.
Acid-Soluble Radioactivity into the Incubation Medium
125by Yolk Sacs during Uptake of I-fdBSA.
Figure 4.3.2e Effect of Calf Serum Concentration on the Release of
Incubation Time (h)
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The acid-soluble radioactivity released into the incubation medium 
is expressed as mean values. These results are from the experiments 
shown in Figure 4.3.2c, and are summarized in Table 4.3.2b. A 
detailed study of the acid-soluble radioactivity released into the 
incubation medium during the first hour of incubation is shown in 
Figure 4.3.2i.
Radioactivity that becomes Associàtëd with Yolk-Sac
. 125Tissue during Uptake of I-fdBSA
Figure 4.3.2f Effect of Calf Serum Concentration on thé Quantity of
Key: O— O  0% Serum 20% Serum
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The quantity of radioactivity that becomes associated with 
yolk-sac tissue (tissue-associated radioactivity, T.A.R.) is 
expressed as mean values (± S.E.M.). These results are from 
the experiments shown in Figure 4.3.2c.
Figure 4.3.2g Effect of Calf Serum Concentration on the Disposal
Time of 125I-fdBSA after Uptake by Yolk Sacs
Key: 0 — 0  0% Serum □-- □ 20% Serum
•— • 10% Serum ■— ■ 50% Serum
Disposal time is calculated as (T.A.R. x period of incubation (h)/ 
uptake), and it represents the mean time 123I-fdBSA is associated 
with the tissue before acid-soluble fragments are released. These 
results are from the experiments shown in Figure 4.3.2c.
Figure 4.3.2h Effect of Calf Serum Concentration on the Uptake of
125I-fdBSA by Yolk Sacs during the First Hour of 
Incubation
Key: O — O  0% Serum □-- □ 20% Serum
10% Serum 50% Serum
125The method used was as described in Section 4.2. I-fdBSA
was present at a concentration of 1 yg/ml. Each uptake plot shows 
mean values (± S.E.M.) from 3 to 4 separate experiments. The uptake 
during 5h of incubation is shown in Figure 4.3.2c.
Figure 4.3.2i Effect of Calf Serum Concentration on the Release of
Acid-Soluble Radioactivity into the Incubation Medium
125by Yolk Sacs during the First Hour of Uptake of I-fdBSA.
Key: 0 — 0  0% Serum D— □ 20% Serum
•---• 10% Serum ■---■ 50% Serum
The acid-soluble radioactivity released into the incubation medium 
is expressed as mean values (± S.E.M.)» These results are from the 
experiments shown in Figure 4.3#2h. The acid-soluble radioactivity 
released into the incubation medium during 5h of incubation is shown 
in Figure 4.3.2e.
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4.4 Discussion
The effect of altering the composition of the incubation medium 
on pinocytosis in the yolk sac was investigated both by changing the 
non-macromolecular components of the medium and by altering the amount of 
serum present. First, the effect of changing the composition of the 
non-macromolecular components of the medium in which yolk sacs were 
incubated on the rate of fluid-phase pinocytosis was examined. The 
uptake data for I-PVP were more scattered when yolk sacs were 
incubated in either Minimal Essential Medium or Earle’s Salts rather than 
in Medium 199, indicating that incubations in the more complex medium 
may yield more reproducible results. However, substituting either 
Earle’s Salts or Minimal Essential Medium for Medium 199 had very little 
effect on the rate of fluid-phase pinocytosis in yolk sacs, despite the 
yolk sacs experiencing "step-down" conditions. Perhaps the yolk sac 
contains sufficient reserves of most major nutritional compounds to 
allow it to maintain its usual pinocytic rate over a 6 hour incubation 
period. However, yolk sacs incubated in physiological saline showed 
no evidence of pinocytosis. Evidently tissues require the presence 
of certain components in the medium for pinocytosis to occur. Extra­
cellular calcium ions, for example, have been shown to be required for 
pinocytosis in both the rat yolk sac (Duncan & Lloyd, 1978) and the 
rat peritoneal macrophage (Pratten & Lloyd, 1979). By adding 
various compounds to a basal fluid such as physiological saline 
in which yolk sacs are incubating, it may be possible to identify some 
of the components that are essential for ongoing pinocytic activity.
Secondly, the effect of "step-up" conditions on the rate of fluid- 
phase pinocytosis in the yolk sac was investigated by increasing the 
concentration of serum in the incubation medium. It was found that 
increasing the proportion of serum in the incubation medium led to a
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125fall in the rate of uptake of I-PVP by the yolk sac. These data 
extend the observation of Ibbotson & Williams (1979) that addition of 
serum (10%, v/v) to Medium 199 induces a fall in the Endocytic Index 
of the tissue. However, addition of serum to medium 199 will dilute 
the concentrations of some of the components of the medium, and at 
a dilution of 50% [i.e. in the presence of 50% (v/v) serum] this may 
be important. One could postulate that the fall in the pinocytic 
rate may be due to a decrease in the concentration of some of these 
components, rather than an increase in the amount, of serum. It seems 
unlikely that the dilution of some of the more complex components of 
the medium will affect the rate of pinocytosis of the tissue, since 
incubation of the yolk sacs in Earle's Salts or Minimal Essential 
Medium had no detectable effect on the rate of fluid-phase pinocytosis. 
But it is possible that a dilution of some of the low-molecular 
weight compounds may have occurred (despite the presence of many 
organic and inorganic constituents provided by the serum), and these 
may influence the rate of uptake of I-PVP. [This could easily 
be investigated by using a more concentrated stock solution of Medium 
199 so that dilution with serum will always result in a concentration 
of each of its components that is at least equal to that in single­
strength Medium 199.]
Finally, the effect of "step-up" conditions on the rate of
adsorptive pinocytosis in the yolk sac was examined by measuring the
125effect of serum on the rate of uptake of I-fdBSA. It was found
that increasing the serum concentration led to a decrease in the E.I, 
125of I-fdBSA. However, the fall in the rate of uptake of the 
125I-labelled protein was proportionately much greater than the fall
125in the rate of uptake of I-PVP, so that the effect could not be 
explained entirely in terms of a decrease in the rate of fluid uptake,
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and suggests that there is competition between I-fdBSA and the serum 
proteins for binding sites on the surface of the plasma membrane.
When the serum concentration was very high, not only did the rate 
of pinocytic uptake fall, but the quantity of radioactivity associated with 
the tissue (the T.A.R. value) increased with time, as did the disposal 
time. The last two of these changes are indicative of large amounts of 
protein reducing the capacity of the tissue to degrade the radiolabelled 
protein, and several alternative suggestions can be proposed to explain 
these findings. First, the presence of large amounts of protein may 
inhibit the fusion of pinosomes with lysosomes. Second, the total 
amount of protein (labelled and unlabelled) accumulated within the 
lysosomes may be too great for the lysosomal enzymes to cope with, so 
that the degradative step, rather than pinocytosis, becomes rate-limiting 
in the overall process of uptake and digestion. Third, the lysosomal 
enzymes may degrade the unlabelled serum proteins in preference to the 
radiolabelled protein. Finally, the degradation of large amounts of 
protein may increase the intracellular levels of amino acids, thereby 
reducing the need for the pinocytic capture of extracellular proteins.
One, could therefore envisage that elevated pools of intracellular amino 
acids constitute a negative feedback signal to inhibit pinocytosis.
It is therefore interesting to extend the findings by investigating 
the effects of varying the incubation medium composition on the rate of 
degradation of endogenous proteins in the yolk sac. If a fall in the 
rate of pinocytosis results in a loss of nutritional components (e.g. 
amino acids) entering the cell, the cell may respond by increasing the 
rate of degradation of endogenous proteins as a short-term solution to a 
loss of an essential nutrient. Alternatively, since pinocytosis and 
autophagy (possibly an important route of degradation of endogenous proteins 
in some cells) are both membrane-related phenomena, then a stimulus
125
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that causes a fall in the pinocytic rate may also cause a fall in the 
rate of degradation of endogenous proteins. (Some homeostatic 
mechanism containing elements of both of these extremes may also be 
envisaged.)
The data on the effect of different media composition on the rate 
of degradation of endogenous protein in the rat yolk sac were compiled 
by F.J. Ballard and S.E. Knowles in a collaborative study, and their 
data are shown in Table 4.4a. A comparison of the control data for 
each set of results shows that the mean rate of protein degradation is 
greater with yolk sacs incubated in Earle's Salts than in Minimal 
Essential Medium. This finding is in agreement with findings with 
other cell types (see Section 4.1) which show that degradation of 
endogenous proteins increases under "step-down" conditions. The 
addition of increasing amounts of fetal calf serum led to a decrease 
in the rate of degradation of endogenous protein. Adding formaldehyde- 
denatured BSA also led to a decrease in the rate of degradation of 
endogenous protein, although the extent of the inhibition was approximately 
the same on addition of 0.5 and 3.0 mg/ml, presumably because the 
effect was maximal at 0.5 mg/ml; addition of native BSA had no 
inhibitory effect upon the rate of degradation of endogenous protein. 
Addition of amino acids decreased the rate of degradation of endogenous 
protein and the effect of amino acids at twice the normal concentration 
was the same as that at five-times the normal concentration. Neely et al. 
(1977) found that addition of amino acids to perfusedrat livers caused 
a reduction in total proteolysis, and at both four-and ten-times the 
physiological concentration, the extent of inhibition was the same; this 
inhibition was to fifty per cent of the control value. The effects 
of these components on the rate of degradation of endogenous protein in 
rat yolk sacs generally follow the predicted results for "step-up"
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conditions. These effects are very small, but are none-the-less 
consistent. It is also important to bear.in mind that if the proportion 
of the degradation of endogenous protein which is sensitive to changes 
in the extracellular medium is lysosomal and is of the order of 20-30% 
of the total (as discussed in Section 4.1), then this represents a 
substantial inhibition of this lysosomal component.
In summary, the maximal rate of fluid-phase pinocytosis was 
observed in serum-free medium 199: the effect of "step-up" conditions 
(i.e. increased serum concentrations) on the rat yolk sac was to reduce 
the rate of both fluid-phase and adsorptive pinocytosis. The reduction 
in the rate of pinocytosis was accompanied by a fall in the rate of 
degradation of exogenous proteins following their accumulation by the 
tissue, implying an inhibition of the intralysosomal digestive capacity 
of the yolk sac. If the fall in the rate of degradation of endogenous 
proteins within the tissue arises from a reduction in the rate of 
intralysosomal digestion (effectively resulting from a fall in the rate 
of autophagy), then the stimulus that induced a fall in the rate of 
pinocytosis (possibly the intracellular levels of amino acids) may 
also have induced a fall in the rate of-autophagy by virtue of them 
both being membrane-related processes. Such a stimulus, however, 
appears to elicit a differential level of response in these two membrane 
processes.
Table 4.4a Effect of Fetal Calf Serum, Amino Acids and BSA on
Intracellular Protein Degradation by Yolk Sacs Incubated 
in Different Serum-Free Media (F.J. Ballard &
S.E. Knowles: Unpublished Data)
The method used was as described in Section 4.2. Yolk sacs were 
incubated in Minimal Essential Medium (M.E.M.) or Earle's Salts (E.S.), 
and the percentage degradation of intracellular proteins is expressed 
as the mean over a 4h period of 3 to 4 separate determinations. BSA 
was added either in its native form, or after being denatured with 
formaldehyde (fdBSA).
Medium Addition Mean Protein Degradation (%)
Mean Protein 
Degradation as 
% of Control (%)
None (Control) 15.67 100.0
M.E.M. Fetal Calf Serum (1%) 15.41 98.3
Fetal Calf Serum (10%) 14.66 93.6
None (Control) 13.55 100.0
M.E.M. fdBSA (0.5 mg/ml) fdBSA (3.0 mg/ml)
12.76
12.70
94.1
93.7
Native BSA (3.0 mg/ml) 13.30 98.2
None (Control) 14.74 100.0
F Q fdBSA (0.5 mg/ml) 13.56 92.0fdBSA (3.0 mg/ml) 13.96 94.7
Native BSA (3.0 mg/ml) 14.96 101.5
None (Control) 15.78 100.0
M.E.M. Amino Acids (x2) 14.67 93.0
Amino Acids (x5) 14.65 92.8
None (Control) 16.27 100.0
E.S. Amino Acids (x2) 14.52 89.2
Amino Acids (x5) 14.40 88.5
CHAPTER 5
THE EFFECTS OF INSULIN AND ANTIBIOTICS ON 
PINOCYTOSIS AND PROTEIN DEGRADATION IN THE
RAT VISCERAL YOLK SAC
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5.1 Introduction
Both in vivo and in vitro, cells are greatly influenced by the
composition of their extracellular environment. For example, in the
yolk-sac system the presence or absence of a variety of nutrients has been
found to be of great importance in influencing both the rate of pinocytosis
125of exogenous substrates and the subsequent rate of digestion of I-labelled
3exogenous proteins; the.rate of degradation of [ H]leucine-labelled 
endogenous protein is likewise affected (see Chapter 4). Hormones have 
been found to influence the rate of degradation of endogenous protein, for 
example a lot of work has been done on the effect of glucagon on the rate 
of digestion of endogenous protein by in vitro cell systems. Using electron 
microscopy Shelburne et al. (1973) demonstrated that intraperitoneal 
injection of either cyclic AMP or dibutyryl cyclic AMP induced a wave of 
autophagy in rat liver which closely resembled that produced by glucagon 
(5’-AMP failed to produce a wave of autophagy), and they presented this as 
preliminary evidence that glucagon-stimulated autophagy is mediated, at 
least in part, by cyclic AMP. Hopgood e_t al_. (1980) augmented these 
findings by measuring the effect of glucagon and dibutyryl cyclic AMP 
on the rate of proteolysis in rat hepatocyte monolayer cultures; 
proteolysis was stimulated by both of these agents, and, since their 
effects were not additive, it was proposed that glucagon may act via 
cyclic AMP to stimulate cellular autophagy and thus increase proteolysis. • 
The effect of glucagon on autophagy in perfused rat livers has been 
further investigated by Schworer et al. (1979) who found that glucagon 
was capable of affecting the distribution of lysosomal markers by 
enhancing lysosomal density. Schworer & Mortimore (1979) investigated 
the effect of glucagon on autophagy and proteolysis in perfused rat 
livers, and found that the ability of glucagon to increase autophagy and 
protein degradation was only elicited at certain amino acid concentrations; 
their results indicated that this effect was mediated by an hormonally-
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induced depletion of the amino acids glycine, alanine, glutamate and 
glutamine. They have therefore expanded the hypothesis proposed above 
to suggest that glucagon acts on gluconeogenesis, amino acid transport 
and metabolic interconversions, leading to an intracellular amino acid 
depletion which induces autophagy, and results in an increase in 
endogenous protein digestion.
Another hormone that has been extensively studied for its effect 
on the rate of endogenous proteolysis in vitro is insulin. Ballard 
and co-workers (Ballard e£ al., 1980 $ Gunn eit al., 1980) have found 
a consistent and marked inhibition of endogenous protein breakdown by 
insulin in a variety of normal and transformed cell lines in culture. 
Libby & Goldberg (1981) found the same pattern in cultured chick-embryo 
muscle cells, Pfeifer (1977) presented electron microscopic evidence for 
inhibition of autophagic vacuole formation by insulin in rat liver in 
vivo (following an intraperitoneal injection of the hormone) and both 
Amenta & Brocher (1980a) and Marzella _et al. (1980), working on rat 
embryo fibroblasts and rat liver respectively, found that insulin 
blocked induced proteolysis, but had little or no effect on basal and 
non-inducible proteolysis. Amenta & Brocher also found no "catch up" 
proteolysis when cultures in "step-down" medium containing insulin were 
transferred to fresh insulin-free medium, and there was no accumulation 
of autophagic vacuoles in insulin-treated cells. This is further 
evidence that insulin inhibits endogenous proteolysis by inhibiting the 
formation of autophagic vacuoles. Hopgood et al. (1980) demonstrated 
that insulin decreased the rate of proteolysis in cultured hepatocyte 
monolayers in vitro. They found that insulin decreased glucagon- 
stimulated proteolysis, but net the glucagon-elevated intracellular cyclic 
AMP concentration. Since glucagon-induced inhibition of autophagy is 
believed to be mediated via cyclic AMP, it was concluded that the
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inhibition of proteolysis by insulin was independent of cyclic AMP.
(They also found that the continuous presence of either insulin or 
glucagon was necessary for full expression of the effects.) However, 
such studies do not always show a strong insulin effect since Woodside 
& Massaro (1979) found no effect of insulin on the rate of degradation of 
either short or long half-life proteins in rabbit pulmonary macrophages.
Other growth factors have also been shown to influence endogenous 
protein degradation in vitro. Gunn £t al. (1980) demonstrated a 
suppression of endogenous proteolysis in normal and transformed 
monolayer cell cultures with epidermal growth factor (EGF) and fibroblast 
growth factor (FGF). This study was expanded to include insulin-like 
growth factor-I (IGF-I) and insulin-like growth factor-II (IGF-II)
Ballard et al., 1980L
Another group of substances, some of which have been shown to have 
an effect upon endogenous protein degradation are the antibiotics.
Schwarze & Seglen (1981) showed that streptomycin, penicillin and 
Garamycin (a mixture of gentamycins and antioxidants) all inhibited 
protein synthesis in primary rat hepatocyte cultures at concentrations 
above 0.1 mM. However, the extent of inhibition of proteolysis 
differed for each antibiotic. Penicillin was found to be effective at 
inhibiting protein degradation at concentrations above 0.1 mM, whereas 
streptomycin and Garamycin showed only slight inhibition at concentrations 
greater than 1 mM. It was not possible to comment on the mechanism 
of proteolytic inhibition since no attempt was made to distinguish 
lysosomal from non-lysosomal degradation.
Another antibiotic that has been studied to a greater extent is 
cycloheximide. This well-known inhibitor of protein synthesis has 
been examined for its effect upon endogenous protein degradation, and 
there are now many reports of this antibiotic inhibiting proteolysis.
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For example, Hopgood et^  al. (1980) have shown that cycloheximide can 
inhibit protein breakdown in hepatocyte monolayers. The decreased 
proteolytic capacity found in the presence of the antibiotic was still 
responsive to glucagon but not to insulin; this gave support to the 
suggestion that cycloheximide inhibits autophagocytosis. Amenta et al.
(1978) demonstrated that, in cultured rat embryo fibroblasts, cyclo­
heximide depressed protein synthesis by up to eighty per cent and 
proteolysis by up to seventy per cent. The inhibition of basal 
proteolysis was not immediate but gradually increased over twenty-four 
hours, whereas the inhibition of induced protein degradation (thought to 
be effected by increased activity of the autophagic-lysosomal system) 
was almost immediate. They also measured, the level of activity of 
three different lysosomal enzymes during the course of these experiments, 
and found them to vary independently of each other. From their data 
they postulated that the cell proteinases are inactivated by a mechanism 
that is not sensitive to cycloheximide, and that under such conditions 
the new steady-state levels of the enzymes remain exactly proportional 
to the level of protein synthesis within the cells; they state that 
the proposed mechanism relates protein synthesis to protein breakdown.
The addition of hormones or antibiotics to the extracellular 
medium in vitro poses several questions. For example, how do they 
gain entry into the cell, and what effect do they have on cellular 
processes (other than protein synthesis and degradation) such as 
endocytosis? Some of the antibiotics are fairly large molecules and 
are probably too large to enter the cell by diffusion so may well be 
taken up partly or even completely by endocytosis (fluid-phase or 
adsorptive). Insulin is known to enter cells via receptor-mediated 
pinocytosis although its fate, once inside the cell, is under dispute. 
Carpentier et al. (1979) produced evidence that I-labelled insulin
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was localized on the plasma membrane of isolated rat hepatocytes, but
was subsequently internalized and became preferentially associated with
lysosomes. This finding was supported by Marshall & Olefsky (1979,
1980) who examined the effects of two lysosomotropic agents (chloroquine
125and NH.Cl) on the interaction between I-labelled insulin and rat 4
125adipocytes. They presented data which indicated that the I-labelled 
insulin was taken into the tissue by an energy-dependent mechanism, 
possibly pinocytosis, and,when lysosomal function was inhibited, the 
radiolabelled substrate accumulated intracellularly. (In the absence of 
inhibitors, degradation products were normally detected within five 
minutes of endocytosis occurring). They suggest their data indicate 
that insulin is degraded by a lysosomal pathway. However, other workers
in this field have obtained evidence to suggest that internalized
125 ,I-labelled insulin does not become associated with lysosomes in the
cell. Three such studies have involved intravenous injection of
125 .I-labelled insulin into rats, followed by rapid excision of the liver
125and examination of the sub-cellular distribution of the I-labelled
hormone (Desbuquois e£<il., 1979a,b; Papachristodoulou et^  al., 1979).
Each group found that the radiolabelled substrate became associated with the
microsomal fraction and that little or no radioactivity became associated
with the mitochondrial-lysosomal fraction; however radioactivity
125was released into the cytosol as I-labelled monoiodotyrosine.
. 125Bergeron et al. (1979) also studied capture of I-labelled insulin by 
rat liver following its injection, and followed its fate by electron 
microscope autoradiography. After 3 min the insulin was found bound 
to the hepatocyte plasmamembrane, and then later associated with the 
Golgi. At ten minutes both secretory elements of the Golgi and 
lysosome-like vacuoles were labelled, although the latter did not stain 
for acid phosphatase and were presumably not lysosomal. These three 
studies, in contrast to the ones presented above, do not suggest a
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prominent role for lysosomes in the degradation of I-labelled 
insulin.
The effects of hormones and antibiotics on the endocytic activity
of tissues has been studied to a limited extent. Brown & Segal (1977)
and Livesey (1978) examined the effect of glucagon (10 to 10 ^M)
on the rate of pinocytosis in the rat yolk sac. Uptake of both 
125I-PVP (Livesey, 1978) and yeast invertase (Brown & Segal, 1977) were
inhibited strongly by glucagon; rates of uptake were 30% of those of
_6controls in the presence of 10 M glucagon; the uptake of formaldehyde- 
denatured I-labelled BSA was similarly decreased. Haigler et al.
(1979) studied the effect of epidermal growth factor (EGF) on the rate 
of fluid-phase pinocytosis (as measured by uptake of horseradish 
peroxidase) in human carcinoma cells. They reported that addition of 
low concentrations of EGF produced a ten-fold increase in the rate of 
pinocytosis within thirty seconds, but that this effect was transient, 
the pinocytic rate returning to its control value within fifteen minutes.
The effect of tunicamycin (an antibiotic that specifically inhibits 
the formation of N-acetylglucosaminylpyrophosphorylpolyisoprenol, a 
precursor of oligosaccharide side chains N—glycosidically-linked to a 
protein core) on the transport of lysosomal enzymes in cultured skin 
fibroblasts has been investigated (von Figura et al,,1979). It was 
found that tunicamycin did not affect receptor-mediated endocytosis in 
a general manner, but instead inhibited uptake of 8-N-acetylglucosaminidase 
that had been formed in the presence of tunicamycin. From this they 
deduced that tunicamycin interfered with receptor-mediated pinocytosis 
by influencing the expression of phosphomannose receptors on the cell 
surface of fibroblasts and the synthesis of phosphomannosyl residues 
on lysosomal enzymes.
Another antibiotic that has been studied for its effect upon
125
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pinocytosis is bacitracin (Maxfield et al., 1979; Davies et al., 1980; 
Dickson et al., 1981). They found that bacitracin (0.7 mM) inhibited 
clustering of rhodamine-labelled epidermal growth factor or c^-macro- 
globulin in Chinese hamster ovary (CHO) cells and BALB/c3T3 cells.
At a concentration of 2 mg/ml, bacitracin was found to be an inhibitor 
of o^-macroglobulin clustering in rat kidney fibroblasts, CHO and 
3T3 cells. They looked for a correlation between inhibition of 
transglutaminase activity and inhibition of clustering and subsequent 
internalization of c62“macroglobulin; their observations indicated that 
a transglutaminase is required for receptor-mediated endocytosis of 
certain ligands. This model was expanded to accommodate the observation 
that bacitracin directly blocks binding to high-affinity sites in 
plasmamembranes of cultured fibroblasts, and it is suggested that a 
transglutaminase-like activity is required for conversion of low affinity 
receptors to high affinity receptors in the membrane (the data did 
not support a model in which bacitracin affects only receptor recycling).
It is conceivable that endocytically-active cells normally gain ' 
appreciable quantities of amino acids either by ingesting free amino acids 
by fluid-phase pinocytosis or by degradation within lysosomes of proteins 
captured by adsorptive pinocytosis. Inhibition of endocytosis could 
therefore produce a similar effect to a "step-down" change in the 
incubation medium. Both manipulations may result in a fall in the 
intracellular levels of amino acids in some common pool. A fall in the 
levels of certain amino acids could well act as a signal to trigger either 
an increase in autophagy or a general increase in the degradation of 
endogenous proteins to restore the amino acid levels to normal. There 
may thus be reason to anticipate an inverse relation between inhibition
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of pinocytosis and the degradation of endogenous proteins if this 
"nutritional hypothesis" is valid. Conversely, as lysosome reduction 
and autophagy are membrane-related events, then agents that interfere with 
the mechanism of pinocytosis may also have a similar effect on these 
processes. Thus agents that interfere with endocytosis would also 
be expected to reduce the rate of turnover of endogenous proteins. 
Observation of a parallel decrease in the degradation of endogenous 
protein and the ingestion of exogenous protein would be compatible 
with this "membrane-mediated hypothesis".
Both hormones and antibiotics are important constituents of the
cellular environment in vivo and iri vitro respectively, and thus serve1
as obvious agents to investigate for their effects on endocytosis and 
intracellular proteolysis and to test the above hypotheses. The rat 
yolk-sac system is an excellent system for quantitating pinocytosis and 
has also been used to determine the rates of degradation of endogenous 
proteins (Chapter 4). Therefore a collaborative investigation was 
instigated with F.J. Ballard and S.E. Knowles (see Chapter 4) to see if 
there was any effect of these agents on rates of fluid—phase pinocytosis 
and intracellular protein degradation in rat yolk sacs.
Insulin was chosen for investigation of its effects upon pinocytosis 
and proteolysis of exogenous proteins since glucagon, the agonist of 
insulin, had already been investigated in this system (see above).
F.J.B. and S.E.K. measured the effects of both of these hormones on 
the rate of endogenous proteolysis in rat yolk sacs. It is also of 
great importance to examine the effects of antibiotics because they 
are common constituents of virtually all of the commonly-used cell 
culture media, and it is desirable to know whether, at the concentrations 
at which they are normally used, they greatly affect cellular processes 
so that in vitro cell culture results may be interpreted with confidence.
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Cycloheximide was one of the compounds chosen for study since it has
already been shown to be an inhibitor of endogenous protein degradation
in a variety of cell types (see above). Another antibiotic (which is
well-known because of its mechanism of inhibition of protein synthesis),
puromycin, was studied to see if its effects are similar to those of
cycloheximide. Again, studies of the rates of fluid-phase pinocytosis
in the rat yolk sac were complemented by measurements of the rates of
endogenous protein degradation within yolk sacs, made by F.J.B. and
S.E.K. (Data obtained by F.J.B. and S.E.K. will be presented in Section
5.4.) The final antibiotic chosen for study was bacitracin. This
cyclic dodecapeptide antibiotic was selected since it is reported to
have an effect on receptor-mediated pinocytosis by inhibiting receptor
clustering for certain ligands (see above), and it is also known to
inhibit various proteolytic enzymes (Makinen, 1972). Using the rat
yolk-sac system the effects of bacitracin both on the rate of fluid-
125phase pinocytosis (as determined by the rate of uptake of I-PVP) and on
125the rate of adsorptive pinocytosis of formaldehyde-denatured I- 
labelled BSA were established, to see if bacitracin interfered either with 
uptake or with the intralysosomal degradation of this protein.
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5.2 Materials and Methods
All the equipment and materials used in the experiments in this 
chapter were as described in Section 2.1. Formaldehyde-denatured
1 or l o t
I-labelled BSA ( I-fdBSA) was prepared as described in Section 
2.2.2. All the uptake experiments were performed as described in 
Section 2.3, and all assays as in Section 2.4. Medium 199 was used
throughout, and all experiments were performed in the absence of serum.
125 125I-PVP was always used at a concentration of 2 yg/ml and I-fdBSA
at a concentration of 1 yg/ml. The various agents were added 20 min
125prior to the addition of I-labelled substrate, and the concentrations 
employed were as described in the text.and in the legends to figures 
and tables.
In Sections 5.3.2 and 5.3.3, the measurement of the recovery of 
125I-PVP uptake by yolk sacs after exposure to various agents was
as described in Section 2.12. In Section 5.3.3, the effect of
125bacitracin on the release of I-PVP from yolk sacs was measured as 
described in Section 2.10.
The method of F.J. Ballard and S.E. Knowles for measuring the 
rate of endogenous protein degradation m  the rat yolk sac (see 
Tables 5.4a and b) was as described in detail by Livesey et al.
(1980) and as outlined in Section 4.2. The concentrations of the 
various agents used, and the period of preincubation (if appropriate) 
were as described in Tables 5.4a and b.
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125 1255.3.1 Effect of Insulin on the Uptake of I-PVP arid I-fdBSA by 
Yolk Sacs
The effect of the hormone insulin on the rate of fluid-phase 
pinocytosis in the rat yolk sac was investigated by measuring the rate of 
uptake of 125I-labelled PVP (125I-PVP). The uptake of 125I-PVP with 
time in the presence of a range of concentrations of insulin (from 
10 to 10 M) in serum-free medium 199 is shown in Figure 5.3.1a.
The uptake plots were linear with time under all the conditions tested, 
and in the presence of the higher insulin concentrations, there appeared 
to be a slight inhibitory effect upon fluid-phase pinocytosis. (Error 
bars are not shown on this graph; their presence would introduce 
unnecessary confusion since most of them would overlap.) The values 
of the rates of uptake (Endocytic Indices) of I-PVP in the presence 
of different concentrations of insulin are shown in Table 5.3.1a. The 
mean E.I. in the absence of any insulin was 3.15 ± 0.19 yl/mg yolk-sac 
protein per h, which compared well with values found previously (see 
Chapters 3 and 4). Addition of insulin to the incubation medium up to 
a concentration of 10-11M caused virtually no change in the rate of 
uptake of 12^I-PVP; at a concentration of 10 1^M the mean E.I. was 
89 ± 8% of the control value in the absence of insulin. Further 
increasing the insulin concentration up to 10 led to a fall in the 
mean E.I. to 72 ± 5% of the control value.
The effect of insulin on the rate of adsorptive pinocytosis in
rat yolk sacs was determined by following its effect on the rate of
125 125uptake of formaldehyde-denatured I-labelled BSA ( I-fdBSA).
This protein was chosen since its fate in the rat yolk-sac incubation 
system has been well documented, and it is known to be degraded 
intralysosomally; this has been discussed in Chapter 4. Results from 
Chapter 4 led to the conclusion that not only was the rate of uptake of
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I-fdBSA affected by the presence of calf serum in the medium, but
the rate of degradation within the lysosomal system was also affected.
Therefore, in order to remove this complication from these experiments,
all the incubations performed in this chapter (including Sections 5.3.2-
and 5.3.3) were in serum-free medium 199. The effect of different
“XX -8  X25insulin concentrations (from 10 to 10 M) on the uptake of I-fdBSA
125in serum-free medium is shown in Figure 5.3.1b. As with I-PVP, all
the plots were linear, and the lower concentrations of insulin appear
125to have very little effect upon the rate of uptake of I-fdBSA; in
the presence of 10 insulin there is some indication of a slight
inhibitory effect. The rates of uptake (the gradients of these plots)
are summarized in Table 5.3.1b. In the absence of insulin (the control)
the mean E.I. was 77 ± 2 yl/mg yolk-sac protein per h. The addition of
10 insulin to the medium resulted in no detectable change in this
value. At the higher concentrations of insulin, the mean E.I. was
“8109 ± 8% of the control value in the presence of 10 M insulin, and
—688 ± 3% in the presence of 10" M; this very slight inhibition at
“6 X2510 M insulin was less than was found with I-PVP. This finding
(that insulin at a concentration of 10 appeared to have a slightly
125greater relative inhibitory effect upon the rate of uptake of I-PVP
125compared to that of I-fdBSA) is illustrated in Figure 5.3.1c.
125The observation that the uptake of I-PVP is more affected by 125
125increasing insulin concentrations than is the uptake of I-fdBSA is 
not easy to explain. Competition between insulin and I-fdBSA for 
binding sites is thought to occur (Livesey & Williams, 1982) but 
would result in the pattern being the opposite of that observed. A 
possible explanation of this effect is that insulin decreases the radius 
of the ttascent pinosomes (without affecting the number formed in unit
3time). Since volume is proportional to r whereas area is proportional
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2 125to r , it follows that uptake of I-PVP (which is ingested in the
125fluid phase) will be more affected than uptake of I-fdBSA (which is 
ingested almost entirely in the adsorptive phase). A 10% decrease in 
the pinosome radius would be expected to decrease fluid phase uptake to 
73% of the control rate, whereas adsorptive uptake would fall to 81% 
of the control rate.
125The rate of uptake of I-fdBSA in the absence of serum (77 ± 2 yl/mg
yolk-sac protein per h) was much less than was reported in Section
4.3.2, Table 4.3.2b (355 yl/mg yolk-sac protein per h). This was
125simply due to the fact that two different batches of I-fdBSA were
used for these two different sets of experiments. After labelling the
protein with [ iliodide, the radiolabelled protein is denatured by
exposure to formaldehyde solution (see Section 2.2) for a period of
72h, but the degree of denaturation is never constant. This is the
125reason for different batches of I-fdBSA being taken up at different
rates by the rat yolk sac (but always at a constant rate within one
batch). This finding is consistent with the observations reported by
Ibbotson & Williams (1979).
125Following uptake of I-fdBSA by the yolk sacs, the release of 
acid-soluble digestion products into the medium was measured and was 
found to be linear with time (results not shown in detail); the rate 
of their release is shown in Table 5.3.1b, and was found to be approximately 
the same as the mean E.I. for each insulin concentration studied. The 
quantity of radioactivity that became associated with the tissue 
(T.A.R. value) was approximately the same for each insulin concentration 
investigated, and showed no tendency to rise progressively during the 
incubation period (Figure 5.3.Id). The mean T.A.R. values (approximate^ 
25 yl/mg yolk-sac protein) are reported in Table 5.3.1b. The mean time 
that the protein was associated with the tissue before its release as
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acid-soluble fragments (the disposal time), after different periods of 
incubation, are shown in Figure 5.3.1e. As with the T.A.R. values, 
the mean disposal times (slightly over 0.3h) were unaffected by the 
presence of insulin. Mean disposal times for the protein in the presence 
of each insulin concentration differed little (Table 5.3.1b).
Figure 5.3.1a Effect of Insulin on the Uptake of 125I-PVP by Yolk
Sacs Incubated in Serum-Free Medium
Incubation Time (h)
Key: O— O No Addition 
Insulin (10_13M) 
Insulin (10 
Insulin (10
—8Insulin (10 M) 
Insulin (10 Si)
125The method used was as described in Section 5.2. I-PVP was
present at a concentration of 2 yg/ml; insulin was added 20 min prior 
to this substrate. Each uptake plot shows mean values from 3 to 11 
separate experiments; individual S.E.M. values (not shown) are less 
than 1.5. These results are summarized in Table 5.3.1a.
Table 5.3.1a Summary of the Effect of Different Concentrations of Insulin
125on the Uptake of I-PVP by Yolk Sacs Incubated m  Serum- 
Free Medium
These data summarize the results shown in Figure 5.3.1a. Each Endocytic 
Index (E.I.) is expressed as yl/mg yolk-sac protein per h, and is given 
with its Correlation Coefficient (Corr. Co.) in parentheses .
Insulin
Cone.
(M)
No Addition 
(Control)
10-13
10-12
10-11
10-8
10 -6
E.I.(Corr.Co.) Mean E.I.± S.E.M. Mean E.I. as
(HI/mg y.s. (yl/mg y.s. % of Control
protein per h) protein per h) (%)
3.34 (0.978)
2.45 (0.973)
2.99 (0.990)
2.78 (0.975)
3.63 (0.983)
3.82 (0.996) 3.15 ± 0.19 100.0 ± 6.0
2.38 (0.957)
2.18 (0.975)
3.44 (0.983)
3.99 (0.992)
3.63 (0.981)
1.86 (0.949)
2.92 (0.958) 2.87 ± 0.57 91.1 ± 18.1
3.83 (0.990)
3.28 (0.981)
3.70
2.19
(0.991)
(0.965) 3.24 ± 0.37 102.8 ± 11.8
3.80 (0.955)
2.46 (0.882)
2.56 (0.984)
1.96 (0.952)
2.91 (0.983) 2.81 ± 0.24 89.2 ± 7.9
2.48 (0.957)
3.71 (0.990)
3.60 (0.995)
2.44 (0.969)
3.45
1.34
(0.992)
(0.859) 2.28 ± 0.45 72.4 ± 14.3
1.87 (0.878)
2.19 (0.992)
2.36 (0.943)
1.79 (0.970) 2.27 ± 0.15 72.1 ± 4.8
2.72 (0.961)
2.31 (0.967)
Figure 5.3.1b Effect of Different Concentrations of Insulin on the
125Uptake of I-fdBSA by Yolk Sacs Incubated m  Serum- 
Free Medium
s3
3.
0)
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Key: O— O
□---□
Incubation Time
No Addition
Insulin (10 ^M)
Insulin (10 ^M)
”6Insulin (10 M)
(h)
125The method used was as described in Section 5.2. I-fdBSA was
present at a concentration of 1 pg/ml; insulin was added 20 min prior 
to this substrate. Each uptake plot shows mean values from 4 to 7 
separate experiments; individual S.E.M. values (not shown) are all less 
than 30. These results are summarized in Table 5.3.1b.
Table 5.3.1b Summary of the Effect of Different Concentrations of
125Insulin on the Uptake of I-fdBSA by Yolk Sacs 
Incubated in Serum-Free Medium
These data summarize the results shown in Figures 5.3.1b, d and e. Each 
Endocytic Index (E.I.) is expressed as yl/mg yolk-sac protein per h, and 
is given with its Correlation Coefficient (Corr. Co.) in parentheses. The 
relative effect of each insulin concentration on the E.I., expressed as 
a percentage of the control value (no addition of insulin), is given in 
parentheses beneath each mean E.I. value (± S.E.M.). The rate of 
release of acid-soluble radioactivity (Sol. Rel.) from the tissue is 
expressed in yl/mg yolk-sac protein per h), and the mean tissue-associated 
radioactivity value (T.A.R.) is expressed as yl/mg yolk-sac protein.
The relative effect of each insulin concentration on the T.A.R. value, 
expressed as a percentage of the control value, is given in parentheses 
beneath each mean T.A.R. value. The mean disposal time was calculated 
from (mean T.A.R./mean E.I.) and has the units of h.
Insulin
Cone.
(M)
E.I.(Corr.Co.) 
(yl/mg y.s. 
protein/h)
Mean E.I.
± S.E.M. 
(yl/mg y.s. 
protein/h)
Rate of 
Sol. Rel. 
(yl/mg y.s. 
protein/h)
Mean
T.A.R.
(yl/mg y.s. 
protein)
Mean
Disposi
Time
(h)
No
Addition
(Control)
72.21 (0.942) 
76.36 (0.986) 
85.07 (0.984) 
80.52 (0.978) 
73.02 (0.990)
77.44 ± 2.41 
(100.0 ±3.1)
72.47 23.23
(100.0)
0.30
K f 11
89.15 (0.991) 
70.50 (0.982) 
90.91 (0.990)
61.15 (0.981)
77.93 ± 7.25 
(100.6 ±9.4)
75.55 25.68
(110.1)
0.33
10~8
84.23 (0.949) 
86.76 (0.981) 
97.98 (0.981) 
69.66 (0.989)
84.66 ±5 -82 
(109.3± 7.3)
86.37 26.05
(111.7)
0.31
lef6
66.20 (0.973) 
57.92 (0.974) 
73.15 (0.997) 
74.35 (0.980) 
76.80 (0.981) 
62.29 (0.990) 
62.86 (0.981)
68.37 ± 2.56 
(88.3 ±3.3)
70.43 24.76
(106.2)
0.36
Figure 5.3.1c Effect of Different Concentrations of Insulin on the Relative
125 125Endocytic Indices of I-PVP and I-fdBSA by Yolk Sacs 
Incubated in Serum-Free Medium
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Each point represents the mean E.I. of the substrate at a 
particular insulin concentration expressed as a percentage of the 
mean control E.I. in the absence of insulin. These results are from 
the data summarized in Tables 5.3.1a and b.
Figure 5.3.Id Effect of Insulin on the Quantity of Radioactivity that
becomes Associated with Yolk-Sac Tissue during Uptake 
125of I-fdBSA in Serum-Free Medium
Incubation Time (h) 
Key: O— O  No Addition
•----• Insulin (10 ^ M)
□---- □ Insulin (10 M)
■ .. ■"* Insulin (10 ^ M)
The quantity of radioactivity that becomes associated with 
yolk-sac tissue (tissue-associated radioactivity, T.A.R.) is expressed 
as mean values; individual S.E.M. values (not shown) are less than 3. 
These results are from the experiments shown in Figure 5.3.1b.
Figure 5.3.1e Effect of Different Concentrations of Insulin on the
125Disposal Time of I-fdBSA after Uptake by Yolk Sacs 
in Serum-Free Medium
I
to
COO
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CO
Q
Incubation Time (h)
Key: O— o No Addition
Insulin (10
Insulin (10 ^M)
■— Hi Insulin (10 ^M)
Disposal time is calculated as (T.A.R. divided by the rate of 
uptake up to a given incubation time), and represents the mean time 
125j_fdBSA is associated with the tissue before acid-soluble fragments 
are released. These results are from the experiments shown in 
Figure 5.3.1b.
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5.3.2 Effects of CyClOhéximidé and Puromycin on thé Uptake of 
125I-PVP and 125I-fdBSA by Yolk Sacs
The effects of the two antibiotic protein synthesis inhibitors,
cycloheximide and puromycin, on the rates of fluid-phase and adsorptive
pinocytosis in the rat yolk sac were investigated using the radiolabelled 
125 125substrates I-PVP and I-fdBSA. The effects of these two agents
-4  125(both at the concentration of 10 M) on the uptake of I-PVP with time 
are shown in Figure 5.3.2a. Puromycin had no effect upon the rate of 
uptake of this fluid-phase marker, whereas cycloheximide had an
125inhibitory effect. Table 5.3.2a shows the Endocytic Index of I-PVP 
under the different conditions. In the absence of any agent, the mean 
control E.I. was 2.95 ± 0.12 yl/mg yolk-sac protein per h, and in the
-4presence of puromycin (10 M) the mean E.I. was 3.04 yl/mg yolk-sac 
protein per h (or 103 ± 7% of the control value). The presence of 
10 cycloheximide reduced the mean E.I. to 59 ± 8% of the control 
value.
The effects of cycloheximide and puromycin on the time course of uptake 
125of I-fdBSA is shown in Figure 5.3.2b. The effects of these two
agents on uptake of this substrate were the same as their effects on 
125I-PVP; at the concentration tested, puroraycin had no effect on the 
rate of uptake of the protein, but cycloheximide had an inhibitory effect. 
The values of the Endocytic Indices for individual determinations are 
reported in Table 5.3.2b. The mean E.I. in the absence of any agent 
was 7 4 + 1  yl/mg yolk-sac protein per h, and in the presence of 10 
puromycin was 97 + 5% of this control value. Addition of cycloheximide 
to the incubation medium resulted in a reduction of the mean E.I. to 
51 ± 2% of the control value.
The production of acid-soluble fragments following intralysosomal
125digestion of the internalized I-fdBSA was found to be linear with
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time (results not shown in detail), and the rate of this release (as
shown in Table 5.3.2b) was similar to the mean E.I. for each set of
conditions. The quantity of radioactivity associated with the yolk-
sac tissue at different time points during the incubation are illustrated
in Figure 5.3.2c. Table 5.3.2b shows that the mean T.A.R. value in
the absence of any agent and in the presence of puromycin were
virtually the same, being 24 and 22 yl/mg yolk-sac protein respectively.
-4In the presence of 10 M cycloheximide, the mean T.A.R. value fell to 
51% of the control value; this fall corresponds exactly to the fall in 
mean Endocytic Index. The mean time during which the substrate is 
associated with the tissue before its release into the medium as acid- 
soluble fragments (the disposal time) was unaffected by either agent 
during the whole of the incubation period (see Figure 5.3.2d and Table 
5.3.2b).
The ability of the yolk-sac tissue to recover its pinocytic capacity
in serum-free medium following previous exposure to cyclohexinu.de
(10-Si) was investigated, and the results are shown in Table 5.3.2c.
During an initial exposure to cycloheximide, over a period of 2.5h, the
125rate of uptake of I-PVP was reduced to 75% of the control value in the
absence of inhibitor (this reduction was 15% less than was reported in
Table 5.3.2a; this difference may be attributable to the smaller number
of determinations in these recovery experiments). Washing the yolk sacs
in incubation medium at 37°C had virtually no effect upon the rate of
uptake of i-PVP for a further 2.5h in the control experiments (3.69
and 3.45 yl/mg yolk-sac protein per h before and after washing,
125respectively), and the rate of uptake of I-PVP by yolk sacs that had 
been washed following exposure to cycloheximide was 106% of the control 
value. Therefore the inhibitory effect of 10 cycloheximide upon 
the rate of fluid-phase pinocytosis in the rat yolk sac is fully reversible
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after exposure for a period of 2.5h.
Figure 5.3.2a Effect of Cycloheximide and Puromycin on Uptake of
125I-PVP by Yolk Sacs Incubated in Serum-Free Medium
0 _____ I_____I----- 1_____ I_____ I_____ l
0 1 2 3 4 5 6
Incubation Time (h)
Key: O— O  No Addition
-4•--•  Puromycin (10 M)
a-- □ Cycloheximide (10 ^ M)
12 SThe method used was as described in Section 5.2. I-PVP
was present at a concentration of 2 pg/ml; either cycloheximide or 
puromycin were added 20 min prior to this substrate. Each uptake 
plot shows mean values (± S.E.M.) from 6 to 13 separate experiments. 
These results are summarized in Table 5.3.2a.
125the Uptake of I-PVP by Yolk Sacs Incubated in Serum-Free 
Medium
Table 5.3.2a Summary of the Effect of Cycloheximide and Puromycin on
These data summarize the results shown in Figure 5.3.2a. Each Endocytic 
Index (E.I.) is expressed as yl/mg yolk-sac protein per h, and is given 
with its Correlation Coefficient (Corr. Co.) in parentheses.
Agent
E.I. (Corr. Co.) 
(yl/mg y.s. 
protein per h)
Mean E.I. 
(yl/mg 
protein
± S.E.M. 
y.s.
per h)
Mean E.I. as 
% of Control 
(%)
No Addition 
(Control)
3.05 (0.964) 
2.65 (0.987) 
2.68 (0.977) 
3.09 (0.977)
2.39 (0.962) 
3.04 (0.988) 
3.37 (0.989)
2.40 (0.993)
3.06 (0.993) 
3.84 (0.994) 
3.34 (0.978) 
2.45 (0.973) 
2.99 (0.990)
2.95 ± 0.12 100.0 ± 4.1
Puromycin
(io‘4M)
2.86 (0.968) 
2.35 (0.977) 
3.22 (0.981) 
2.89 (0.972)
3.87 (0.961) 
3.04 (0.959)
3.04 ± 0.20 103.1 ± 6.8
Cycloheximide
(io’4M)
2.43 (0.945) 
1.40 (0.964) 
1.23 (0.987) 
1.35 (0.947) 
1.46 (0.970) 
2.48 (0.986)
1.73 ± 0.23 58.6 ± 7.8
Figure 5.3.2b Effects of Cycloheximide and Puromycin on Uptake of
125I-fdBSA by Yolk Sacs Incubated in Serum-Free 
Medium
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Incubation Time (h)
Key: O— O  No Addition
# — #  Puromycin (10 ^M)
□-- o Cycloheximide (10~^M)
1 9SThe method used was as described in Section 5.2. I-fdBSA
was present at a concentration of 1 yg/ml; either cycloheximide or 
puromycin was added 20 min prior to this substrate. Each uptake 
plot shows mean values (± S.E.M.) from 3 to 9 separate experiments. 
These results are summarized in Table 5.3.2b.
Table 5.3.2b Summary of the Effects of Cycloheximide and Puromycin
125on the Uptake of I-fdBSA by Yolk Sacs Incubated in 
Serum-Free Medium
These data summarize the results shown in Figures 5.3.2b, c and d. The 
abbreviations used are as in Table 5.3.1b. The relative effect of 
aither cycloheximide on puromycin on the E.I. or T.A.R. value, expressed 
as a percentage of the control value (no addition of agent), is given in 
Parentheses beneath each mean E.I. and mean T.A.R. value, respectively.
E.I.(Corr.Co) Mean E.I.
Agent (yl/mg y.s. (± S.E.M.)
protein/h) (yl/mg y.s.
protein/h)
71.21 (0.965)
68.89 (0.985)
68.64 (0.980)
No 78.52 (0.989)
Addition 76.51 (0.991) 73.53 ± 1.25
(Control) 77.53 (0.951) (100 ±1.7)
71.91 (0.882)
72.21 (0.942)
76.36 (0.986)
72.79 (0.993)
57.27 (0.971)
Puromycin 79.21 (0.977) 70.97 ± 3.87
(io"4M) 80.90 (0.985) (96.5 ± 5.3)61.85 (0.951)
73.82 (0.956)
Cyclo­ 34.78 (0.949) 37 18 + 1.31heximide
(io-Am)
39.28
37.48
(0.935)
(0.981) (50.6 ± 1.8)
Rate of 
Sol. Rel. 
(yl/mg y.s. 
protein/h)
Mean
T.A.R.
(yl/mg y.s. 
protein)
Mean
Disposal
Time
(h)
72.06 24.26
(100.0)
0.33
69.25 21.98
(90.6)
0.31
36.50 12.44
(51.3)
0.33
of Radioactivity that becomes Associated with Yolk-Sac
125Tissue during Uptake of I-fdBSA in Serum-Free Medium
Figure 5.3.2c Effect of Cycloheximide and Puromycin on the Quantity
Incubation Time (h)
Key: O — O  No Addition 
•— •  Puromycin (10 4M)
□ — □ Cycloheximide (io"4M)
The quantity of radioactivity that becomes associated with 
yolk-sac tissue (tissue-associated radioactivity, T.A.R.) is expressed 
as mean values (± S.E.M.). These results are from the experiments 
shown in Figure 5.3.2b.
Figure 5.3.2d Effect of Cycloheximide and Puromycin on the Disposal
125Time of I-fdBSA after Uptake by Yolk Sacs in
Serum-Free Medium
Incubation Time (h)
Key: Q — O No Addition
. -4Puromycin (10 M)
□ — □ Cycloheximide (io"4M)
Disposal time is calculated as (T.A.R. divided by the rate of 
uptake up to a given incubation time), and it represents the mean 
time 125i_fdBgA is associated with the tissue before acid-soluble 
fragments are released. These results are from the experiments 
shown in Figure 5.3.2b.
Table 5.3.2c Uptake of I-PVP by Yolk Sacs Incubated in Serum-Free125
Medium Following Previous Exposure to Cycloheximide
The method used was as described in Section 5.2. Briefly, the rate of 
uptake of 125i-pvp (2 Vg/ml) was monitored over 2.5h in the absence or 
presence of cycloheximide (10“% )  in serum-free medium; cycloheximide 
was added 20 min prior to this substrate. The yolk sacs were washed, 
and then reincubated in serum-free medium for a further 2.5h in the 
presence of ^^5j_pyp aione. Mean uptake rates were calculated from 
the slopes of mean uptake vs. time plots.
Mean Uptake Rates:
Before Washing r After Washing
Agent in 
Initial 
Incubation
No
Addition 5 3.69 (100.0) 3.45 (100.0)
(Control)
Cyclo­
heximide 3 2.76 (74.8) 3.66 (106.1)
(10-%)
No. of 
Determina­
tions
r- — - / As % \ yl/mg y.s. / —  ..
protein per h yof Control^ protein per h \of Control/
yl/mg y.s. As %
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5.3.3 Effect of Bacitracin on the Uptake of 125I-PVP and 125I-fdBSA 
by Yolk Sacs
The influence of the dodecapeptide antibiotic bacitracin on the rate
of fluid-phase pinocytosis, as measured by the rate of uptake of 
125I-PVP, is shown in Figure 5.3.3a. Addition of bacitracin at a
—6concentration of 0.01 mg/ml (7 x 10 M) to the serum-free medium 199
caused a slight inhibition of uptake, and progressively increasing the
~3concentration of this agent to 10.0 mg/ml (7 x 10 M) led to a progressive
125fall in the uptake of I-PVP with time; uptake was always virtually
125linear with time. The rates of uptake of I-PVP in the presence of
different amounts of bacitracin are reported in Table 5.3.3a. The mean
control E.I. (± S.E.M.) in the absence of bacitracin was 3.23 ± 0.17 pl/mg
yolk-sac protein per h. The presence of bacitracin at a concentration
of 0.01 mg/ml (7 x 10 ^M) resulted in a fall in the mean E.I. to
81 ± 2% of the control value. An inhibition of uptake to 50% of
the control value was achieved at a concentration of 1.0 mg/ml (7 x lo”Si),
and at the highest concentration used (10.0 mg/ml, 7 x 10 M) the mean
E.I. had fallen to 15 ± 2% of the control value.
The effect of different concentrations of bacitracin on the rate of
adsorptive pinocytosis in the rat yolk sac was followed by measuring
125the rate of uptake of I-fdBSA. A range of bacitracin concentrations
_5 _o
from 0.1 mg/ml to 10.0 mg/ml (7 x 10 M to 7 x 10 JM) was investigated,
and these results are shown in Figure 5.3.3b. This agent inhibited 
125 •uptake of I-fdBSA in a dose—dependent manner, the lowest bacitracin
concentration used having only a small effect upon uptake, whereas the
highest concentration, caused uptake to virtually cease. The Endocytic
Indices from all the individual experiments are shown in Table 5.3.3b.
125The mean control E.I. of I-fdBSA, in the absence of bacitracin, was 
337 ± 41 yl/mg yolk-sac protein per h. The E.I. fell to 50% of the
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control value in the presence of 1.0 mg/ml bacitracin; this degree
of inhibition for this concentration of agent is the same as was found
125for the uptake of I-PVP. However, the effect of the highest
125bacitracin concentration on the uptake of I-fdBSA was much greater
125than was found with I-PVP; this finding is illustrated more fully
125in Figure 5.3.3c. [The mean control E.I. of I-fdBSA in serum-free
medium was much higher than was found in Section 5.3.1, Table 5.3.1b and
in Section 5.3.2, Table 5.3.2b. This is because a new batch of 
12 SI-fdBSA was prepared for these experiments with bacitracin; this 
variable is more fully discussed in Section 5.3.1.]
The release of acid-soluble radioactivity into the incubation medium 
following uptake and digestion of the protein by the tissue is shown 
in Figure 5.3.3d to be linear with time. The rate of this release 
(as reported in Table 5.3.3b) was similar to the rate of uptake of the 
protein for concentrations of bacitracin up to 5.0 mg/ml; at a bacitracin 
concentration of 10.0 mg/ml there was no detectable release of acid- 
soluble radioactivity up to 5h.
The effect of bacitracin on the quantity of radioactivity that 
became associated with the yolk-sac tissue during the incubation (T.A.R.) 
is shown in Figure 5.3.3e. In the absence of bacitracin the T.A.R. 
remained constant during the entire incubation period, as expected for 
a steady-state situation between incoming protein from pinocytosis and 
outgoing digestion products following contact of the protein with 
the lysosomal system. In the presence of 0.1 mg/ml bacitracin the 
mean T.A.R. appeared to rise slightly during the incubation period, and 
in the presence of 1.0 mg/ml bacitracin this increase in T.A.R. with 
time was quite marked. Under these three conditions the mean T.A.R. 
values at lh were very similar (so one may compare them directly), and 
then they diverged with increase in incubation time, presumably because
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bacitracin is exerting some kind of progressive effect. In the presence
125of higher concentrations of bacitracin the uptake of I-fdBSA was 
very much lower, and therefore the initial T.A.R. values were much 
lower; this means that these data cannot be compared directly with 
those above. Nevertheless, even when the rate of uptake of the protein 
was very low (at 5 mg/ml bacitracin), one can still detect a steady 
rise in T.A.R. values with time; the inhibition of uptake in the presence 
of a concentration of 10.0 mg/ml bacitracin was so great that it was 
impossible to determine whether there was any progressive tissue 
accumulation.
125The mean time during which the radiolabelled substrate, I-fdBSA, 
is associated with the tissue before its release as acid-soluble 
fragments (the disposal time) is shown in Figure 5.3.3f. In the absence 
of bacitracin the disposal time is constant during the entire incubation 
period, and has a value of approximately 0.3h; this compares well with 
the values found in Table 5.3.1b and in Table 5.3.2b. The disposal 
time in the presence of the lowest bacitracin concentration used (0.1 mg/ml) 
was very similar to that of the control. As the concentration of 
bacitracin was further increased the magnitude of the disposal time at 
any point during the incubation increased. Moreover, the effect of a 
given concentration of bacitracin appeared to increase progressively with 
time, as reflected in the effect on disposal time. Such an effect 
is indicative of a progressive accumulation of active inhibitor within 
the lysosomal system rather than it reaching a steady-state value within 
5h. Although Figure 5.3.3f clearly shows that the increase in disposal 
time with increase in incubation time to be virtually linear in the 
presence of 1.0 and 5.0 mg/ml bacitracin, in the presence of 10.0 mg/ml 
bacitracin the data were more scattered. This may reflect the toxic 
nature of these very high concentrations of bacitracin (see below).
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The ability of yolk-sac tissue to recover its pinocytic capacity
following exposure to different concentrations of bacitracin was
125investigated using the fluid-phase marker I-PVP, and the results are
shown in Figure 5.3.3g and Table 5.3.3c. During the initial uptake
phase (2.5h) in the presence of different amounts of bacitracin,
increasing the concentration of agent increased the inhibition of
uptake; the mean uptake rates over this shorter period of uptake are
similar to the mean Endocytic Indices reported in Table 5.3.3a for
uptake over a 5h period. After exposure of the yolk sacs to bacitracin
they were washed in warmed (37°C) medium and then reincubated in
125bacitracin-free medium, and the mean rates of uptake of I-PVP over
the 2.5h recovery period, are also reported in Table 5.3.3c. [In these
experiments the mean uptake rate for a given bacitracin concentration was
calculated from the mean uptake plot, and not calculated as a mean of
the rates from individual uptake plots. This was because the data
tended to be quite scattered following the washing procedure, and it
was therefore decided that a rate calculated from the mean uptake plot
would be more accurate. Data obtained during the initial 2.5h incubation
phase was treated in the same manner to allow for direct comparisons
with the recovery phase.] Recovery of the pinocytic capacity of the
tissue was virtually complete following exposure to bacitracin
concentrations of up to 1.0 mg/ml. At the higher concentration of
5.0 mg/ml the recovery was slight, but at the highest concentration
investigated (10.0 mg/ml) there was no recovery of the pinocytic capacity
125of the tissue as measured by uptake of I-PVP.
Since high concentrations of bacitracin appear to irreversibly
125affect the ability of the yolk sac to pinocytose I-PVP, experiments
were performed to look for evidence of damage to the tissue under these
125conditions. Pinocytosis of I-PVP by the yolk sac results in its
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accumulation within the lysosomal compartment of the cells. The 
rate of loss of this substrate from the tissue in control incubations 
is usually observed to be minimal, being less than 1% of the accumulated 
substrate/mg yolk-sac protein per h (Williams et al., 1975a).
125Yolk sacs were therefore incubated for 2.5h in the presence of I-PVP
and high concentrations of bacitracin, washed, and then reincubated in
substrate-free medium which still contained the same high concentrations
of bacitracin. The results obtained are shown in Figure 5.3.3h. Increasing
the concentration of bacitracin increased the percentage release of 
125I-PVP from the tissue, and the rates of release of the substrate are
125reported in Table 5.3.3d. (The rate of release of I-PVP was calculated
from the linear part of the plots between the time points 0.8h and 2.5h,
since during the first part of this reincubation period the large release
of radioactivity probably arises from incomplete washing; this has been
fully discussed in Section 4.3.1.1 The mean total uptake of ^^I-PVP
during the 2.5h "loading phase" is reduced in the presence of bacitracin
because of its inhibitory action upon pinocytosis. Nevertheless,
125in spite of the small accumulation of I-PVP, during this initial
125phase, the absolute amount of I-PVP released during the reincubation 
phase, in ng released/mg yolk-sac protein per h, is greater in the 
presence of the highest concentration of bacitracin. To permit a 
more direct comparison between these values, the results are also 
expressed as a percentage of the tissue-associated radioactivity released.
In the presence of 5.0 mg/ml bacitracin this rises from 0.88% (the 
control value) to 2.36% released/mg yolk-sac protein per h, and to 
3.91%/mg yolk-sac protein per h in the presence of 10 mg/ml bacitracin.
(This is equivalent to a 2.7- and 4.4-fold increase in release of accumulated 
substrate over the control value respectively.) These data suggest 
some damage to the tissue in the presence of high concentrations of
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bacitracin.
[ A preliminary report of these findings has been made (Forster &
Williams, 1981).]
Figure 5.3.3a Effect of Different Concentrations of Bacitracin on the
125Uptake of I-PVP by Yolk Sacs Incubated in Serum-Free 
Medium
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Incubation Time (h)
Key: O— O  No Addition
•— • Bacitracin (0.01 mg/ml)
¿*---- a Bacitracin (0.1 mg/ml)
h---- a  Bacitracin (1.0 mg/ml)
□---- a Bacitracin (5.0 mg/ml)
Bacitracin (10.0 mg/ml)
125The method used was as described in Section 5.2. I-PVP was
present at a concentration of 2 pg/ml; bacitracin was added 20 min prior 
to this substrate. Each uptake plot shows mean values (±S.E.M.) from
3 to 4 separate experiments. These results are summarized in Table 5.3.3a.
125Bacitracin on the Uptake of I-PVP by Yolk Sacs
Table 5.3.3a Summary of the Effect of Different Concentrations of
Incubated in Serum-Free Medium
These data summarize the results shown in Figures 5.3.3a and c. Each 
Endocytic Index (E.I.) is expressed as yl/mg yolk-sac protein per h, and 
is given with its Correlation Coefficient (Corr. Co.) in parentheses.
Bacitracin E.I.(Corr. Co.) Mean E.I. ± S.E
Cone. (yl/mg y.s. (yl/mg y.s.
(mg/ml) protein per h) protein per h)
No Addition 
(Control)
3.56
2.98
3.15
(0.991)
(0.967)
(0.964)
3.23 ± 0.17
2.68 (0.992)
0.01 2.552.44
(0.984)
(0.979) 2.60 ± 0.06
2.71 (0.965)
2.28 (0.996)
0.1 2.41 (0.984) 2.34 ± 0.04
2.34 (0.975)
1.74 (0.995)
1.0 1.22 (0.888) 1.62 ± 0.20
1.89 (0.976)
1.16 (0.972)
5.0 1.30 (0.978) 1.16 ± 0.08
1.01 (0.943)
0.55 (0.901
10.0 0.58 (0.955) 0.49 ± 0.07
0.35 (0.956)
Mean E.I. as 
% of Control 
(%)
100.0 ± 5.3
80.5 ± 1.9
72.4 ± 1.2
50.2 ± 6.2
35.9 ± 2.5
15.2 ± 2.2
Table 5.3.3a Summary of the Effect of Different Concentrations of
125Bacitracin on the Uptake of I-PVP by Yolk Sacs 
Incubated in Serum-Free Medium
These data summarize the results shown in Figures 5.3.3a and c. Each
Endocytic Index (E.I.) is expressed as yl/mg yolk-sac protein per h, and
is given with its Correlation Coefficient (Corr. Co.) in parentheses.
Bacitracin E.I.(Corr. Co.) Mean E.I. ± S.E.M. Mean E.I. as
Cone. (yl/mg y.s. (yl/mg y.s. % of Control
(mg/ml) protein per h) protein per h) (%)
No Addition 
(Control)
3.56
2.98
3.15
(0.991)
(0.967)
(0.964)
3.23 ± 0.17 100.0 ± 5.3
2.68 (0.992)
0.01 2.552.44
(0.984)
(0.979) 2.60 ± 0.06 80.5 ± 1.9
2.71 (0.965)
2.28 (0.996)
0.1 2.41 (0.984) 2.34 ± 0.04 72.4 ± 1.2
2.34 (0.975)
1.74 (0.995)
1.0 1.22 (0.888) 1.62 ± 0.20 50.2 ± 6.2
1.89 (0.976)
1.16 (0.972)
5.0 1.30 (0.978) 1.16 ± 0.08 35.9 ± 2.5
1.01 (0.943)
0.55 (0.901
10.0 0.58 (0.955) 0.49 ± 0.07 15.2 ± 2.2
0.35 (0.956)
Figure 5.3.3b Effect of Different Concentrations of Bacitracin on
125the Uptake of I-fdBSA by Yolk Sacs Incubated in 
Serum-Free Medium
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Bacitracin (5.0 mg/ml)
Bacitracin (10.0 mg/ml)
125The method used was as described in Section 5.2. I-fdBSA was
present at a concentration of 1 pg/ml; bacitracin was added 20 min prior 
to this substrate. Each uptake plot shows mean values (± S.E.M.) 
from 3 to 5 separate experiments. These results are summarized in 
Table 5.3.3b.
125Bacitracin on the Uptake of I-fdBSA by Yolk Sacs 
Incubated in Serum-Free Medium
Table 5.3.3b Summary of the Effect of Different Concentrations of
These data summarize the results shown in Figures 5.3.3b, c and d. 
The abbreviations used are as in Table 5.3.1b.
Bacitracin
Cone.
(mg/ml)
E.I.(Corr.Co.) 
(yl/mg y.s. 
protein/h)
Mean E.I.
± S.E.M. 
(yl/mg y.s. 
protein/h)
Mean E.I. as 
% of Control 
(%)
Rate of Sol. 
Rel. (yl/mg 
y.s. protein 
per h)
No
Addition
(Control)
450.47 (0.962) 
410.96 (0.961) 
245.08 (0.978) 
319.20 (0.925) 
259.39 (0.977)
337.0 ±40.7 100.0 ± 12.1 335.6
0.1
282.87 (0.967) 
273.03 (0.955) 
327.90 (0.997)
294.6 ±16.9 87.4 ± 5.0 278.6
1.0
173.95 (0.980)
171.65 (0.969)
165.65 (0.983) 
150.46 (0.969)
165.4 ± 5.3 49.1 ± 1.6 123.5
5.0
22.46 (0.964) 
21.97 (0.918) 
29.66 (0.969)
24.7 ± 2.5 7.3 ± 0.7 14.7
10.0
2.80 (0.867) 
2.49 (0.891) 
5.14 (0.962)
3.5 ± 0.8 1.0 ± 0.2 0.2
Figure 5.3.3c Effect of Different Concentrations of Bacitracin on
125 125the Relative Endocytic Indices of I-PVP and I-fdBSA 
by Yolk Sacs Incubated in Serum-Free Medium
•  125I-fdBSA
Each point represents the mean E.I. (± S.E.M.) of the substrate 
at a particular bacitracin concentration expressed as a percentage 
of the mean control E.I. in the absence of bacitracin. These results 
are from the data summarized in Tables 5.3.3a and b.
Figure 5.3.3d Effect of Different Concentrations of Bacitracin on
the Release of Acid-Soluble Radioactivity into the 
Incubation Medium by Yolk Sacs during Uptake of
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The acid-soluble radioactivity released into the incubation medium 
is expressed as mean values. These results are from the experiments 
shown in Figure 5.3.3b, and are summarized in Table 5.3.3b.
Figure 5.3.3e Effect of Different Concentrations of Bacitracin on the
Quantity of Radioactivity that becomes Associated with
125Yolk-Sac Tissue during Uptake of I-fdBSA in Serum-
Free Medium
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Key: O — O  No Addition
▲---▲ Bacitracin (0.1 mg/ml)
^---* Bacitracin (1.0 mg/ml)
■---■ Bacitracin (5.0 mg/ml)
D---n Bacitracin (10.0 mg/ml)
The quantity of radioactivity that becomes associated with yolk-sac 
tissue (tissue-associated radioactivity, T.A.R.) is expressed as 
mean values (± S.E.M.). These results are from the experiments 
shown in Figure 5.3.3b.
Figure 5.3.3f Effect of Different Concentrations of Bacitracin on
125the Disposal Time of I-fdBSA after Uptake by Yolk 
Sacs in Serum-Free Medium
Incubation Time (h)
Key : O — O  No Addition 
A— A Bacitracin (0.1 mg/ml) 
A— A Bacitracin (1.0 mg/ml) 
■— ■ Bacitracin (5.0 mg/ml) 
□— □ Bacitracin (10.0 mg/ml)
Disposal time is calculated as (T.A.R, divided by the rate of up­
take up to a given incubation time), and it represents the mean time 
l-fdBSA is associated with the tissue before acid-soluble fragments 
are released. These results are from the experiments shown in 
Figure 5.3.3b.
Figure 5.3.3g Recovery of the Capacity to Ingest I-PVP by Yolk125
Sacs Incubated in Serum-Free Medium following Exposure 
to Different Concentrations of Bacitracin
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Key: O — O  No Addition
▲--- a Bacitracin (0.1 mg/ml)
a--- a Bacitracin (1.0 mg/ml)
■--- ■ Bacitracin (5.0 mg/ml)
□— a Bacitracin (10.0 mg/ml)
The method used was as described in Section 5.2. Briefly, the rate 
of uptake of 125i-pvP (2yg/ml) was monitored over 2.5h in the absence 
or presence of different concentrations of bacitracin in serum-free 
medium; bacitracin was added 20 min prior to this substrate. The yolk 
sacs were then washed, and reincubated in serum-free medium for a further 
2.5h in the presence of 1^5j_pyp alone. Each uptake/recovery plot 
shows mean values (± S.E.M.) from 2 to 5 separate experiments. These 
results are summarized in Table 5.3.3c.
Yolk Sacs Incubated in Serum-Free Medium following 
Exposure to Different Concentrations of Bacitracin
125Table 5.3.3c Summary of the Recovery of Uptake of I-PVP by
These data summarize the results shown in Figure 5.3.3g. Mean 
uptake rates and correlation coefficients (shown in parentheses) 
for each bacitracin concentration were calculated from the gradients of 
these plots.
Mean Uptake Rates:
Before Washing/Uptake After Washing/Recovery
Bacitracin No. of /*■------------ ------- ---- - "N / ----- ---- ^
Cone. Détermina- yl/mg y.s. As % yl/mg y.s. As %
(mg/ml) tions protein per h of Control protein per h of Control
No
Addition 5 3.69 (0.990) 100.0 3.45 (0.996) 100.0
(Control)
0.1 3 2.31 (0.997) 62.6 3.32 (0.994) 96.2
1.0 3 2.11 (0.999) 57.2 3.07 (0.989) 89.0
5.0 2 1.40 (0.995) 37.9 1.92 (0.977) 55.7
10.0 2 0.94 (0.989) 25.5 1.00 (0.992) 29.0
125Release of I-PVP from Yolk Sacs Incubated in 
Serum-Free Medium
Figure 5.3.3h Effect of High Concentrations of Bacitracin on the
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The method used was as described in Section 5.2, Each release 
plot represents the quantity of radioactivity released with time 
from yolk sacs that had previously been incubated in the presence of 
125i_pvp, Each experiment point is a mean value (± S.E.M.) from 
6 separate experiments.
125Bacitracin on the Release of I-PVP from Yolk 
Sacs Incubated in Serum-Free Medium
Table 5.3.3d Summary of the Effect of High Concentrations of
These data summarize the results shown in Figure 5.3.3h. Each rate of
release of radioactivity was calculated from the gradients of these 
plots between time points 0.8 and 2.5h. Results are expressed both 
as ng of l2i>I-PVP released and as a percentage of the radioactivity 
associated with the tissue at the start of the reincubation period.
Bacitracin Mean Total 125I-PVP Released Radioactivity
Cone. Uptake (ng/ (ng/mg y.s. Released (%/mg
(mg/ml) mg y.s. protein) protein per h) y.s. protein per
No
Addition 23.65 0.21 0.88
(Control)
5.0 12.36 0.29 2.36
10.0 7.61 0.38 3.91
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5.4 Discussion
A number of hormones are known to influence the degradation of
endogenous proteins in certain cell types iji vitro, and a collaborative
study was undertaken to investigate the effects of insulin, a known
inhibitor of the degradation of endogenous proteins in many cell types
(see Section 5.1), on both the rate of pinocytosis (data reported in
Section 5.3.1) and on the rate of endogenous protein degradation in
the rat yolk sac (unpublished data compiled by F.J. Ballard and
S.E. Knowles, reported in Table 5.4a). The effect of insulin on
the rate of fluid-phase pinocytosis in the rat yolk sac was not very
marked over the concentration range used. [There was no detectable
-11inhibition of pinocytosis up to a concentration of 10 M insulin, but 
-fi 125by 10 M the rate of uptake of I-PVP had fallen to approximately
70% of the control value in the absence of insulin^ Strangely,
125the effect of this hormone on the rate of uptake of I-fdBSA was
_8even less pronounced, with no inhibition of uptake up to 10 M
insulin, and only a slight indication of inhibition of adsorptive 
“6 •pinocytosis at 10 M insulin. A possible explanation of this effect
125was advanced in Section 5.3.1. With I-fdBSA as substrate, there 
was no evidence of accumulation of the radiolabelled-protein within 
the tissue (Figure 5.3.Id), indicating no detectable net inhibition 
of proteolysis by this agent. Likewise, the presence of insulin
•1  1 —‘f i(10 to 10 M) had no effect on the rate of degradation of the
endogenous protein of rat yolk sacs (Table 5.4a, data from F.J.B. &
S.E.K.). This lack of response to insulin is atypical of many cell
types; for example, Hopgood et al. (1980) demonstrated that hepatocyte
monolayers were sensitive to inhibition of endogenous proteolysis by
—8insulin at a concentration of 10 M, and Libby & Goldberg (1981) 
demonstrated that 10 "*M insulin could inhibit the degradation of cell
Ill
protein to 40% of the control value in cultured muscle cells from 
11-day old chick embryos.
The response of the yolk sac to the insulin agonist, glucagon,
has already been investigated (Brown & Segal, 1977; Livesey, 1978).
125The latter showed that the rate of uptake of I-PVP by rat yolk sacs
was inhibited in a dose-dependent manner by glucagon over the
—11 —6concentration range 10 to 10 M. Only slight inhibition of
uptake was detected at the lower concentrations used, but in the 
—6presence of 10 M glucagon uptake fell to only approximately 30%
of the control value. At this high concentration, the rate of uptake 
125of I-fdBSA was also inhibited, to 40% of the control value.
However, glucagon (over the same concentration range) had no effect 
on the degradation of endogenous protein (F.J.B. & S.E.K.,. unpublished 
data). This lack of response of endogenous protein degradation in 
yolk sacs to the presence of glucagon (at these concentrations) is 
again atypical of many cell types (Hopgood ejt al., 1980) . Clearly, 
only the pinocytic activity of the yolk sac is affected by these two 
hormones, and the tissue is more responsive to the presence of 
glucagon.
Antibiotics are another group of substances of which some have 
been found to influence rates of endogenous protein degradation in 
different cell types fn vitro. Probably one of the most well examined 
is cycloheximide which, in addition to acting as an inhibitor of protein 
synthesis, also inhibits proteolysis within some cell types. This 
antibiotic was chosen, along with another antibiotic protein-synthesis 
inhibitor, puromycin, to see if they influence pinocytosis and rates 
of endogenous protein degradation within the rat yolk sac. (This 
investigation too was a collaborative study with F.J.B. and S.E.K.).
Data on the rates of pinocytosis are reported in Section 5.3.2. and the
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data provided by F.J.B. and S.E.K. are to be found in Table 5.4b.
-4At a concentration of 10 M, puromycin was found to affect neither
the rate of fluid-phase pinocytosis nor the rate of adsorptive
pinocytosis in the rat yolk sac,and had no effect upon the intra-
125lysosomal degradation of I-fdBSA following its uptake by the tissue. 
However, puromycin (at the same concentration) was found to inhibit 
degradation of endogenous proteins to 80% of the control value (see 
data provided by F.J.B. and S.E.K., Table 5.4b) in yolk sacs incubated 
in Minimal Essential Medium.
In contrast to puromycin, cycloheximide was found to inhibit the 
rate of fluid-phase pinocytosis in yolk sacs to 60% of the control
-4value at a concentration of 10 M. At this concentration a similar
125degree of inhibition of the rate of uptake of I-fdBSA was observed,
the mean Endocytic Index falling to 50% of the control value. The
quantity of radioactivity associated with the tissue during the incubation
of the protein with yolk sacs, in the presence of cycloheximide, also
fell to 50% of the control value, and was constant throughout the
incubation period. These results suggest that cycloheximide
influences only the rate of pinocytosis, the normal rate-limiting
step in the digestion of exogenous proteins by the yolk sac. There
was no evidence of any inhibition of the degradative capacity of the
yolk sac by this antibiotic; this is in agreement with the observation
of Freikopf-Cassel & Kulka (1981), that cycloheximide (4x10 ^M) has
125no effect upon the rate of degradation of I-labelled BSA, introduced 
into cultured hepatoma cells by erythrocyte ghost-mediated injection.
~4However, cycloheximide (10 M) was found to inhibit the degradation 
of endogenous proteins in rat yolk sacs, both in Minimal Essential 
Medium and in Earle's Salts, to approximately 80% of the control value 
(see Table 5.4b); this is the same degree of inhibition as was found
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with 10 Si puromycin. Since cycloheximide had no effect upon the
125degradation of the pinocytosed I-fdBSA, then presumably this 
lysosomal site of proteolysis is independent from the sensitive 
endogenous-proteolytic site. Inhibition of proteolysis of endogenous 
proteins by cycloheximide has also been found in many other cell 
types, for example, Hopgood et al. (1980) with hepatocyte monolayers, 
and Amenta et al. (1978) with rat embryo fibroblasts. Examination 
of a range of concentrations of both of these antibiotics may have 
yielded more information, but the concentration chosen for this 
brief study was known to be effective in other cell types.
Both of these antibiotics, cycloheximide and puromycin, have 
consistent effects on the degradation of endogenous protein in 
virtually all cell types, and the recovery, following removal of these 
inhibitors from extracellular medium, is known to be rapid. Many 
workers (e.g. Ballard, 1977) have argued that this suggests the need 
for a short half-life protein for rapid protein degradation. The object 
of the work reported in this chapter toas to expand this proposal by 
suggesting that if the effect on endogenous protein degradation is 
mediated by a putative protein that is essential to the process of 
autophagy, then the protein may be a membrane component rather than 
some lysosomal enzyme . It is therefore likely that such a putative 
protein may also influence pinocytosis, another membrane-related 
process. Although the data collected on the effect of cycloheximide 
on pinocytosis in yolk sacs supports this suggestion, the absence of 
any effect of puromycin on pinocytosis clearly refutes this proposal. 
Presumably the effect of cycloheximide on pinocytosis in the rat yolk 
sac is independent of its role as an inhibitor of protein synthesis.
The third antibiotic examined in this study was bacitracin.
Its effects upon pinocytosis in yolk sacs are reported in detail in
114
Section 5.3.3. The concentrations used were greater than those of 
insulin and the other two antibiotics, the lowest concentration of 
bacitracin investigated being higher than the largest insulin 
concentration, and the range was extended well beyond those of both 
cycloheximide and puromycin. Bacitracin was found to inhibit the 
rate of fluid-phase pinocytosis, as determined by the rate of uptake 
of I-PVP, in a dose-dependent manner. At concentrations of up to 
1.0 mg/ml (7x10 4M) , the inhibition of uptake induced by bacitracin 
was fully reversible. [It is interesting to note that the degree of
■toe  /
inhibition of I-PVP uptake in the presence of 7x10 M bacitracin 
and 10"4M cycloheximide (both fully reversible) was 50% of the control 
value in the absence of any agent in each case.] At higher concentrations 
of bacitracin the inhibition of uptake was not fully reversible, and 
evidence of damage to the tissue was found under these conditions 
(see Figure 5.3.3h and Table 5.3.3d).
Bacitracin also inhibited the adsorptive uptake of I-fdBSA
by yolk sacs in a dose-dependent manner over the concentration range
0.1 mg/ml (7x10 ^M) to 10.0 mg/ml (7x10 ^M). The relative inhibition
of uptake of this protein,in the presence of bacitracin concentrations
in excess of 1 mg/ml, was always greater than that of I-PVP.
A possible explanation of this effect is that bacitracin is a hydro-
phobic compound and competes with the radiolabelled protein for hydro-
phobic binding sites (Livesey & Williams, 1982) on the surface of the
yolk sac (see Section 3.1). During the course of the incubation of 
125I-fdBSA in the presence of bacitracin, it was found that the 
quantity of radioactivity associated with the yolk-sac tissue increased 
with time, and that the length of time that the protein was associated 
with the tissue before being released as acid-soluble radioactive 
fragments (the disposal time) also increased with the duration of the
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incubation (Figure 5.3.3f.). This progressive accumulation of 
125I-fdBSA by the tissue with time indicates that intralysosomal 
proteolysis is being inhibited, and suggests that bacitracin can 
either inhibit the degradative capacity of the lysosomal enzymes 
so that intralysosomal digestion becomes rate-limiting or that it 
prevents pinosome-lysosome fusion. Since bacitracin is known to 
inhibit various proteolytic enzymes (Makinen, 1972) the former 
explanation seems more likely.
Since the completion of this work, another group (studying 
fibroblasts in culture) has reported on the effects of bacitracin on 
endocytosis (van Leuven & Cassiman, 1981 and van Leuven et^  al., 1981).
They found that bacitracin inhibited the receptor—mediated endocytosis
125of I-labelled o^Macroglobulin-trypsin complexes. In the presence 
of 0.1 mg/ml bacitracin endocytosis decreased to 80% of the control 
value (compared with 87 ± 5% in the yolk sac), 50% inhibition was 
achieved at a concentration of 0.25 mg/ml, and a concentration of 
1.0 mg/ml decreased the rate of uptake to 20% of the control value. 
Bacitracin at this last concentration (1.0 mg/ml) only inhibited 
pinocytosis in the yolk sac to 50% of the control value, thus 
fibroblasts appear to be more sensitive to this agent than yolk sacs.
From measuring kinetic parameters of the receptor-mediated endocytosis 
in fibroblasts, van Leuven elt al. concluded that bacitracin inhibited 
endocytosis of I-labelled o^Macroglobulin-trypsin complexes in a 
competitive fashion. They also examined the effect of this antibiotic 
on the intracellular half-life of these internalized 125I-labelled o^Macro 
globulin-trypsin complexes. Under control conditions they reported 
the half-life of the complexes as 2.1h. In the continuous presence of 
0.25 mg/ml bacitracin the intracellular half-life was 2.5-2.7h. Their 
comment on this finding was that bacitracin does not appreciably affect
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intracellular degradation of endocytosed I-labelled a^ Macroglobulin-
trypsin complexes. Grinde & Seglen (1980) also reported that bacitracin,
at a concentration of 2mM (approx. 3 mg/ml), had no significant effect
14upon the degradation of endogenous [ C]valine-labelled proteins in 
isolated hepatocytes in culture. However, the data of Ballard e_t al. 
(1980) show that, in osteogenic sarcoma cells, bacitracin at a 
concentration of 1.0 mg/ml inhibited endogenous protein degradation by 
7 %, and at a concentration of 10.0 mg/ml, inhibited degradation of 
endogenous protein by 43%. The same paper also showed that, in the 
same cell type, bacitracin (1.0 mg/ml) inhibited the rate of degradation 
of exogenous I-labelled insulin by almost 90%. The effects of 
bacitracin appear to vary somewhat according to cell type. In summary, 
the antibiotic inhibits pinocytosis in both fibroblasts and the yolk 
sac, and inhibits the degradation of endocytosed, radiolabelled proteins 
in osteogenic sarcoma cells and yolk sacs, but van Leuven ejt al. (1980) 
claim no such effect in fibroblasts. The effect of bacitracin on 
the rate of endogenous protein degradation also varies between cell 
types; Grinde & Seglen (1980) found no effect in isolated hepatocytes 
and Ballard et^  al_. (1980) found an inhibitory effect in osteogenic 
sarcoma cells.
At the beginning of this chapter, two hypotheses were proposed 
to relate the rate of pinocytosis to the rate of endogenous protein 
degradation within a tissue (see Section 5.1). One suggestion was 
that a fall in the intracellular levels of amino acids acts as a 
trigger to increase autophagy or to increase the rate of pinocytosis in 
a tissue, so that a fall in the rate of capture of exogenous protein 
may induce an increase in the rate of endogenous protein degradation; 
this suggestion was called the "nutritional hypothesis". The second 
proposal was that, since pinocytosis and autophagy are both membrane-
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related processes, any agent interfering with pinocytosis may also be 
expected to interfere with endogenous protein turnover at the stage of uptake 
into the lysosomal system, and this suggestion was called the "membrane- 
mediated hypothesis". The effects of all the agents used in this 
chapter on pinocytosis and proteolysis in the rat visceral yolk sac 
are summarized in Table 5.4c, alongside their reported effects on some 
other cell types. The effect of insulin is to suppress the rate of 
degradation of endogenous proteins in all cell types other than the rat 
yolk sac and the rat pulmonary macrophage. The effect of glucagon is 
to stimulate proteolysis in many cell types, but again this agent had 
no effect on the^degradation of either endogenous or exogenous proteins 
in the rat yolk sac. [The effects of these hormones on pinocytosis do 
not appear to have been investigated in other tissues, preventing 
comparison between the yolk sac and other tissues.] Thus the data 
from investigations with these hormones support neither hypothesis.
The effect of puromycin on the rat yolk sac again did not support 
either of the two hypotheses, and no recent data from other cell types 
could be located in the literature. The inhibitory effect of cyclo- 
heximide on the rate of degradation of endogenous proteins in hepatocyte 
monolayers and rat embryo fibroblasts was consistent with the effect 
in the yolk sac; an inhibitory effect was also observed for pinocytosis 
in the yolk sac. This possibly supports a"membrane-related" hypothesis.
The effect of bacitracin is to suppress both pinocytosis and proteolysis 
in most cell types shown in Table 5.4c, and again may be taken as an 
indication of some common control mechanism. [Unfortunately no data 
are available on the effect of this antibiotic on the rate of 
endogenous protein degradation in the rat yolk sac.]
In summary, not only does the yolk sac behave atypically compared 
with other tissues, but there is no coherent pattern of evidence to
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strongly support either the "nutritional hypothesis" or the "membrane- 
related hypothesis". Clearly more data, from many cell types, are 
needed to establish the mechanisms by which pinocytosis and autophagy 
are controlled and any possible relation between the two.
Protein Degradation in Yolk Sacs (F.J. Ballard & S.E. Knowles:
Table 5.4a Effect of Different Concentrations of Insulin on Endogenous
Unpublished Data)
The method used was as described in Section 5.2. The tissue was 
incubated in Minimal Essential Medium for a 1.5h preincubation period 
in the presence of the same concentration of insulin as was used 
during the degradation period; degradation of endogenous radiolabelled 
proteins was monitored for a total of 4h following the preincubation 
period.
Insulin
Cone.
(M)
No. of
Determinations
Mean Total Protein 
Degradation 
(%)
Mean Degradation as 
% of Control 
(%)
No addition 
(Control) 5 12.78 100
10-11 5 13.09 102
0f—l1or“4 5 13.03 102
to'9 5 12.57 98
- 10-8 5 12.72 100
r-*1O»—1 5 12.69 99
io"6 5 13.24 104
Table 5.4 b Effect of Cycloheximide and Furomycin on Endogenous Protein Degradation in Yolk Sacs (F.J. Ballard
& S.E. Knowles: Unpublished Data)
The method used was as described in Section 5.2. The tissue was incubated either in Minimal Essential Medium 
(M.E.M.) or Earle's Salts (E.S.). Sometimes a 1.5h preincubation period in the presence of the same 
concentration of agent as was used during the degradation period was incorporated into the experiment, and the 
degradation of endogenous radiolabelled proteins was monitored for a total of 2 or 4h following the optional 
preincubation period.
Agent
(10-^M)
No. of M.E.M. Pre­ Mean Total Protein Mean Degrad, as Mean Total Protein Mean Degrad, as
Determ­ or incubation Degrad, in 2h % of Control in Degrad, in 4h % of Control in
inations E.S. for 1.5h (%) 2h (%) (%) 4h (%)
Control 3 M.E.M. No — — 16.31 100
Cyclohex. 3 M.E.M. No — — 14.36 88
Control 4 M.E.M. No — — 16.03 100
Cyclohex. 3 M.E.M. No — — 12.84 70
Control 3 M.E.M. Yes — — 15.93 100
Cyclohex. 3 M.E.M. Yes — — 10.96 69
Control 4 E.S. No — — 16.69 100
Cyclohex. 4 E.S. No — — 13.59 81
Control 3 E.S. Yes - — 14.97 100
Cyclohex. 3 E.S. Yes — — 12.21 82
Control 3 M.E.M. Yes 9.78 100 - -
Cyclohex. 4 M.E.M. Yes 7.75 79 — “
Control 3 M.E.M. Yes — — 15.84 100
Cyclohex. 4 M.E.M. Yes — — 12.04 76
Control 4 M.E.M. No — — 15.12 100
Puromycin 4 M.E.M. No - - 12.41 82
Agent
Insulin
Glucagon
Puromycin
Cycloheximfde
Bacitracin
Table 5 .< c The E ffe c ts  o f  Various Agents on P in ocytosis  and P rotein  Degradation in  D ifferen t T issues
Effects Observed in Rat Visceral Yolk Sac , Effects Observed in Other Tissues
Pinocytosis Degradation of Exogenous Proteins
Degradation of 
Endogenous Proteins Pinocytosis
Degradation of 
Exogenous Proteins
Degradation of 
Endogenous Proteins
Slight suppression 
(Section 5.3.1)
No  Effect 
(Section 5.3.1)
No Effect 
(Table 5.4a) - -
Suppression of Proteolysis/Autophagy 
int-
i) Chick embryo muscle cells (Libhy
A Goldberg, 1981
ii) Rat embryo fibroblasts (Amenta A 
Brocher, 1980a)
iii) Rat hepatocyte monolayers 
(Hopgood et al., 1980) 
iv) Rat Liver (Pfeifer, 1977;
Marzella et al., I960) 
v) Normal and transformed cell lines 
(Ballard et al., 1980; Gunn et 
al., 19B0T~
No Effect in:-
1) Rabbit pulmonary macrophages 
(Woodside A Massaro, 1979)
Suppression 
(Llvescy, 1978; 
Brown A Segal, 
0977)
No Effect 
(Livesey; 1978)
No Effect 
(F.J.B. « S.E.E., 
unpublished data)
- -
Enhancement of Proteolysis/Autophagy in 
i) Rat hepatocyte monolayers 
(Hopgood et al., 1980) 
ii) Rat liver Tshetburne et al., 1973; 
Schworer A Moritmore, 1979)
No Effect 
(Section 5.3.2)
No Effect 
(Section 5.3.2)
Suppression 
(Table 5.4b)
- -
Suppression 
(Section 5.3.2)
No Effect 
(Section 5.3.2)
Suppression 
(Table 5..4b) -
Suppression of Proteolysis int- 
i) Rat embryo fibroblasts (Amenta 
et al., 1978)
ii) Rat hepatocyte monolayers 
(nopgood et al., 1980)
Suppression 
(Section 5.3.3)
Suppression 
(Section 5.3.3) -
Suppression of Tinocytosis / 
Receptor Clustering int-
i) Chinese hamster ovary cells 
(Maxfield et al., 1979}• 
Davies et~al., 1980; 
Dickson it.il., 1981) 
il) Fibroblasts (Van teuven A 
Cassiman, 1981; Van Leuven 
et al., 1981)
H i )  BALB7c3T3 cells
(Maxfield et^ al., 1979; 
Davies ft at., 1980; 
Dickson et al., 1981)
Suppression in:-
i) Osteogenic sarcoma cells 
(Ballard et al., 1980)
No Effect in:—
i) Fibroblasts (Van Leuven A 
Cassiman, 1981; Van Leuven 
ii.fi-* 1981)
Suppression of Proteolysis in:- 
i) Osteogenic sarcoma cells 
(Ballard et al., 1980)
No Effect in:-
i) Hepatocytes (Grinde A 
Seglen, 1980)
CHAPTER 6
GENERAL DISCUSSION
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General Discussion
The main aims of this project were to examine the effects of certain 
factors on the pinocytic activity of the rat visceral yolk sac in vitro and also 
to investigate their effects on the rates of uptake of proteins and on 
the rates of degradation of the proteins after pinocytic capture. The 
purpose of this discussion is firstly to emphasize the main points from 
the discussion sections of the individual chapters and then to try to 
draw some general conclusions.
The first factor examined was the influence of changes in the physical 
structure of a protein molecule on its rate of uptake by the tissue.
Although the uptake of simple proteins by the rat yolk sac has now been 
studied quite extensively [Williams £t al., 1975b; Moore et al., 1977;
Agarwal & Moore, 1979; Ibbotson & Williams, 1979; Livesey & Williams, 1979; 
Livesey & Williams, 1981; Kooistra & Williams, 1981; Kooistra et al.,
1981; Livesey & Williams, 1982], and the effects of chemical modifications 
and of size and charge differences between proteins analyzed in detail, 
little information has been gained on the influence of minor changes in 
protein structure (of the kind which may be expected to occur in vivo) 
on the rates of uptake and digestion of proteins. Four bovine pancreatic 
ribonucléase molecules were chosen for this investigation (see Chapter 3): 
ribonucléase A was chosen as it is a polypeptide chain of 124 amino acids; 
ribonucléase B is a glycosylated form of this simple protein which proffers a 
simple oligosaccharide subunit; ribonucléase S is a modified version of the 
ribonucléase A molecule resulting from cleavage by subtilisin between amino 
acid residues 20 and 21 with the two fragments remaining bound together 
non-covalently; ribonucléase S protein is the ribonucléase S molecule 
after removal of the eicosapeptide. This part of the project produced 
some questions as well as some answers. An interesting result was that 
"nicking" of a single peptide bond was found to greatly increase the rate of
120
uptake of the radiolabelled protein by the yolk sac (from comparing
the rates of uptake of ribonucleases A and S, see Section 3.3.1) which
gave support to the suggestion of Dice & Goldberg (1976) that
limited extracellular proteolytic cleavage may be a sufficient signal
to ensure the rapid removal of proteins from the circulation. This
part of the study also showed no evidence of a mannose receptor on the
yolk sac (since the rates of uptake of ribonucleases A and B were the
same, see Section 3.3.1), furthermore the presence of the simple
oligosaccharide present on ribonuclease B did not appear to mask any
binding sites on the simple protein core.
Once associated with the yolk-sac tissue, it was expected that the
radiolabelled proteins would be degraded exclusively intralysosomally.
[Livesey & Williams (1979) have already provided a strong argument for
125formaldehyde-denatured I-labelled BSA being degraded entirely
intralysosomally within the rat yolk sac, and, with the exception of
glucagon, other proteins also seem to be degraded only within lysosomes.]
However, a study of the effect of 2,4-DNP on the rate of uptake of the
radiolabelled ribonucleases (see Section 3.3.2), led to the observation
that the production of acid-soluble radioactivity following incubation
125of yolk sacs with either I-RNase S or Spr in the presence of 2,4-DNP
was greater than could be accounted for by a change in pinocytic rate
alone. The "inflated" rates of production of acid-soluble radioactivity
with these substrates were caused by proteolytic activity that was
neither initially associated with the medium nor released into the medium
from the tissue (see Section 3.3.3). A yolk-sac homogenate was found
to degrade all the radiolabelled ribonucleases with maximal activity
at pH 4-5. However, limited degradative capacity towards ribonucleases
other than ribonuclease A was present at neutral pH [this was found
125neither with formaldehyde-denatured I-labelled BSA nor with other
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125I-labelled proteins (Livesey, 1978)]. These observations are
consistent with, although not direct evidence for, proteolytic activity
being present on the surface of the yolk sac that would lead to the
125production of acid-soluble radioactivity from I-RNases S and Spr
in the absence of pinocytosis by the yolk sac. (Some suggestions
for further investigation of these observations are discussed in
125Section 3.4.) Since the degradation of I-RNases A and B in the 
presence of 2,4-DNP can be linked to the pinocytic activity of the 
tissue it is assumed that these two ribonucleases are degraded intra- 
cellularly. The presence of the oligosaccharide affords no protection 
against degradation by intracellular enzymes.
The second of the two factors which could potentially influence the 
pinocytic activity of the rat visceral yolk sac in vitro is the composition 
of the incubation medium. Some of the more complex media contain not 
only inorganic salts and glucose, but also a wide variety of other 
components such as vitamins, nucleotides, amino acids, and antibiotics.
It is no.t known which components are essential for yolk-sac survival and 
function. The addition of serum further increases the complexity of 
the incubation medium. It is important to try to gain some insight 
into how these constituents influence pinocytosis and the subsequent 
digestion of internalized proteins. In studies of such factors it is 
desirable to use a radiolabelled protein whose behaviour has previously 
been extensively studied in the yolk-sac incubation system,and whose 
site of degradation is well established. The protein substrate 
chosen for these studies was therefore formaldehyde-denatured ^^I-labelled 
BSA ( I-fdBSA).
Addition of increasing amounts of serum to the medium 199 in which 
yolk sacs were incubated led to a fall in the rates of pinocytosis (see 
Section 4.3.2); the effect of the serum on the rate of adsorptive uptake
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of I-fdBSA was proportionally greater than the effect on the rate of 
fluid-phase pinocytosis, presumably due to competition between the
I
radiolabelled protein and non-labelled serum proteins for binding sites 
on the surface of the yolk sac. Increasing the amount of serum in 
the extracellular medium also led to an accumulation of the radiolabelled 
substrate within the tissue during the course of the incubation.
Assuming that this was not a result of inhibition of pinosome-lysosome 
fusion, the increased intralysosomal half-life of I-fdBSA may again 
arise from competition, but this time between the radiolabelled substrate 
and non-labelled serum proteins for the lysosomal enzymes. An alternative 
suggestion is that, following digestion of exogenous proteins, an increase 
in the concentrations of amino acids in an intracellular pool (following 
digestion of large amounts of protein) may act as a signal to switch 
off lysosomal proteolysis, and may also be envisaged as a possible 
signal for a reduction in the pinocytic rate of the tissue. If such 
a homeostatic nutritional mechanism operates, then access to large amounts 
of protein in the extracellular medium may also reduce the need for 
degradation of endogenous proteins. This suggestion is compatible 
with observations of the behaviour of many cell types in vitro (see 
Section 4.1), and, following a collaborative study with F.J. Ballard 
and S.E. Knowles, the same may operate in the rat yolk sac (see Section 
4.4). Since serum has such a profound effect on fundamental cellular 
processes, its presence must always be noted and borne in mind when 
interpreting _in vitro data. The removal of serum enables culture 
conditions to be better defined since, being a biological product, the 
precise composition of the serum probably varies between batches derived 
from different animals. However, it is not always possible to avoid 
this complication by simply omitting serum from the culture medium 
since some cell types cannot be incubated or cultured successfully if
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serum is not present in the medium. To negate the need for the presence 
of serum in incubation media, some groups of workers have been investigating 
the possibility of replacing the serum with single proteins (e.g. serum 
albumin) or with milk. Thus, Steimer & Klagsbrun (1981) have examined the 
effects of growing certain fibroblastic cells in a medium supplemented with 
bovine milk. They found that some cell types (the non-transformed cell 
lines) did not grow at all in milk-supplemented medium, and that other 
cell types (transformed cells) survived by growing as large clusters in 
suspension instead of being attached to the culture dishes; addition of 
fibronectin was found to reverse some of these adverse effects. Sereni 
& Baserga (1981) found that, for a variety of cell lines, when supplementing 
media with milk instead of serum, in order to get a good plating efficiency 
calf serum still had to be added to a final concentration of 0.5% to the 
medium containing milk. They underline the economic advantages of 
using milk in place of serum as a culture-medium supplement, but this 
change in procedure raises the problem as to whether milk (like serum) 
affects fundamental cellular processes such as pinocytosis and protein 
degradation in vitro.
Removal of certain components from a complex medium resulted in no
change in the pinocytic capacity of the yolk-sac tissue (for a comparison
of results in Earle's Salts and Minimal Essential Medium with those in
medium 199, see Section 4.3.1). Although it is not known what precise
ingredients of these media are responsible for pinocytosis in the rat
yolk sac, it appears that the rates of uptake of the fluid-phase marker,
125I-PVP, measured in all these defined media, are compatible with the 
yolk sac exhibiting its maximum rate of pinocytosis under all these 
incubation conditions, hence not all of the low molecular weight 
ingredients of medium 199 can be absolutely essential for pinocytic 
activity.
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Since serum can influence both the degradation of exogenous and 
endogenous proteins and the rate of pinocytosis within the rat 
visceral yolk sac, other substances known to influence the degradation 
of endogenous proteins were investigated for their effects on pinocytosis 
and subsequent degradation of internalized proteins. The first group 
of substances investigated was hormones. Glucagon had previously 
been shown to have an inhibitory effect on pinocytosis in the yolk sac. 
(Brown & Segal, 1977; Livesey, 1978), but in contrast to this the 
agonist of glucagon, insulin,was found to have very little effect on 
pinocytosis in the yolk sac until relatively high concentrations were 
reached (see Section 5.3.1). These two hormones have been shown to 
have opposite and very marked effects on rates of degradation of 
endogenous proteins in many cell types in vitro (see Section 5.1), but 
the collaborative study with F.J.B. and S.E.K. showed that these two 
hormones had no effect at all on the rate of degradation of endogenous 
proteins in rat yolk sacs (see Section 5.4). The main conclusion 
reached in this part of the study was that the response of rat visceral 
yolk sac to these hormones is not representative of most cell types 
that have been studied.
The other group of substances investigated for their effects on 
pinocytosis and proteolysis in the rat yolk sac was the antibiotics.
It is important to investigate these compounds since not only do some of 
them influence the rate of degradation of endogenous proteins (see 
Section 5.1), but they are commonly added to many media to increase the 
shelf-life. The first two antibiotics examined, cycloheximide and 
puromycin, are both inhibitors of protein synthesis. From the 
collaborative study with F.J.B. and S.E.K. (see Section 5.4) it was 
found that both of these antibiotics had inhibitory effects on the 
rate of degradation of endogenous proteins. This led to the suggestion
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that if these compounds inhibit endogenous protein breakdown via an 
inhibition of autophagy, then it is possible that some short-lived protein 
is necessary for the associated membrane events to occur. If 
pinocytosis, another membrane-related process, is under the influence of 
the same control mechanism then presumably these two substances would 
have the same effect upon pinocytosis. However, only cycloheximide 
was found to have an effect on pinocytosis in the yolk sac. From these 
results it can be concluded that, in the rat yolk sac, even if autophagy 
is under the control of some short-lived protein, pinocytosis is not.
The other antibiotic used in this study was bacitracin (see Section
5.3.3). It was found to inhibit both pinocytosis and the degradation of 
125endocytosed I-fdBSA in a dose-dependent manner in the yolk sac. This 
latter finding was in agreement with data from osteogenic sarcoma cells 
(Ballard jet '£1., 1980), but contrasted with the findings in fibroblasts 
(van Leuven et al., 1981). However, bacitracin was reported to inhibit 
pinocytosis of I-labelled o^macroglobulin-trypsin complexes in 
fibroblasts (van Leuven et: 'al, 1981). [Bacitracin has also been shown 
to differ in its effects on the rate of endogenous protein degradation 
in different cell types (see Section 5.4).] In conclusion, the effects 
of the antibiotics used in this study were found to be varied, their 
effects being dependent upon the cell type under investigation.
In summary, from the data presented in this study, three simple but 
nonetheless important factors have emerged. First, a minor change 
in the structure of a protein (the cleaving of a single peptide bond) 
can be sufficient to cause rapid uptake by the yolk sac. Such a 
cleavage is possibly of the type that may occur in vivo, and if so, 
supports the suggestion of Dice & Goldberg (1976) that proteolytic 
"nicking" may be a signal for a protein to be removed from the circulation. 
Second, it appears that not all exogenous proteins are degraded entirely
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within the lysosomal system of the rat yolk sac, as had previously been
125thought [from the study of a large number of I-labelled simple proteins 
(Livesey, 1978)]. Further experimentation is required to support or 
refute this suggestion, but it does outline the need for caution when 
attempting to predict the outcome of an experiment on the basis of even 
a well-established general trend. [It is interesting to note that the 
two protein preparations that are not totally degraded within the lysosomal 
system are the ones produced by proteolytic cleavage with subtilisin. 
Possibly the preparations as marketed still contain subtilisin activity 
which contributes to the process of extralysosomal degradation. This 
possibility should not be overlooked in any future attempts to explain 
these anomalous results.]
The third and most overwhelming factor to emerge is the extent to 
which the composition of the incubation medium can influence the behaviour 
of the tissue. Many medium components frequently used in cell culture 
have very pronounced effects upon both pinocytosis and proteolysis 
within the tissue, and the manner in which each tissue may respond to 
these components is not always easy to predict.
One of the aims of this project was to try and gain evidence for 
a homeostatic control mechanism based on amino acid levels in cells, by 
looking for some coordination between the ingestion of protein from 
outside the cell with the rate of intracellular proteolysis. Serum had 
an inhibitory effect on all of these processes in the yolk sac [which 
agrees well with other cell types (see Section 4.1)],but there appeared 
to be no correlation between the influence of hormones on pinocytosis 
and on proteolysis, nor between the response of the yolk sac and the 
response of other tissues to these hormones. This raises the question 
of the physiological role (s) of the yolk sac. This membrane has long 
been considered to be important in the nutrition of the embryo before 
the full development of the placenta (Beck et al., 1967). More recently,
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Freeman ejt al. (1981) have demonstrated that proteins are taken up by 
the yolk sac at 9 days gestation, broken down to amino acids, and then 
these amino acids are taken up by the embryo and inserted into its 
own proteins. It may be that this bulk catabolic function of the 
pre-placental yolk sac is conserved following the development of the 
placenta, and is still present at 17.5 days gestation. Another 
physiological role proposed for the yolk sac is that of protection of the 
embryo, a role most likely to be functional right up to the end of 
gestation. (By sequestering and degrading such substances as maternal 
antigens and toxic agents, the yolk sac may prevent such materials from 
reaching the embryonic tissues.) Ongoing, non-regulated pinocytic and 
proteolytic capacities may therefore be essential to the efficient 
functioning of the yolk sac, and so, in contrast with other cell types, 
the yolk sac may well be deliberately non-responsive to hormonal control. 
This does not, however, preclude the tissue from being responsive to 
basic components affecting pinocytosis, such as non-physiological metabolic 
inhibitors, cytoskeletal inhibitors (Duncan & Lloyd, 1978; Duncan et al., 
1979), and the supply of protein from the extracellular environment 
(Chapter 4). Thus the yolk sac remains a valuable diagnostic tool 
for the investigation of such controlling factors in pinocytosis.
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iAPPENDIX I
Computer Program to Calculate the Uptake of a Non-Degradable Substrate
Input Data H(X) Duration of the yolk-sac incubation period (h)
I(X) Mean observed radioactivity count for 1.0 ml of 
incubation medium
K(X) Mean observed radioactivity count for 1.0 ml of 
yolk-sac solution
L(X) Total protein content of the yolk sac (mg)
0020 REM KEW 125-IPVP PROGRAM,MODIFIED NOV.,1974 
0030 DIM H (15),1(15),K(15),L(15,R(15)
0060 PRINT "NON-DIGESTIBLE PROG. ENTERED"
0070 PRINT "EXTT.N0. (DIGITS 0NLY)=";
0080 INPUT Z
0090 PRINT "BACKGROUND IN CPM=";
0100 INPUT A
0110 PRINT "COUNTING TIME FOR EACH ML OF MEDIUM, SECS=";
0120 INPUT C
0130 PRINT "COUNTING TIME FOR EACH ML OF YS SOLUTION, SECS=";
0140 INPUT D
0150 PRINT "NO. OF POINTS IN PL0T=";
0160 INPUT G
0165 PRINT "NAME OF DATA FILE:";
0167 INPUT Fl$
0170 PRINT "NAME OF REGRESSION FILE:";
0174 INPUT F2$
0176 FILES £1,F1$,£2,F2$
0180 PRINT "NAME OF RESULTS FILE:";
0184 INPUT F3$
0186 FILES £3,F3$
0190 FOR X=1 TO G
0200 INPUT £1, H(X),I(X),K(X),L(X),
0210 NEXT X
0220 FOR X=1 TO G
0230 LET M=(I(x)*60/C)-A
0240 LET Q=((K(X)*60/D)-A)*5
0250 LET N=M+Q/20
0260 LET R(X)=(Q*1000)/(N*L(X))
0265 LET A$=,2£.2£,4£.4£'
0266 LET C$=’" ",2£.2£,2£.2£>4£.4£*
0270 PRINT USING A$,£2,H(X),R(X)
0280 NEXT X 
0310 PRINT £3, " "
0320 PRINT £3, " "
0330 PRINT £3, "INCUBATION TIME (HOURS)"."PROTEIN IN YS",” UPTAKE" 
0340 PRINT £3,
0350 FOR X=1 TO G
0360 PRINT USING C$,£3,H(X),L(X),R(X)
0370 NEXT X 
0380 STOP 
0010 DIM C$30
I X
APPENDIX II
Computer Program to Calculate the Uptake óf a Degradable Substrate
Input Data: H(X) Duration of the yolk-sac incubation period (h)
I(X) Mean observed radioactivity count for 1.0 ml of 
incubation medium
J(X) Mean observed acid-soluble radioactivity count 
for 1.0 ml of incubation medium
K(X) Mean observed radioactivity count for 1.0 ml of 
yolk-sac solution
L(X) Total protein content of the yolk sac (mg)
0020 REM PROTEIN PROGRAM .REVISED OUTPUT ,N0V. 1974
0030 DIM E(12),H(12),I(12),J(12),K(12),L(12),S(12)
0040 DIM C$30
0060 PRINT "PROTEIN PROGRAM ENTERED"
0070 PRINT "EXPT. NO. (DIGITS ONLY)*";
0080 INPUT V
0090 PRINT "BACKGROUND IN CPM=";
0100 INPUT A
0110 PRINT "PERCENT SOLUBLES IN PREP*";
0120 INPUT B
0130 PRINT "COUNTING TIME MEDIUM TOTALS,SECS=";
0140 INPUT C
0150 PRINT "COUNTING TIME MEDIUM SOLUBLES,SECS=";
0160 INPUT Z
0170 PRINT "YS COUNTING TIME,SECS=";
0180 INPUT D
0190 PRINT "CORRECTION FACTOR FOR MEDIUM TOTALS*";
0200 INPUT Y
0210 PRINT "CORRECTION FACTOR FOR MEDIUM SOLUBLES*"
0220 INPUT R
0230 PRINT "NO. OF POINTS IN PLOT*";
0240 INPUT G
0264 PRINT "NAME OF DATA FILE:";
0265 INPUT Fl$
0266 PRINT "NAME OF REGRESSION FILE:";
0267 INPUT F2$
0269 FILES £1,F1$,£2,F2$
0270 PRINT "NAME OF RESULTS FILE:";
0272 INPUT F3$
0275 FILES £3,F3$
0277 FOR X*1 TO G
0280 INPUT £1, H(X),I(X),J(X),K(X),L(X),
0290 NEXT X
0300 FOR X*1 TO G
0310 LET M= (I(X)*60/C-A)*Y
0320 LET N*(J(X)*60/Z-A)*R
0330 LET 0=N-(M*B/100)
0340 LET CH(K(X)*60/D)-4*5
0350 LET P“ (M-N)+0/2
cont • * • •
I l l
0360 LET F=((10*0)+Q)*1000 
0370 LET E(X)=(Q*1000)/(L(X)*P)
0380 LET S(X)=F/(L(X)*P)
0385 LET A$=,2£.2£,4£.4£'
0387 LET C$=,4£.4£,4£.4£,4£.3£,4£.3£’
0390 PRINT USING A$,£2,H(X),S(X)
0400 NEXT X 
0430 PRINT £3, " "
0440 PRINT £3, " "
0450 PRINT £3, " INCUBATION ","PROTEIN","MICROLITRES"," 
0460 PRINT £3, "TIME (HOURS)"," IN YS "," PER MG YS " 
0470 FOR X=1 TO G
0480 PRINT USING C$,£3,H(X),L(X),E(X),S(X)
0490 NEXT X 
0500 STOP
UPTAKE"
iv
Computer Program to Calculate the Release of Radiolabelied Substrates 
from Yölk Sacs
APPENDIX III
This program is designed to calculate the release of both non- 
degradable and degradable radioiodinated substrates from yolk sacs when 
reincubated in substrate-free medium, after being initially incubated 
in substrate-containing medium. The release is expressed in two forms: 
as the percentage of the amount of substrate associated with the tissue 
at the beginning of the reincubation period which is released per h per 
mg yolk-sac protein, and as ng of material released per h per mg
yolk-sac protein.
Input data: P(X) Serial number of sample
Q(X) Duration of the reincubation period of yolk 
sacs (h)
R(X) Mean observed radioactivity (total uncorrected 
count in time stated) in 1.0 ml of reincubation 
medium.
S(X) Mean observed acid-soluble radioactivity (total 
uncorrected count in time stated) in 1.0 ml
of reincubation medium.
0010 REM EX0CYT0SIS PROGRAMME, DECEMBER 1980 
0020 DIM P(20),Q(20),R(20),S(20),T(20),U(20),W(20) 
0030 DIM A(20),B(20),C(20)
0040% "EX0CYT0SIS PROGRAMME ENTERED"
0050 % "EXPERIMENT NUMBER «
0060 INPUT VI$
0070 % "BACKGROUND IN CPM 
0080 INPUT D
0090 % "TOTAL VOLUME OF UPTAKE MEDIUM, ML = ";
0100 INPUT B1
0104 % "TOTAL VOLUME OF RELEASE MEDIUM, ML
0106 INPUT B2
0110 % "NUMBER OF SAMPLES AT EACH TIME
0120 INPUT K
0130 % "NUMBER OF TIMES SAMPLES WERE TAKEN
0140 INPUT E
0150 % "MG SUBSTRATE/ML UPTAKE MEDIUM =";
0160 INPUT Q1
0170 % "MEAN CPM PER ML UPTAKE MEDIUM
0180 INPUT L2
0190 % "CORRECT CPM IN 5ML Y.S. SOLUTION
0200 INPUT A
V0210 
0220 
0230 
0240 
0250 
0260 
0270 
0280 
0290 
0300 
0310 
0320 
0330 
0340 
0350 
0360 
0370 
0380 
0390 
0400 
0410 
0420 
0430 
0440 
0450 
0460 
0470 
0480 
0490 
0500 
0510 
0520 • 
0530 
0540 
0550 
0560 
0570 
0580 
0582 
0584 
0586 
0590 
0600 
0610 
0620 
0625
0630
0631
0632
0634
0635 
0643
0645
0646 
0650 
0655 
0660 
0670
% "MG OF Y.S.PROTEIN =";
INPUT Y 
FOR 1=1 TO 2 
% "DATA FOR ";
.IF 1=2 THEN 280 
% "TOTALS"
GOTO 290 
% "SOLUBLES"
% "COUNTING TIME»SECS=";
INPUT C(I)
% "CORRECTION FACTOR =";
INPUT M(I)
NEXT I
% "NAME OF DATA FILE =";
INPUT Fl$
% "NAME OF RESULTS FILE =";
INPUT F2$
FILES £1,F1$,£2,F2$
J=0
L=0
FOR X=1 TO E
INPUT £1,P(X) , Q(X),R(X), S(X)
NEXT X 
FOR X=1 TO E
F=((R(X)*60.0/C(1))-D)*M(1)
J=J+F*K
REM J IS COUNTS SO FAR REMOVED
t (x )=j+<s:b2-k )*f )
REM T(X) IS TOTAL COUNTS SO FAR EXOCYTOSED 
G=((S(X)*60.0/C(2))-D)*M(2)
L=L+G*K
REM L IS SOLUBLES SO FAR REMOVED 
U(X)=L+((B2-K)*G)
REM U(X) IS TOTAL SOLUBLES SO FAR EXOCYTOSED
NEXT X
V=T(E)+A
REM V IS TOTAL ACTIVITY TAKEN UP 
FOR X=1 TO E
A(X)=1000*T(X)*B1*Q1/((L2*B1+V)*Y)
B(X)=1000*U(X)*B1*Q1/((L2*B1+V)*Y)
C(X)=A(X)-B(X)
T(X)=100*T(X)/V 
U(X)=100*U(X)/V 
REM CONVERTED TO PERCENTAGES 
W(X)=100*U(X)/T(X)
M4=100*V/(B1*L2+V)
NEXT X 
GOTO 930 
% £2,
% £2
% £2,’"THIS IS EXOCYTOSIS EXPT CODED ";V1$ 
M5=Q1*B1*V/((B1*L2+V)*Y)
% £2,"EFFICIENCY OF UPTAKE =";M4;"%" '
% £2,"TOTAL UPTAKE PER MG PROTEIN (MG) =" ;M5 % £2
% £2*"AND NOW FOR THE JUICY BITS ..."
% £2,
% £2,"SERIAL NO","TIME","% ACTIVITY SOLUBLES"
vi
0680 % £2,"OF SAMPLE", "(HOURS)","EXOCYTOSED","SO FAR"
0690 X £2,
0700 % £2,
0710 FOR X=1 TO E
0720 % £2,P(X),Q(X),T(X),W(X)
0730 NEXT X 
0740 X £2,
0750 % £2,
0760 % £2,
0765 % £2,"MICROGRAMS","MICROGRAMS","MICROGRAMS"
0770 % £2, "PROTEIN ","SOLUBLES","INSOLUBLES"
0780 % £2,"EXOCYTOSED","EXOCYTOSED","EXOCYTOSED"
0790 % £2,"PER MG YS","PER MG YS","PER MG YS"
0800 % £2,
0805 FOR X=1 TO E 
0810 % £2,A(X),B(X),C(X)
0820 NEXT X
0825 IF P3=2 THEN 900
0826 % £2,
0826 % £2,
0830 % £2,"YS INSOLUBLES =";Z1;"MICR0GRAMS/MG"
0835 % £2,"YS SOLUBLES =";Y9;"MICROGRAMS/MG"
0840 Z2=Y9+B(E)
0845 Z3=Z1+C(E)
0850 Z4=100*Z2/(Z2+23)
0855 % £2,
0860 % £2,"TOTAL SOLS PRODUCTION = ";Z2;"MICROGRAMS PER MG"
0865 % £2"T0TAL INSOLS PRODUCTION - ";Z3;"MICROGRAMS PER MG"
0870 % £2,"THIS IS ";Z4;"% SOLUBLES"
0900 STOP
0930 % "DO YOU HAVE DATA FOR YS SOLS (IFOR Y,2 FOR N)"
0935 INPUT P3
0940 IF P3=2 THEN 632
0945 %"INPUT CORRECT SOLS CPM IN WHOLE YS"
0950 INPUT Y4
0955 Y9=1000*Y4*B1*Q1/(Y*(B1*L2+V))
0960 Z1=(1000*A*B1*Q1/(Y*(B1*L2+V)))-Y9
0965 GOTO 632
